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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Surgery for Morbid Obesity —
Where Are We Going?
Surgery for morbid obesity is pre
dicated on the fact that obesity is a
life-threatening condition for which
there is no successful nonoperative
treatment. Over the past two decades,
we have gone from jejunocolic to sev
eral modifications of jejunoileal by
pass, to gastric bypass and finally, to
at least a dozen variations of gastric
partitioning (gastroplasty) procedures.
In this issue of the Journal (page
283), Deitel and colleagues review
their experience with intestinal by
pass and gastric partitioning. Over a
9-year period, 174 patients were oper
ated on. Initially, jejunoileal bypass
was used exclusively (64 patients) and
thus the authors have longer follow-up
data for this group. An average weight
loss of 35% is certainly acceptable,
particularly because weight regain
ing did not occur. However, we
do not know how many of the 64
individuals had this acceptable weight
loss.
The authors are apparently fas
tidious in their follow-up because they
were not bothered by the multitude
of well-known metabolic complica
tions associated with this procedure.
Apparently, regular clinic visits kept
the problems to a minimum. One by
pass had to be reversed and two re
vised. The implication is that the
other 61 patients are well and being
followed. However, this is not specif
ically stated and one wonders if the
authors really have perfect (100%)
follow-up. If this is not the case, the
paucity of metabolic complications
and low incidence of reversal cannot
be properly assessed. Similarly, the
authors use expressions such as
“some” and “generally” in discussing
serial liver biopsies. Not one patient
had serious liver disease. While it is
known that fatty infiltration improves
with time after jejunoileal bypass,
particularly if protein is administered,
more precise data would have been
VOLUME 25, NO. 3, M A Y 1982
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appropriate. The authors were ap
parently able to control diarrhea —
the greatest problem after jejunoileal
bypass. They stated that diarrhea
after 1 year was not a problem and
that it was easily controlled with
medical treatment. This conflicts
sharply with the world literature,
which shows progressive, intractable
diarrhea in up to 45% of the patients
in the early postoperative period,
persisting after 1 year in nearly 20%
of patients and being the main cause
for reversal of the bypass.
Gastric partitioning was performed
in 110 patients. The authors used the
simple technique of Pace and col
leagues to solve a real surgical dilem
ma. Gastric bypass was a time-con
suming, dangerous technique whereas
removal of three or four staples from
a TA90 stapler produced a simple
gastroplasty that could be performed
by anyone. Many surgeons jumped on
to the bandwagon and used this opera
tion, only to obtain similarly dismal
results when patients were followed
up for 1 year or longer. Deitel and
colleagues operated on 56 patients
before realizing that weight loss with
this technique was inadequate. One
wonders if they could have operated
on a smaller number of patients and
followed them up before undertaking
such a large number.
Subsequently, 54 patients had re
inforcement of the 12-mm stoma with
a “nonexpanding” imbricating suture.
Our experience and that of others
clearly indicates that a running, sero
muscular suture around the gastrogastrostomy does not guarantee per
fect results. Although there was a
mean 31% weight loss at 1 year, only
five patients were followed up for
more than 12 months. We predict that
with a longer follow-up Deitel and his
colleagues will see more patients with
dilated stomas and inadequate weight
loss or weight gain.

There are four causes for inade
quate weight loss: three are technical
— stomal dilatation, pouch dilatation
and staple-line disruption; the other is
patient compliance — one cannot
assume that the mere placement of
two rows of staples across the stom
ach will cure a lifetime addiction to
food! Each of the technical problems
can occur at the time of operation or
subsequently, when they are generally
related to poor patient compliance.
Admittedly, stomal dilatation is the
single greatest problem because most
surgeons doing this operation are
careful to make a small pouch and
to apply the stapling instrument twice
rather than once. However, reinforc
ing sutures are not the final solution.
Despite initial problems with Marlex
wrapped around the stoma, more sur
geons are returning to this technique
because of the persistent and trouble
some problem of stomal dilatation.
Incidentally, most deaths have been
related to aggressive attempts to nar
row the stoma because such attempts,
with or without Marlex, devascularize
the stomach and lead to leaks. In this
regard, the paucity of serious com
plications and absence of deaths in
Deitel’s series is commendable.
Deitel and colleagues reoperated on
five patients, again without serious
mishap, although note should be
made, in passing, that the mortality
for gastroplasty revisions is nearly
4% . As stated, dilatation of the stoma
is the commonest cause of inadequate
weight loss or weight regain. If a
properly constructed, nonobstructing
stoma can enlarge, is it not reasonable
to presume that one which is too
small will also distend with time? A
feeding jejunostomy, routinely in
serted during gastric partitioning, per
mits one to wait for 6 months or even
longer in patients with stomal obstruc
tion and avoids the necessity for early
reoperation. Such patients go home
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feeding themselves through the jejunostomy. When they remain in hos
pital, the temptation to tackle the
problem surgically is too great even
for the most conservative surgeon.
Bariatric surgical data should al
ways include absolute failure rates
rather than average weight lost. For
example, if two patients, each weigh
ing 140 kg, had gastroplasties and one
lost 50% (70 kg) while the other lost
only 10% (14 kg), the average per
centage lost would be 30% with a
failure rate of 50% ! Similarly, data
should be presented as a percentage
o f weight lost (or, alternatively, as a
percentage of excess weight lost) and
not as kilograms lost. Using the pre
ceding example, the average weight
loss was 70 + 14 -f- 2 = 42 kg
but with a 50% failure rate. Kilo
grams lost are even more misleading
when patients weighing over 140 kg
(who tend to have, but do not necessar
ily sustain, huge weight losses in the
early postoperative months) are com
pared with less obese patients weigh
ing between 90 and 140 kg. Each re
port should list the number o f patients
with inadequate results, with failures

defined as those patients who have
lost less than 15% o f their initial
weight, at a minimum follow-up o f
24 months, with patients lost to fol
low-up being included as failures.
Adequate follow-up is essential. Many
patients who lose much weight ini
tially, fail to correct the poor eating
habits that led to the operation and
hence will regain lost weight if not
seen monthly for dietary and exercise
counselling.
Taking Deitel’s gastroplasty group
as a whole, one can illustrate the im
portance o f looking critically at data.
They did 110 gastroplasties over an
unstated period o f time. The first 56
patients were all failures because
weight loss was inadequate and the
procedure was abandoned. In the sec
ond group of 54 patients, only 5 were
followed up for more than 1 year and
the percentage o f patients lost to fol
low-up is not given. Our data show
a minimum technical failure rate of
20% at 24 months — it is higher if
one includes patients who refuse to
return for follow-up or those who re
quire revision for inadequate weight
loss. So, at least 11 patients (20%

o f 54) from Deitel's second group o f
patients will likely be failures in addi
tion to all 56 patients from the first
group. This adds up to 67 failures out
o f 110 for a m in im u m failure rate of
61% at 1 year.
On a more positive note, one must
appreciate that certain modifications
are necessary during the temporal de
velopment o f surgical procedures.
With time, we may come closer to
perfection with gastric partitioning.
Also, the success of nonoperative
treatment for morbid obesity is less
than 5% . Hence, even a failure rate
o f 60% in a surgical series still leaves
40% o f patients operated on with
adequate weight loss — an eightfold
improvement over conservative ther
apy.
J o e l B. F r e e m a n , m d , f r c s [c ], facs
H ea th er B u r c h e t t , rn
Division of general surgery,
University of Ottawa,
Ottawa General Hospital,
Ottawa, Ont.
Editors’ note.— The response of Deitel
and colleagues to this editorial appears
in the Correspondence section of this
issue (page 348).

Alkaline Reflux Gastritis
In this issue (page 337) Tasse and col
leagues describe the collective experi
ence o f the Hopital St-Luc, Montreal,
in the operative management o f pa
tients putatively afflicted with the
elusive (perhaps illusory) syndrome of
alkaline reflux gastritis.
In one respect, this report is un
usual because more than one third
of the patients subjected to remedial
operation had not undergone an ear
lier procedure involving the creation
of a gastroenteric stoma. Indeed, in
three, no previous intra-abdominal
surgery o f any sort had been per
formed. Under these circumstances,
the diagnosis appears to have been
established by the histologic dem
onstration of a “ primary (as opposed
to a secondary) reflux gastritis” •—
a distinction of which I was previously
unaware — associated with the pres
ence o f typical symptoms, typical en
doscopic findings and, presumably,
the absence o f other demonstrable
abnormalities o f the upper gastrointes
tinal tract or biliary tree.
In most respects, however, this re
248

port gives one a sense o f deja vu be
cause it echoes the findings o f so
many o f the earlier surgical series
addressing the syndrome: for select
ing patients for operation, a heavy
reliance is placed on the presence or
absence o f typical symptoms and of
those endoscopic and histologic in
dices supposedly specific for reflux:
there is no quantitative assessment
o f reflux volume or composition per
se; near universal failure of a variety
o f nonoperative treatment regimens
is followed by near-universal success
on short-term follow-up when upper
intestinal content is shunted away, at
least in theory, from the gastric mucus
membrane by creating a Roux-en-Y
limb. Indeed, the superlative results
described in the present study, when
added to those o f earlier surgical re
ports, make it extremely tempting
to declare an unequivocal Q.E.D. for
the syndrome under consideration.
This would be a mistake. In the
first instance, for reasons that are not
entirely clear, these results contrast
sharply with those reported in two
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recent series, equally carefully anal
ysed. In one, patient selection was just
as rigorous, yet the outcome was very
different: only two thirds of patients
subjected to remedial operation had
complete or even partial relief of
symptoms. Furthermore, when symp
tomatic, endoscopic or histologic
predictors o f success or failure were
sought, few could be reliably iden
tified on a statistical basis. Outcome
seemed almost random in this regard.
In the second study,2 even less salutory results were reported: only 47%
o f patients achieved a satisfactory
result from diversion. Patients with
delayed gastric emptying preoperatively fared especially poorly, un
doubtedly because a Roux-en-Y limb
itself can cause marked and trouble
some delays in gastric emptying.3 It
is o f interest that 5 (22% ) of the 23
patients in Tasse’s series demonstrated
gastric stasis postoperatively, although
none required further operation.
Most importantly, the objective in
dices that Tasse and associates accept
as being specific to the syndrome may
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not be as specific as many have
claimed.4 The typical endoscopic find
ings of mucosal edema and erythema
almost invariably disappear following
diversion, but, as noted, patients do
not invariably improve. In those who
do, the histologic features of the re
sidual gastric pouch have been re
ported to revert towards normal,5 to
remain the same5 or to worsen,7 de
pending upon the histologic criteria
used. The capacity of the residual
gastric pouch to secrete hydrochloric
acid, bile staining of the mucosa, even
the demonstration of enterogastric
reflux during endoscopy, all have been
shown to be inaccurate predictors of
outcome. Given these ambiguities and
discrepancies, it is not surprising that
some have questioned the very exist
ence of the syndrome.8
In my opinion, the clinical diagnosis
of alkaline reflux gastritis will be
rendered scientifically acceptable and,
therefore, clinically useful only after
four general conditions have been
satisfied. First, a wider appreciation
must be gained of which symptoms
can reasonably be ascribed to excessive
enterogastric reflux. Tasse and col
leagues may have hit upon them:
the simultaneous complaints of mild
burning epigastric pain associated
with bilious vomiting. These are the
only symptoms that are regularly in
duced when endogenous upper in
testinal content from typically symp
tomatic patients is instilled into their
residual stomachs'9 or are predictably
relieved when reflux has been quan
titatively eliminated by operation.5,7
Second, the existence of a specific
clinical syndrome based on the rela
tion between symptoms and excessive
reflux must be rigorously established,
by demonstrating that the syndrome
always occurs in the presence of
excessive reflux, never occurs in the
absence of excessive reflux, is elimi
nated by eliminating excessive reflux
and is induced by inducing excessive
reflux. None of the major clinical
series purporting to assess the syn
drome even begin to address these
conditions because not one has studied
a simultaneous cohort of asymptomat
ic patients.
Third, the precise etiologic factors
in upper intestinal content that are
responsible for inducing symptoms
(if, indeed, symptoms and reflux are
related) must be clearly identified.
As Tasse and colleagues indicate,
several reasonable candidates are
available although none can be im
plicated with certainty at present.
Finally, and most importantly, ob
jective and discriminative diagnostic
VOLUME 25, NO. 3, M A Y 1982
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maneuvers must be developed to dis
tinguish reliably those patients who
have the syndrome from those who
do not. Promising approaches are the
use of provocative testing with either
concentrated sodium hydroxide10 or
autologous intestinal content,0 the
measurement of intragastric bile-acid
concentration5 and the direct assess
ment of reflux volume by gamma
scintigraphy following the injection of
hydroxyiminodiacetic acid (HIDA)
labelled with technetium-99m.u Be
cause methodologies for these last
two tests are well described and they
can be done at most major hospital
centres, I believe no patient should be
subjected to remedial operation until
an objective assessment of reflux
volume is obtained by one or both of
these modalities.
Until these conditions are satisfied,
the syndrome of alkaline reflux gas
tritis cannot be considered a proven
clinical entity and the prudent surgeon
should approach remedial therapy,
particularly in the absence of previ
ous gastric surgery, with considerable
circumspection.
W a lla ce P . R it c h ie ,

jr

.,

m d, ph

d

Professor of surgery,
University of Virginia,
Charlottesville, Va. 22908
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Enteral nutrition begins in the
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Vivonex Jejunostomy Kit
All you need to perform a
needle-catheter jejunostomy in one
complete, economical kit.
Each kit contains:
- hinged easy access tray
- 90 cm (36”) 5 Fr radiopaque polyurethane catheter
- 100 cm ‘soft tip’, stainless steel, flexible guidewire
- No. 14 gauge, thin-wall, non-coring needles (2)
- No. 20 gauge, needle cannula with female adapter hub
- catheter/adapter sleeve for nonshearing, leak- and
kink-proof connection
- specially designed anchoring catheter retainer to
prevent accidental dislodgement
- instruction sheet

______

REVIEW ARTICLE

Carcinoma of the Sigmoid: a Complication
of Ureterosigmoidostomy
J u l e s C h a rro n , m d , f r c s [c ]* and R e je a n D e l is l e , MDf

The case of a 58-year-old man who
had carcinomatous change in the
sigmoid colon many years after
ureterosigmoidostomy prompted the
authors to review the French and
English literature on the subject. They
found 47 cases in addition to their
own, and noted a dramatic increase
in the last 10 years, even though
ureterosigmoidostomy is now seldom
used. The latency of this complication
makes it pertinent today.
In the hope of determining the
etiology of the complication, the
authors studied the relation between
the initial lesion for which the
diversion was carried out and the
nature of the colonic tumour that
ensued, and have attempted to draw
some conclusions. None of the current
theories of pathogenesis seem
satisfactory.
By underlining the early clinical
manifestations, the authors attempt to
promote earlier diagnosis and better
chances of survival for patients with
carcinoma of the colon after
ureterosigmoidostomy.

note une augmentation spectaculaire
au cours des 10 dernieres annees,
en depit du fait que I’uretero-sigmoidostomie soit rarement utilisee. La
periode de latence de cette complication
en fait actuellement un sujet fort
pertinent.
Dans I’espoir de determiner
I’etiologie de cette complication,
les auteurs ont etudie le rapport
pouvant exister entre la lesion initiale
pour laquelle la derivation fut pratiquee
et la nature de la tumeur colique qui
a suivi, et ils ont tente d’en tirer
des conclusions. Aucune des theories
actuelles sur la pathogenese de
cette atteinte ne semble
satisfaisante.
Soulignant les manifestations
cliniques precoces, les auteurs
essaient de favoriser un diagnostic
plus hatif et d'ameliorer les chances
de survie des patients atteints d’un
cancer du colon apres une
uretero-sigmoi'dostomie.

found an apparent increase in the
incidence of carcinomatous change.
Although the earliest case reported
was by Hammer3 in 1929, half of the
48 cases reported to date were found
in the last 10 years (Table I). The
incidence of this complication is im
possible to determine and is obviously
low, but we have been struck by the
apparent delay in making the diag
nosis, betraying a lack of awareness
of the complication.
The mechanism by which ureterosig
moidostomy may cause carcinoma of
the colon is presumptive and cannot
be proven, even on a statistical basis,
because of the paucity of cases. But
the tendency of these lesions to devel
op near the anastomotic site and the
occasional transitional cell carcinoma
is strongly suggestive of a carcino
genic role of ureterosigmoidostomy.
Although the ileal conduit is now
preferred as a means of urinary
diversion, the latency of carcinoma
resulting from ureterosigmoidostomy
makes this complication a matter of
current interest, since patients oper
ated on more than 20 years ago may
only now be vulnerable.
In an attempt to define the various
facets of this complication, we re
port a recent case and analyse those

From the department of surgery,
Hopital Notre-Dame, Universite de
Montreal, Montreal, PQ
*Attending urologist, associate professor
of surgery (urology); t senior resident,
Hdpital Notre-Dame, Universite de
Montreal
Accepted for publication Dec. 10, 1981
Reprint requests to: Dr. J. Charron,
Ste. 601, 1851 Sherbrooke St. E,
Montreal, PQ H2K 4L5

Because the bowel wall adjusts read
ily to the constant presence of urine,
bowel has been used extensively as a
means of urinary diversion.1,2 It has
been used as a bladder and ureter
substitute for almost a century and is
the only tissue capable of transport
ing and storing urine with a mini
mum of complications.
Transplanting the ureters into the
sigmoid colon is perhaps the oldest
technique of closed urinary diversion.
Its complications are well known
and their prevention and man
agement are well defined. However,
the sigmoid mucosa, after a long
period, becomes vulnerable to carci
nomatous change. We recently treated
a patient with carcinoma of the sig
moid colon after ureterosigmoidos
tomy and this prompted us to review
the literature on the subject. We
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L’apparition chez un homme de 58
ans de changements carcinomateux
dans le colon sigmoi'de, plusieurs
annees apres une uretero-sigmoidostomie a incite les auteurs a fouiller
la documentation medication francaise
et anglaise sur le sujet. ils y ont
decouvert 47 cas additionnels et ont
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T a b le
1— In c id e n c e
of
C a r c in o m a t o u s
C h a n g e in t h e S ig m o id a fte r U r e t e r o s ig 
m o id o sto m y

P e r io d

N o. o f
c a s e s re p o rte d

1910-1930
1930-1940
1940-1950
195 0-1 960
196 0-1 970
197 0-1 980

1
0
2
3
18
23

T o tal

47
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reported in the French and English
literature.
Case Report

A 58-year-old white man had a his
tory of chronic pain in the left flank
and renal insufficiency from progressive
hydronephrosis. He had refused opera
tion for his bladder exstrophy until, at
38 years of age, he accepted an “in
ternal” urinary diversion. A bilateral
ureterosigmoidostomy was carried out
using a Coffey I technique. Pyelonephritic changes were already present
bilaterally and a small caliceal stone
was identified on the left side. The
blood urea nitrogen value was 49 mg/dl
(17.5 urea, mmol/1).
Renal stones eventually developed
bilaterally; a right pyelolithotomy and

FIG. 1—Intravenous pyelogram show
ing dilatation of left collecting system
and distribution of contrast medium in
left colon and sigmoid.

a left nephrolithotomy had to be done.
At the age of 45 years he was again
admitted to hospital because of colicky
abdominal pain and vomiting, compati
ble with partial occlusion of the intestine.
The blood urea nitrogen level was 42
mg/dl (15.0 urea, mmol/1) and there
was mild acidosis.
Roentgenography after a barium
enema revealed a mass, 4 cm in great
est dimension, in the lumen of the
sigmoid, possibly at the level of the
ureterosigmoid anastomosis. However,
there were no signs of obstruction on
the intravenous pyelogram,
which
showed good excretion of dye on both
sides. Pyelonephritic changes had pro
gressed slightly. The acute episode of
occlusion subsided and the patient was
discharged without further investigation.
He was seen at irregular intervals for
the following 12 years, when he com
plained again of abdominal pain. An
intravenous pyelogram showed severe
obstruction at the left ureterosigmoid
anastomosis, demonstrated only by a
drip infusion of dye (Fig. 1). The blood
urea nitrogen level was 47 mg/dl (16.8
urea, mmol/1), creatinine 1.8 mg/dl
(159 ,umol/l) and hemoglobin 10.2 g/dl.
The patient again refused surgical treat
ment. He was discharged and was not
seen again until the present admission 1
year later.
He complained of persistent pain in
the left flank, anorexia and weakness.
Laboratory findings were as follows:
serum creatinine 2.5 mg/dl (221 u.mol/1),
chloride HO mmol/1 and carbon dioxide
13.2 mmol/1, blood urea nitrogen 48
mg/dl (17.1 urea, mmol/1) and hemoglo
bin 10.1 g/dl. Intravenous pyelography by
drip infusion showed progression of the
pyelonephritic changes of the right kidney
and an almost inactive left kidney.
The patient finally accepted operation
in the hope that his pain would be
alleviated. A double-barrelled cutaneous
ureterostomy was chosen because the
difficult personality of the patient made
it imperative to do a diversion that was
most likely to reduce the obstruction
and necessitate the least postoperative
care. Because the ureters were wide and

FIG. 2—Moderately differentiated adenocarcinoma originat
ing from colonic mucosa. Area of submucosal scarring suggests
site of ureteric anastomosis (hematoxylin-phloxine-saffron stain,
reduced by 49% from X 25).
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tortuous from chronic distension, we
thought that a bowel conduit might not
relieve the obstruction adequately, and
the patient would not accept a second
procedure.
At operation the ureterosigmoid
anastomoses were identified with sur
prising ease. The left anastomosis was
very firm on palpation and suggested
the presence of an impacted stone. The
right anastomosis appeared soft and
supple. The left anastomosis was widely
resected, including a 3-cm segment of
ureter and a large segment of sigmoid.
A similar procedure was carried out on
the right side.
The left ureter was brought out through
a tunnel under the parietal peritoneum
and the right ureter was brought out
alongside the sigmoid mesentery; the
possibility of volvulus was diminished by
tenting a long segment of posterior peri
toneum to the abdominal wall around the
ureter.
A frozen section of the excised speci
men from the left side showed a fibrotic
and chronically inflamed lesion; there
was no neoplasm. However, the perma
nent microscopic section revealed a
moderately differentiated adenocarcinoma
of the sigmoid colon, with superficial
muscular invasion. This confirmed our
earlier suspicion of a neoplasm (Figs.
2 and 3).
The patient refused more extensive
bowel surgery. The findings on roent
genography after a barium enema and
proctoscopy were normal. Kidney func
tion was improved and the patient
adapted remarkably well to the cutane
ous ureterostomy.
Discussion

In the English and French litera
ture we found, in addition to our own
case, 47 cases of carcinoma of the
colon in patients who had undergone
a bilateral ureterosigmoidostomy for
urinary diversion. Although the ana
stomotic technique may have varied,
in no instance was an isolated segment
of bowel used initially, thus permitting

FIG. 3— Invasion of muscle layers of colon by adenocarci
noma (hematoxylin-phloxine-saffron stain, reduced by 49%
from X 250).
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free contact of urine with normal in
testinal contents.
The cases could be divided into
four groups:
• Thirty patients who underwent
diversion for a benign condition (e.g.,
exstrophy of the bladder, urinary in
continence, trauma) and subsequently
had carcinoma (Table II3'“ ).
• Ten patients who underwent
diversion for a benign condition and
subsequently had an adenoma (Table
J J J 4 , 1 0 , 1 4 ,1 7 , 2 4 ,2 6 - 2 8 )

• Six patients who had diversion
for a primary malignant condition and
then had carcinoma (Table iv9'29'32).
• Two patients who had diversion
for a primary malignant condition
and who later had an adenoma (Table

^ 33,34^

A male predominance of 2 to 1 in
the benign group is in keeping with
a much higher incidence of exstrophy
of the bladder in men, as is the some
what similar sex ratio in the group
with malignant disease, where carci

noma of the bladder is much more
common in men.
The age of the patients at the time
of the initial operation is irrelevant
and did not seem to influence the
length of the latent period. However,
it is important to note that this period
varied from 10 to 46 years if the
initial lesion was benign, but was
much shorter, a few months to 9
years, if the initial lesion was malig
nant. This could be explained by the
fact that patients with cancer are

Table II—Carcinoma of the Sigmoid Arising at or near Site of Bilateral
Ureterosigmoidostomy for a Benign Condition

Clinical indication

Sex

Age at
operation,
yr

Bladder exstrophy
Bladder exstrophy
Urinary incontinence
Bladder exstrophy
Bladder'exstrophy
Bladder exstrophy
Bladder exstrophy
Interstitial cystitis
Urinary incontinence
secondaryto
epispadias
Bladder exstrophy
Bladder exstrophy
Rupture of posterior
urethra
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Traumatic ruptureof
urethra
Gunshot wound
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy

M
M
F
F
F
M
F
F
M

50
3
16
18
5
2
4
21
10

10
30
31
15
15
15
29
17
16

F
M
F

2
3
7

23
23
15

Left
Left
Left

M
M
F
M
M
M
M
M

31
19
3
6
6
9
9
7

27
20
20
38
41
46
46
26

Right
Bilateral
Right
Right
Trigone
Bilateral
Bilateral
—

M
F
M
M
F
M
M
M
M
M

8

26
14
24
23
234
25
25
26
334
20

Author
Hammer, 19293
Dixon and Weismann, 19484
Wilson, 1957s
Aldis, 1961°
Sugg,19627
Kozak and associates, 1966s
Urdaneta and associates, 19669
Kille and Glick, 196710
Richter and Ginsberg, 196711
Oetjen and associates, 197012
Whitaker and associates, 197113

Brekkan and associates, 197214
Tank and associates, 197315
Mueller and Thornbury, 197316
Lien,197317
Preissig and associates, 197418
Shapiro and associates, 197419
Harguindey and associates, 197520
Rivard and associates, 197521
Carswell and associates, 197622
Besancenez and associates, 197623
Potet and associates, 197724
Parsons and associates, 197725
Present case

Latency
period,
yr

2
15

21

4
7
3

14

38

Side of ureter
involved by cancer
Trigone
Left
Left
Left
Left
Left
—

Right
Left

Left
—
—
—

Right
Right
Right
—

Right
Left

Table III—Benign Adenoma of Sigmoid Arising at or near Site of
Bilateral Ureterosigmoidostomy for a Benign Condition

Author
Dixon and Weismann, 19484
Markowitz and Koontz, 196626
Kille and Glick, 196719
Haney and McGarity, 197127
Brekkan and associates, 197214
Lien,197317
Lasser and Acosta, 197528
Potet and associates, 197724
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Latency
period,
yr

Clinical indication

Sex

Age at
operation,
yr

Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Urinary incontinence
with epispadias
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy
Bladder exstrophy

M
M
F
M
M

3
1
2
1
4

30
14
15
18
15

F
F
F
M
F

6
3
li
10
9

38
20
234
27
25
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Side of
ureter involved
Right
Left
Right
Right
—

Left
Left
—

Bilateral
Bilateral
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more susceptible to carcinogens.35
The histopathologic types of tu
mour varied little. There were only
four varieties: 33 adenocarcinomas,
12 adenomas, 2 transitional cell car
cinomas and 1 scirrous carcinoma.
The nature of the initial lesion re
quiring urinary diversion bore no rela
tion to the kind of neoplasm devel
oping at the anastomotic site. Adeno
carcinomas occurred with bladder
exstrophy as well as with transitional
cell carcinoma of the bladder and
adenomas developed with either of
these lesions, even with urinary in
continence.
Statistical evidence of a cause-ef
fect relation between long-term ureterosigmoidostomy and carcinoma of
the colon has been suggested by the
work of Urdaneta and associates.9
According to United States statistics,
the incidence of carcinoma of the
colon in persons 45 years of age is
24 per 100 000.9 However, the 83
patients with ureterosigmoidostomy
operated on by Urdaneta’s group
showed an incidence of 13 300 per
100 000 .

The length of time after ureterosig
moidostomy is more important to the
development of carcinoma of the sig
moid than the age of the patient.
Probably the better understanding and
control of complications of ureterosig
moidostomy, such as infection and
acidosis, leading to longer survival,

have permitted this relatively rare
complication to occur.
Speculation concerning the etiology
of neoplasia at the site of a ureterosigmoid anastomosis revolves around
three factors: (a) the role of urine
alone, (b) the role of urine mixed
with fecal material and (c) the role of
bowel-wall changes from ureteric
prolapse into the lumen.
The possibility of a urinary car
cinogen can be excluded, because
carcinomas have developed near a
“dry” anastomosis, following a ne
phrectomy, leaving ureteral stumps
behind. This happened in two of the
cases after operations performed 16
years25 and 8 years12,22 earlier. Scott
and Boyd36 could not induce carci
noma in the bowel of dogs using
/J-naphthylamine during a 20- to 30month period of irrigation. Although
this time period may not be compara
ble, the use of a known carcinogen
as an added stimulant makes the re
sults of this experiment more impor
tant. In spite of the widespread dif
fusion of urine in the colon, the
proximity of the tumour to the
anastomosis is notable.
The association of urine and sig
moid fecal material may be the
common denominator, as we are not
aware of the development of bowel
carcinoma in ileal or isolated sigmoid
conduits.
As a third possibility, the ureteral

nipple may be irritative like a polyp
in the lumen of the bowel. Repeated
microtrauma from feces could induce
malignant transformation.15 However,
we could not find any scientific basis
for this hypothesis; the true etiology
of this cancer remains a mystery.
We believe that the paucity of re
ports of bowel tumour after uretero
sigmoidostomy does not reflect its true
incidence. Better long-term follow-up
of these patients with an awareness
of this complication is required.
Although there are no pathognomo
nic symptoms and signs, there are
some clinical indications that may
suggest the diagnosis. Most patients
have had one or all of the following
at an early stage: vague abdominal
pain suggestive of a ureteral stone,
proctorrhagia sometimes leading to
anemia, and recent obstructive changes
at one or both ureterosigmoid ana
stomoses, demonstrated by intrave
nous pyelography, rapidly interfering
with kidney function. These symp
toms suggest neoplasia of the sigmoid
and must be so considered until
proven otherwise.
Intestinal obstruction is a late stage
that betrays irreversible damage and
is associated with poor survival.
Increased awareness of carcinoma
tous change after ureterosigmoidos
tomy will result in earlier diagnosis
if abdominal pain, proctorrhagia and
obstructive changes are rapidly inves-

T a b le IV — C a rc in o m a o f th e S ig m o id A ris in g a t o r n e a r S ite o f
B ila t e r a l U re te ro s ig m o id o s to m y fo r M a lig n a n t C o n d itio n

A u th o r
R ic h e s a n d P ag e, 195629
M a s s a c h u s e tts G e n e ra l H o s p ita l,
1 9 5 8 3°
S c h e in m a n ,1 9 6 1 31
A m a r , 1 9 6 1 32

U r d a n e t a and a s s o c ia te s , 19669

C lin ic a l in d ic a tio n

Sex

Age at
o p e r a tio n ,
yr

T r a n s itio n a l c e ll
c a rc in o m a o f b la d d e r
T r a n s itio n a l c e ll
c a rc in o m a o f b la d d e r
T r a n s itio n a l c e ll
c a rc in o m a o f b la d d e r
T r a n s itio n a l c e ll
c a rc in o m a o f b la d d e r
T r a n s itio n a l c e ll
c a rc in o m a o f b la d d e r
E p id e rm o id c a rc in o m a

F

61

1

L e ft

M

55

8

R ig h t

M

42

9

L e ft

M

46

4

L e ft

M

58

7 mo

L e ft

M

55

9

R ig h t

L a te n c y
p e rio d ,

yr

S id e o f u r e te r
in v o lv e d by c a n c e r

T a b le V — B e n ig n A d e n o m a o f th e S ig m o id A ris in g a t o r n e a r S ite of
U re te ro s ig m o id o s to m y fo r a M a lig n a n t L e s io n

A u th o r
G illm a n , 196433
M a c G re g o r , 196834
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C lin ic a l in d ic a tio n
T r a n s itio n a l
c a rc in o m a
T r a n s itio n a l
c a rc in o m a

c e ll
o f b la d d e r
c e ll
o f b la d d e r

Sex

Age at
o p e r a tio n ,
yr

L a te n c y
p e rio d ,
yr

S id e o f u r e te r
in v o lv e d by c a n c e r

—

75

7

L e ft

M

57

5

L e ft
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tigated. The condition of patients who
have undergone ureterosigmoidostomy
should be monitored by proctoscopy,
roentgenography after barium enema
and intravenous pyelography, period
ically for life. The longer the time
interval after surgery, the more
critical the assessment becomes. After
10 years, in asymptomatic patients,
a double contrast barium enema, done
every other year, alternating with in
travenous pyelography, should de
tect early neoplastic changes.
Simple nephrectomy for a non
functioning kidney is inadequate, as
many examples of carcinomatous
change around the ureteral stump
have been reported. 4,12‘17,21,22,24,25 A
“collarette” of colon should be in
cluded in the excision and more radi
cal colonic resection is necessary if
malignant change has occurred.
It has been suggested by Carswell
and associates22 that in view of this
complication a reappraisal of the in
dications for ureterosigmoidostomy
should be made and that it should be
restricted to patients over 50 years of
age. We believe that ureterosigmoidos
tomy in younger patients carries the
risk of neoplasia but may be done
provided that follow-up is regular
and thorough.
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Dysfunction of the Detrusor and Urethra in
Multiple Sclerosis: the Role of Drug Therapy
Said A. A wad , m b , b ch , fr cs [c ],* J am es W.L. W il so n , m sc , m d , f
J anet F en em o r e , RNf and H. G eorge K iruluta , m b , b c h , frcs [c L

Urinary tract disorders secondary
to multiple sclerosis are common. In
this series of 24 patients with
multiple sclerosis, 5 had normal
function of the detrusor, 3 had
detrusor hypotonicity and 16 had
detrusor hyperreflexia. The proximal
urethra was evaluated using
radiologic and electromyographic
techniques. These studies showed
that 5 patients had a normal urethra,
15 had some degree of somatic
dyssynergia and 3 had sympathetic
dyssynergia. Detrusor hyperreflexia
with somatic dyssynergia was found in
11 patients and was the most common
pattern. The therapeutic response
to standard pharmacologic preparations
was also evaluated. The regimen was
based on the clinical and urodynamic
findings for each patient. Dicyclomine
hydrochloride was the drug of choice
for detrusor hyperreflexia, bethanechol
chloride for hypotonicity, dantrolene
sodium for somatic dyssynergia and
phenoxybenzamine hydrochloride for
sympathetic dyssynergia. The authors
found that most of their patients were
amenable to drug therapy, the
exception being those with advanced
neurologic lesions.
Les problemes des voies urinaires
secondaires a une sclerose en plaques
sont frequents. Parmi un groupe
de 24 patients souffrant de sclerose
en plaques, 5 avaient un muscle

*Department of urology, Dalhousie
University, Victoria General Hospital,
Halifax, NS
tDepartment of urology, Queen’s
University, Kingston General Hospital,
Kingston, Ont.
XDepartment of surgery (urology),
Memorial University of Newfoundland,
St. John’s, Nfld.
Accepted for publication Oct. 30, 1981
Reprint requests to: Dr. S.A: Awad,
Head, Department of urology,
Dalhousie University, Halifax, NS
B3H 2Y9

Patients and Methods
Twenty-four patients (19 women, 5
men) with multiple sclerosis have
been referred to the urodynamic unit
of the Kingston General Hospital
over the past 5 years for evaluation
and management of urinary tract dis
orders. The mean age was 44.8 years
(range from 23 to 62 years) and the
mean duration of symptoms of mul
tiple sclerosis was 8.6 years (range
from 3 to 20 years). The symptoms
of urinary dysfunction present in these
patients are listed in Table I. Infec
tion, either chronic or recurrent, was
noted in 11 patients.
Patients were assessed on the basis
of their history, the findings on gen
eral physical and neurologic exami
nations and intravenous pyelography,
the results of frequent urine cultures
and determination of blood urea
nitrogen and creatinine levels. Cys
toscopy was done only when indi
cated, for example in those with
hematuria or urinary lithiasis.
Usually, the urodynamic evalua
tion was carried out when urine was
sterile. Cystometrograms were ob
tained with water as the filling me
dium at a rate of 25 ml/min using a
pump with the patient supine. Be
cause of the lack of standardization
in interpreting the cystometrogram,
The incidence of urinary tract dys the criteria used in this study will be
function in patients with multiple listed. The cystometrogram was consclerosis has been documented in
previous reports.1'2 Other investiga
tors3'8 have also reported on the ab
Table 1— Sym ptom s in Patients
normalities of detrusor and sphincter
w ith M u ltip le Scle rosis
function in patients with this disease,
with particular emphasis on the re
No. of
sults of urodynamic testing. However, Sym ptom
patients ( % )
there have been fewer reports on the
13 (57)
results of pharmacologic treatment in HIncontinence
esitancy
8 (35)
patients with multiple sclerosis who Retention
8 (35)
have urinary dysfunction.9 In this Frequency
8 (35)
U
rge
n
cy
paper we evaluate the treatment of
7 (30)
1 (4)
24 patients with urinary dysfunction T e rm inal d rib b lin g
as a result of multiple sclerosis.
vesical fonctionnant normalement,
3 avaient une hypotonicite de
ce muscle et 16 avaient une
hyperreflexie. L'uretre proximate a ete
examinee par des moyens radiologiques
et electromyographiques. C es etudes
ont revele que 5 malades avaient
une uretre normale, 15 souffraient
a divers degres de dyssynergie
somatique et 3 avaient une dyssynergie
sympathique. Une hyperreflexie
du muscle vesical et une dyssynergie
sympathique ont ete retrouvees
chez 11 patients et ceci represente
le tableau le plus frequent.
On a egalement evalue I'activite
therapeutique des preparations
pharmacologiques de reference.
Le regime therapeutique a ete adapte
aux resultats des examens cliniques
et urodynamiques chez chaque patient.
Le chlorhydrate de dicyclomine a ete
utilise comme medicament de choix
pour I’hyperreflexie du muscle
vesical, le chlorure de bethanecol pour
I'hypotonicite, le dantrolene sodique
pour la dyssynergie somatique et
le chlorhydrate de phenoxybenzamine
pour la dyssynergie sympathique. Les
auteurs ont trouve que, a I'exception
de ceux qui avaient des lesions
neurologiques avancees, la plupart
de leurs malades ont repondu a la
medication.
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sidered normal when bladder capacity
was 300 to 700 ml with a minimal
rise in intravesical pressure during
filling until full capacity was reached.10
In addition, patients had normal per
ception of bladder fullness and when
a detrusor contraction occurred, the
patient was aware of its presence and
was able to inhibit it rapidly. Detrusor
hyperreflexia was diagnosed if a det
rusor contraction occurred when the
bladder contained less than 300 ml of
water. On the other hand, the bladder
was considered hypotonic if its capa
city was greater than 700 ml, the pa
tient was unaware of bladder fullness
and there was no change in intra
vesical pressure even at full capacity
or with a detrusor contraction.
The proximal urethra was evalu
ated simultaneously using electromyo
graphy of the external sphincter. Nee
dle electrodes were placed transperineally a few millimetres lateral
to the external urinary meatus in
women and into the bulbospongiosus

muscle in men, and the electromyo
graphic activity was monitored by an
audio-amplifier and an oscilloscope.
Muscle activity was recorded using a
“leaky integrator” (i.e., with an ex
ponential decay) of the electromyo
graphic signals. Normally, electro
myographic activity should disappear
during detrusor contraction.11 Persis
tent muscle activity indicated somatic
dyssynergia. No reduction in activity
was an indication of severe dyssyner
gia, reduced or intermittent activ
ity signified partial dyssynergia. When
there was obstruction of the lower
urinary tract and somatic dyssynergia
was either absent or very mild (seven
patients), a voiding cystourethrogram
was obtained before and after the in
travenous administration of 5 mg of
phentolamine, an a-adrenergic block
ing agent, to rule out the presence of
“sympathetic dyssynergia”.12 Relief of
the obstruction after giving phen
tolamine, as shown radiologically by
an increase in the diameter of the

proximal urethra during voiding or a
decrease in postvoiding residual urine,
indicated that the patient had sym
pathetic dyssynergia.
The results of urodynamic testing
served as a guideline for pharma
cologic treatment as described by
Awad and colleagues.13 Briefly, the
antispasmodic dicyclomine hydro
chloride (60 to 100 mg/d) was used
for the hyperreflexic bladder. One
patient was unable to tolerate dicy
clomine so propantheline bromide
was used. Bethanechol chloride (100
to 200 m g/d) was used for the hypo
tonic bladder. Dantrolene sodium was
given in divided doses increasing from
50 mg/d to 100 mg/d (while liver
function was monitored), often with
diazepam (5 to 20 mg/d), in patients
with somatic dyssynergia. Phenoxybenzamine hydrochloride (Dibenzyline) (10 to 20 mg/d) was given when
sympathetic dyssynergia was consid
ered to be an etiologic factor in ure
thral obstruction.

T a b le II -U ro d y n a m ic Findings and T re a tm e n t in 24 P atien ts w ith M u ltip le Sclerosis
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P atien t
no.

A ge, y r

Sex

i

55

M

Norm al

2

35

F

N orm al

3

32

M

N orm al

4

53

F

Norm al

5
6
7
8
9
10

58
49
62
43
40
57

F
M
F
F
F
F

N orm al
H yperreflexic
H yperreflexic
H yperreflexic
H yperreflexic
H ype rre fle x ic

11

39

F

H yperreflexic

12

60

F

H yp erreflexic

13

43

F

H yperreflexic

14

45

M

H ype rre fle x ic

15

46

F

H yp erreflexic

16

44

F

H yperreflexic

17

56

F

H yp erreflexic

18

27

F

H yperreflexic

19

23

F

H yp erreflexic

20

52

F

H yperreflexic

21

49

M

H yp erreflexic

22

55

F

Hypotonic

23

28

F

Hypotonic

24

51

F

Hypotonic

T re a tm e n t

S phincter

D etru s o r u rin a e

Som atic dyssynergia
(s e v e re )
Som atic dyssynergia
(s e v e re )
S om atic dyssynergia
(p a r tia l)
Som atic dyssynergia
(p a r tia l)
N orm al
N orm al
N orm al
N orm al
N orm al
S om atic dyssynergia
(p a r tia l)
Som atic dyssynergia
(p a r tia l)
Som atic d yssynergia
(p a r tia l)
Som atic dyssynergia
(p a r tia l)
Som atic dyssynergia
(p a r tia l)
Som atic dyssynergia
(p a r tia l)
Som atic dyssynergia
(s e v e re )
Som atic dyssynergia
(s e v e re )
Som atic dyssynergia
(s e v e re )
S om atic dyssynergia
(s e v e re )
S ym p athetic
dyssynergia
S y m p a th e tic -)- som atic
d yssynergia (s e v e re )
S phincter fu n ctio n
in d e te rm in a b le
S phincter fu n c tio n
in d e te rm in a b le
S p h in c te r fu n ctio n
in d e te rm in a b le
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Response
to drugs

D a n tro le n e sodium

Fair

D an tro len e

Good

None

___

D a n tro le n e + diazepam

Poor

None
D icyclom ine hydrochloride
D icyclom ine
D icyclom ine
P ro p a n th e lin e brom ide
D icyclom ine

Good
Good
Poor
Good
Good

D icyclom ine

Good

D icyclom ine

Poor

None
D a n tro le n e
In d w e llin g c a th e te r

_

—

Poor
—

D icyclom ine + d a n tro le n e

Good

D an tro len e + diazepam

Fair

D icyclom ine

Poor

D icyclom ine

Lost to
follow -up
Good

D ibe n zy lin e
In d w e llin g c a th e te r

—

B ethanechol c hloride

Poor

B ethanechol +
dantrolene
In te rm itte n t
c a th e te riza tio n

Good
___
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Results
The urodynamic characteristics of
each patient and the response to
pharmacologic treatment are set forth
in Table II.
The cystometrogram revealed three
patterns of detrusor function: normal
(5 patients), hyperreflexic (16 pa
tients) and hypotonic (3 patients).
The commonest abnormality was
detrusor hyperreflexia in 16 of the
24 patients. Bladder capacities ranged
between 50 and 300 ml (mean 130
ml).
In three patients with detrusor
hypotonicity, the presence of somatic
dyssynergia could not be determined
because detrusor contraction was ab
sent. Eleven of the 15 patients with
somatic dyssynergia had associated
detrusor hyperreflexia, and of the 16
patients who had detrusor hyperre
flexia, 5 did not have somatic dys
synergia (Table II). Thus, the two
commonest abnormalities were fre
quently, but not always, associated.
Three patients showed evidence of
sympathetic dyssynergia in radiologic
studies, one as an isolated abnormal
ity, one combined with somatic dys
synergia and one with detrusor hypo
tonicity. No patients had pyelographic
evidence of hydroureter or hydrone
phrosis secondary to outlet obstruc
tion.
The therapeutic regimen for each
patient (Table II) was based on the
urodynamic findings. The antispasmodic dicyclomine was used to treat
10 of 16 patients with detrusor hyper
reflexia. Five had good results, which
meant that urinary incontinence, if
present, disappeared, and both ur
gency and frequency appreciably de
creased although none of the patients
became asymptomatic. In three pa
tients with minimal or no improve
ment, treatment was considered to
have failed. One patient had a good
response to propantheline after she
failed to tolerate dicyclomine. One
patient was lost to follow-up. In gen
eral, the best results were obtained
when the bladder capacity was greater
than 200 ml.
Of three patients with a hypotonic
bladder, two were treated with bethanechol and one responded well. The
responding patient was assumed to
have a spastic external sphincter in
association with limb spasticity so
dantrolene was added to the regimen,
resulting in a decrease of postvoiding residual urine from more than
200 ml to less than 100 ml. The third
patient, whose urinary retention was
VOLUME 25, NO. 3, M AY 1982
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associated with acute exacerbation of
multiple sclerosis, was treated by in
termittent catheterization rather than
by bethanechol; her bladder function
gradually improved. The number of
patients treated with bethanechol in
this series was too small to warrant
any conclusion as to its value.
Of the patients with somatic dys
synergia, 1 refused treatment and 6
of the remaining 15 were treated with
dantrolene sodium; 2 of the 6 also
received diazepam. Somatic dyssyner
gia was not treated unless the patient
had symptoms of obstruction and
large volumes of residual urine. Two
of the six treated patients had good
results, symptoms lessened and resid
ual urine decreased by approximately
40%. Two patients had fair results
with subjective improvement in symp
toms but without a decrease in resid
ual urine volume and two had poor
results with no improvement.
Of the three patients with evidence
of sympathetic dyssynergia, one had
the isolated lesion and was treated
with Dibenzyline with a good re
sponse. Residual urine volume de
creased from 250 ml to 50 ml and
there was also symptomatic improve
ment. The patient with associated
detrusor hypotonicity was unable to
tolerate the drug because of postural
hypotension and the patient with
combined sympathetic and somatic
dyssynergia refused treatment and
required placement of an indwelling
catheter. The response to the various
drugs is summarized in Table III.
Overall, of the 17 patients treated
with drugs and available for follow
up, the response was good in 9, fair
in 2 and poor in 6.
Discussion
The spectrum of symptoms found
in our patients correlates with that
presented by Bradley and colleagues.3
However, in our series there were
slightly more obstructive symptoms
(hesitancy and large postvoiding re

sidual urine volume) and fewer irri
tative symptoms (frequency and ur
gency) than in their series. Our results
of urodynamic testing also agree
closely with Bradley’s, particularly the
cystometric findings; both showed the
predominance of detrusor spasticity.
This contrasts with the findings in
Schoenberg’s series,8 in which slightly
more than half the patients showed
either hyporeflexic or areflexic de
trusor muscles. Also, the combined
lesion of spastic detrusor and somatic
dyssynergia was encountered most
frequently in our series (11 of 24 pa
tients) in contrast to Schoenberg and
colleagues8 who reported only 13 of
58 patients in this category. Although
detrusor hyperreflexia and somatic
dyssynergia were commonly asso
ciated, several patients had one ab
normality without the other, suggest
ing that the pathogenesis of these dys
functions differs.
When detrusor hyperreflexia was
associated with somatic dyssynergia,
the abnormality that appeared to be
the predominant cause of the patient’s
symptoms was treated first. This was
often the detrusor hyperreflexia. Of
the 11 patients with the combined
abnormality, 5 were treated with
dicyclomine, 2 with dantrolene and
1 with both drugs. We preferred dicy
clomine for detrusor hyperreflexia
because it is better tolerated than
propantheline. However, one patient
in this series tolerated propantheline
better than dicyclomine. Generally,
the results with dicyclomine were bet
ter if bladder capacity was greater
than 200 ml. There was no apparent
increase in the volume of postvoiding
residual urine following dicyclomine
therapy even in the presence of
somatic dyssynergia.
Two patients who had severe de
trusor hyperreflexia (capacity less
than 100 ml) and severe somatic
dyssynergia required an indwelling
Foley catheter. Both patients needed
long-term nursing care because of
the severity of their neurologic lesion.

Table I I I — Response to Drug Therapy
Result
Drug
Dicyclomine hydrochloride
Dantrolene sodium
D ibenzyline
Bethanechol chloride

patients

Good

9
7
2
2

5*
3*
1
1*

Fair
—

2
—

—

Poor
4t
2
1
1

*2 patients had combination drugs, 1 dicyclom ine + dantrolene and 1 bethanechol + d a n tro 
lene.
f l patient failed to tolerate dicyclomine but responded w ell to propantheline bromide.
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Obviously, treatment goals had to be
adjusted to take into account the
nature of the handicap. The minimally
handicapped person could achieve
near-normal bladder function but the
severely handicapped, because of poor
mobility, limb spasticity and de
formities, may have great difficulty
achieving urinary continence and nor
mal voiding habits. In the rapidly
deteriorating patient or one in relapse,
re-evaluation and subsequent adjust
ment of the therapeutic regimen was
necessary; this occurred in two pa
tients as symptoms changed. Recovery
of bladder function following a re
lapse was also seen.
In summary, bladder and urethral
dysfunction in patients with multiple
sclerosis is amenable to pharmacologic
therapy. The regimen should be drawn
up on the basis of clinical symptoms
and the urodynamic findings. The
majority of patients did well with this

approach but there is a small group of
patients with advanced neurologic
lesions whose lower urinary tract dys
function fails to respond to pharma
cologic therapy.

5.
6.
7.

We acknowledge the assistance of
Mr. D. Lywood and his staff in the
biomedical engineering unit, Queen’s
University, Kingston. This study was sup
ported by Physicians’ Services Inc.,
Toronto, Ontario.
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Lymphadenectomy for Testicular Carcinoma
M.P. L aplante ,

Since 5 0 % of patients with testicular
tumour have retroperitoneal metastases
at the time of presentation, there
has been little argument that the
area of primary drainage requires fur
ther treatment following orchiectomy.
Patients with nonseminomatous germ
cell tumours in stages A and B are
candidates for retroperitoneal lym
phadenectomy because this procedure
is of therapeutic value and allows
accurate staging of the disease. The
development of extremely effective
modern, cyclic, multidrug chemo
therapy for extensive nonseminomatous
testicular tumour has led to a rethinking
of the role of lymphadenectomy in
treating testicular cancer. Clinical
staging is still not 100% accurate
even with modern techniques.
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Lymphadenectomy, therefore, continues
to be an important step in managing
patients with nonseminomatous germ
cell tumours. These facts are endorsed
by the authors' review of 72 cases
of nonseminomatous germ cell
tumours managed at McGill University
teaching hospitals over a 10-year
period. The authors also discuss the
indications for retroperitoneal
dissection.
Comme 5 0 % des patients atteints de
tumeurs testiculaires presentent
des metastases retroperitoneales, on
a rarement mis en doute la necessity
d'un traitement d'appoint de la region
de drainage primaire a la suite d’une
orchiectomie. Les patients porteurs
de tumeurs a cellules germinates
non seminomateuses de stade A et
B sont candidats pour une
lymphadenectomie retroperitoneaie
car cette intervention possede une
valeur therapeutique en plus de
permettre d'etablir de facon precise
le stade de la maladie. Le developpement de regimes de polychimiotherapie cyclique extremement
efficaces dans les cas de tumeurs
testiculaires non seminomateuses
etendues, a provoque une remise en
question du role de la lymphade
nectomie dans le traitement des
cancers testiculaires. Le stade clinique
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ne peut encore etre etabli avec 100%
de precision, meme avec les
techniques modernes. En consequence,
la lymphadenectomie demeure une
etape importante dans le traitement
des patients souffrant de tumeurs a
cellules germinates non seminoma
teuses. Ces faits trouvent appui dans
I'etude faite par les auteurs de 72
cas de tumeurs a cellules germinales
non seminomateuses traites dans les
hopitaux affilies a I'Universite McGill
au cours d'une periode de 10 ans.
Les auteurs commentent egalement
les indications de la dissection
retroperitoneaie.

The role of the urologic surgeon in
the initial recognition and removal
of a testicular tumour is not disputed.
But subsequent surgical management
is more controversial, particularly be
cause the development, in recent
years, of extremely effective chemo
therapeutic regimens for advanced
testicular cancer1** has led to a recon
sideration by oncologists of the in
dications for, and extent of, retro
peritoneal lymphadenectomy. A re
view of the history, rationale and re
sults of this surgical procedure is
timely.
At the turn of this century, Most3
and Cuneo4 emphasized that the pri
mary lymphatic drainage of the testis
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was to the region of its embryonic
origin. The first successful retro
peritoneal lymphadenectomy was per
formed by Cuneo in 1906.5 In 1948,
Lewis6 reported on 169 retroperi
toneal lymphadenectomies performed
without a single death and in the late
1950s, Patton and Mallis7 advocated
bilateral lymphadenectomy for testi
cular cancer.
Ray and colleagues8 in 1974 re
ported on the predictable primary
lymphatic drainage from the testes.
Drainage from the right testis is first
to the interaortocaval nodes, then to
the precaval, preaortic, paracaval and
right common iliac nodes in that
order. Subsequently, the left para-aortic and left iliac nodes may be in
volved. Drainage from the left testis
is, in sequence, to the upper left para
aortic nodes (between the left renal
artery and the superior mesenteric
artery), the preaortic nodes and the
left common and external iliac nodes.
Subsequent drainage may be to the
interaortocaval, precaval, paracaval
and right common and external iliac
nodes. Ray and associates also ob
served that most, but not all, lymph
nodes draining the testes are filled
when bipedal lymphangiography is
done and that lymphangiographic
crossover from right to left is common
and may be immediate, whereas cross
over from left to right is rare and
probably occurs after the left primary
nodes are filled with tumour.
Approximately 50% of patients
with nonseminomatous germ cell tu
mours have retroperitoneal lymphnode metastases at the time of sur
gical exploration (Table I9'13). Our ex
perience is similar. In spite of mod
ern, sophisticated diagnostic tech
niques, clinical staging is still far
from precise. Serum tumour markers
(a-fetoprotein and //-human chorionic
gonadotropin) give false-negative re
sults in at least 15% of cases.14,15
Bipedal lymphangiography is unreli
able in demonstrating retroperitoneal

lymph-node metastases, and compu
terized axial tomography and ultra
sonography consistently fail to dem
onstrate small metastatic deposits in
the retroperitoneum.16 Since untreated
retroperitoneal metastases result in
the patient’s death, more accurate
clinical staging is necessary to identify
patients who require additional ther
apy following orchiectomy. Retroperi
toneal lymphadenectomy, to date, is
the most accurate staging procedure
available.
Currently in North America retro
peritoneal lymphadenectomy is fav
oured over radiotherapy for treating
the primary lymphatic drainage area
of nonseminomatous germ cell tu
mours because of its value in staging
and because of its therapeutic effi
cacy. Although the results of numer
ous uncontrolled studies cannot be
used as a reliable comparison, the
survival rates in patients subjected
to retroperitoneal lymphadenectomy,

with or without adjuvant chemothera
py, in stages A (tumour confined to
scrotum) and B (metastatic disease in
retroperitoneum only) are impressive
(Table II17); these results are at least
as good as those in which radiotherapy
has been used.18'20 The strong prefer
ence in North America for retroperi
toneal lymphadenectomy following
orchiectomy for nonseminomatous
germ cell tumours is based on the
demonstrated effectiveness with which
regional control can be achieved
without adjuvant chemotherapy. Local
recurrence following meticulous lym
phadenectomy is rare (Table III17).
The effectiveness of combined chemo
therapy in stage C (metastatic disease
beyond the retroperitoneum) tumours
has been well documented.1'2 It is also
well recognized that because the
maximum tolerable doses of the
drugs must be given for optimal ef
fect, their use may be compromised
by permanent bone-marrow damage

Table II— Nonseminomatous Germ Cell Tumours: Tumour Free Survival
at 24 M onths* of Patients Treated Consecutively by
Retroperitoneal Lymphadenectomy since 1974
Stage, no./total no. ( % )
Series17

A

B

A +B

Staubitz
Donohue
Skinner

21/22 (95)
57/57 (100)
42/42 (100)

15/16 (94)
54/55 (98)
32/35 (91)

36/38 (95)
111/112 (99)
74/77 (96)

*Relapse after 24 mo is extremely rare.

Table Ill— Nonseminomatous Germ Cell Tumours: Recurrence after
Meticulous Lymphadenectomy without Radiotherapy
Stage, no. of patients

Retroperitoneal
recurrence within 24 mo,*
no. of patients

Series17

A

B

A+ B

Donohue
Staubitz
Skinner

57
22
42

55
16
35

112
38
77

1
0
0

121

106

227

1 (0.44%)

Total

*Relapse after 24 mo is extremely rare.

Table I — Incidence of Retroperitoneal Lymph-Node Metastases in Patients with Nonseminomatous
Germ Cell Tumours of Testis Subjected to Abdominal Exploration
Primary tumour type, no./total no. ( % )
Embryonal
carcinoma

Series
Thompson and colleagues, 19619
Ekman and colleagues, 196410
Robsonand colleagues, 196511
Whitmore, 196812
Maier and colleagues, 196913

Teratocarcinoma

Choriocarcinoma

Z J / ox

24/45

Total
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Teratoma

10/13

4

/

------------------

16/51

1/3
211/446 (47)
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secondary to previous radiotherapy.
For this reason and because excellent
results can be obtained by lymphadenectomy with or without adjuvant
chemotherapy and without radio
therapy, the majority of medical and
surgical oncologists treating testicular
cancer in North America omit radio
therapy as a primary treatment in
nonseminomatous germ cell tumours.
The admittedly high rate of infer
tility due to loss of ejaculation follow
ing the procedure is a relatively small
price to pay for such an excellent
chance of cure. It should be empha
sized that erectile potency is not af
fected by the operation nor is the
ability to experience orgasm.
Retroperitoneal Lymphadenectomy

Indications

Not all patients with testicular
carcinoma are necessarily candidates
for this procedure. Since localized
seminoma (stages A and B) can be
cured by radiotherapy, most patients
with pure seminoma do not under
go retroperitoneal lymphadenectomy.
However, all patients with nonsemino
matous germ cell tumours in stages
A, B. (metastases to retroperitoneal
nodes confined to four or fewer
nodes, none of which is larger than 2
cm) and B2 (metastases to retroperi
toneal nodes involving more than
four nodes or any node larger than
2 cm) should undergo retroperitoneal
lvmphadenectomy.
Patients
with
stage B> disease (bulky, probably
nonresectable retroperitoneal disease
without pulmonary metastases) should
be treated initially with intensive
multidrug cyclic chemotherapy. If
there is incomplete resolution of retro
peritoneal tumour, these patients
should be explored and the mass or
masses resected.21 About one third
of these patients will have fibrosis
only, one third will have mature tera
toma and the remainder will have
viable residual tumour.

Only a small number of pa
tients with seminoma are candidates
for retroperitoneal lymphadenectomy.
Patients with apparently pure semi
noma in the primary specimen but
who have an elevated serum a-fetoprotein level are considered to have
nonseminomatous germ cell tumours
and should be treated as such.22
Patients with clinical stage B semi
noma who have incomplete resolution
or progression of metastases follow
ing standard curative doses of radio
therapy should probably undergo ret
roperitoneal exploration if there is
no evidence of pulmonary metastasis.
This may be a relative indication and
the role of chemotherapy in such
cases is becoming more prominent as
the next step in management. Many
centres21,23'25 now treat bulky stage
B seminoma initially with multidrug
cyclic chemotherapy, because the
prognosis when such patients are
treated initially with radiotherapy
appears to be poor, there being a
high rate of pulmonary metastases
subsequently. Patients with anaplastic
seminoma frequently present with
more advanced disease than those
with “classic” seminoma. While
some26,27 believe that, stage for stage,
patients with anaplastic seminoma
fare as well as those with the classic
type, and respond similarly to radio
therapy, others are of the opinion
that anaplastic seminomas behave
more like nonseminomatous germ cell
tumours and should be managed dif
ferently from patients with classic
seminoma.28'31 The significance of
elevated 0-human chorionic gona
dotropin levels in patients with pure
seminoma is uncertain. Any patient
with seminoma, of classic or anaplas
tic types, who persistently has an
elevated 0-human chorionic gonado
tropin level after standard radiothera
py of the retroperitoneum is a reas
onable candidate for retroperitoneal
lymphadenectomy. Finally, in the rare
case of sequential bilateral seminomas
where removal of the first tumour
has been followed by radiotherapy to
the retroperitoneum, retroperitoneal
lymphadenectomy may be indicated
after removal of the second tumour,
if it is thought that the patient mav
not tolerate further curative doses of
radiotherapy.
Technical A spects

FIG. 1—Limits of modified unilateral
dissection for right and left testicular
tumours.
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In view of the pattern of primary
lymph-node drainage from the left
and right testes, and because the er
ror in intraoperative clinical impres
sion of the status of the nodes is less
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than 10%, we believe that a modified
unilateral lymphadenectomy should
be performed (Fig. 1) if the lymph
nodes are judged to be free of meta
static disease at the time of explora
tion. If, however, metastatic nodes
are discovered, we recommend a more
extensive bilateral dissection. Ex
tended suprahilar dissection requiring
thoracoabdominal exposure is not
necessary or desirable, owing to the
associated increase in morbidity. No
improvement in survival has been
demonstrated for patients who have
undergone such a dissection. Using
a high midline transabdominal ap
proach, we accept as the upper limit
of the dissection the inferior margins
of the adrenals (i.e., about 2 cm above
the renal arteries). Exposure for this
part of the dissection is not especially
difficult. The inferior mesenteric vein
is divided with the ligament of Treitz
and the posterior peritoneum is in
cised along the root of the small
bowel mesentery, carried around the
cecum and up the right paracolic gut
ter to the porta hepatis, thus allowing
complete evisceration of the small
bowel to expose the full field of dis
section. The dissection entails com
plete removal of all lymph-node-bear
ing, fatty areolar tissue surrounding
the great vessels within the boundaries
of the dissection (Fig. 1). In a right
sided dissection, because of the known
possibility of right to left lymphatic
crossover, a left hilar dissection is
also routinely performed down to the
level of the inferior mesenteric artery.
An attempt is made to preserve
one or two lumbar arteries on each
side as well as the sympathetic trunks
bilaterally, although the sympathetic
fibres are unavoidably removed with
the lymphatic tissue. The great vessels
are stripped to the subadventitial plane
(Fig. 2), and the psoas muscles and
anterior longitudinal spinal ligament
are bared. This meticulous dissection
is time-consuming, but the liberal
use of hemostatic clips is most useful
in reducing the operating time. All
lymphatic channels must be either
clipped or ligated to prevent forma
tion of postoperative lymphocele. An
interiliac dissection, baring the prom
ontory of the sacrum below the con
fluence of the common iliac veins, is
not routinely performed if the modi
fied unilateral dissection is chosen.
Much of the presacral autonomic
plexus will thereby be preserved and
perhaps also ejaculation.
This procedure is well tolerated by
young patients and the complication
rale is low. The most common post-
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operative problem is prolonged para
lytic ileus, but this almost always
resolves within 7 to 9 days. Careful
attention must be paid to postoperative
fluid balance, as there is consider
able third space loss. Vigorous post
operative physiotherapy and early
mobilization probably reduce the in
cidence of pulmonary and thrombo
embolic complications.
Experience with Testicular Tumours
at M cGill University

In the 10-year period 1970 to 1980
the McGill testis tumour registry
recorded 131 testicular tumours (47
seminomas and 84 nonseminomas).
Although not all seminomas seen in
the McGill-associated hospitals have
been registered, all nonseminomatous
germ cell tumours have been, and the
follow-up of the patients has been
complete. Seventy-two patients have
undergone retroperitoneal lympbadenectomy; 2 had anaplastic seminoma
(1 with an elevated /3-human chori
onic gonadotropin level) and 70 had
primary nonseminomatous germ cell
tumours. Another 10 patients have
been registered with extragonadal
germ cell tumours. Table IV sum-

FIG. 2— Completed modified left
sided dissection. Anomalous left renal
vein passes behind aorta. Right renal
artery marks upper limit of interaortocaval dissection.

marizes the status, 2 years after op
eration, of the 72 patients who un
derwent retroperitoneal lymphadenectomy. Until late 1976, all patients
who underwent retroperitoneal lymphadenectomy received adjuvant (or
prophylactic) cyclic chemotherapy
either with actinomycin D alone or
according to the Mendelson regimen32
(5-fluorouracil,
cyclophosphamide,
methotrexate, and vincristine). Since
then, patients in stages A and Bi have
not received adjuvant chemotherapy
but have been followed by monthly es
timation of the a-fetoprotein and /3human chorionic gonadotropin levels
and chest roentgenography for the
first year, then these studies every 2
months for the subsequent year.
Pulmonary metastases developed in
two stage A patients not receiving ad
juvant chemotherapy. One is in com
plete remission following 18 months
of VAB-IV* chemotherapy2 and the
other died following an incomplete
response to VAB-IV.
Of the stage Bi patients, all but
the three most recent patients received
adjuvant chemotherapy. Of those
who did not, pulmonary metastases
developed within 4 months in one.
This patient is in complete remission
on the VAB-IV regimen. One patient
with stage Bi tumour died. He had
microscopic involvement of two hilar
lymph nodes. Pulmonary metastases
developed within 4 months of the
lymphadenectomy even though he
was receiving the adjuvant Mendel
son regimen. He had a complete
remission with the VAB-IV regimen
but then relapsed and died 19 months
after resection.
In the stage B2 group, the results
were less impressive. Several of the
nine patients who died did not com*The VAB-IV regimen was the fourth
in an evolving series of multidrug cyclic
chemotherapeutic protocols, consisting
of bleomycin, vinblastine and high-dose
cis-platinum, and interval maintenance
therapy, also with multiple agents, given
for a total of 24 months. A further
modification (VAB-VI) using the same
drugs in a more condensed schedule, is
our current protocol.

T a b le IV — S tatus 2 Years a fte r O p e ra tio n of 72 P atien ts
Who U n d e rw e n t R e tro p e rito n e al Lym phadenectom y
Tum our
stage
A
B,
b2
C

A liv e , no. ( N E D ,* % )
30
11
10
5

*N o evidence of disease.
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(9 7 )
(9 1 )
(5 2 )
(5 0 )

D ead, no.
1
1
9
5

ply with their chemotherapy sched
ules and several were treated before
the VAB protocols were introduced.
Two others simply did not respond
even to the most recent chemothera
peutic regimens. In at least three of
these cases, there was gross spillage
of necrotic liquified tumour at the
time of lymphadenectomy.
Five of 10 patients with stage
C tumour are long-term survivors
following retroperitoneal lymphade
nectomy and cyclic chemothera
py. Two had thoracotomy for residual
pulmonary lesions following chemo
therapy. Twelve other patients with
stage C nonseminomatous germ cell
tumours were not subjected to retro
peritoneal lymphadenectomy. Most
had an accelerated downhill course
despite chemotherapy, but one is in
complete
remission. We
antici
pate a higher complete response rate
with the chemotherapy currently in
use.1’2 Our results compare favour
ably with those obtained at other
centres.
D iscussion

There can be no doubt that cur
rent, combined, cyclic chemotherapy
using high doses of vinblastine, bleo
mycin and cis-platinum has greatly
improved the cure rates in nonsemi
nomatous germ cell testicular tu
mours.
Mainly because modern
chemotherapy is so effective in ad
vanced disease, and because full doses
are required for best results, most
North American oncologists are
now convinced that radiotherapy
should be avoided in the primary
treatment of these tumours. Perma
nent bone-marrow suppression fre
quently precludes the use of full dose
schedules of vinblastine in patients
who subsequently require chemothera
py. Radiation to the mediastinum
with scatter to the lungs may limit
the total dose of bleomycin that can
be tolerated in view of the known
risk of pulmonary fibrosis when this
drug is used. Certainly it has been
the experience of medical oncologists
that the use of intensive chemotherapy
is considerably more difficult in pa
tients who have previously received
radiotherapy.1,23
Will the surgeon’s role change in
the future? Certainly the high inci
dence of infertility due to aspermia
following retroperitoneal lymphade
nectomy is distressing, particularly
in young men who have not yet
started their families. It would be
desirable to avoid retroperitoneal
lymphadenectomy in these patients
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provided their survival was not com
promised. Nevertheless, subsequent
chemotherapy, should it be indicated,
will probably have permanent effects
on spermatogenesis. Also, there is a
fairly high rate of impaired sper
matogenesis in patients who harbour
testicular tumours.33 Thus, the im
portance of loss of ejaculation may
have been overemphasized in the ar
guments against the use of retroperi
toneal lymphadenectomy for nonseminomatous germ cell tumours.
Projected improvements in the sen
sitivity of biochemical markers and
other nonsurgical techniques may im
prove the accuracy of clinical stag
ing to the point where extensive retro
peritoneal lymphadenectomy will no
longer be necessary for reliable stag
ing; a more limited sampling of the
primary lymph nodes may become ac
cepted as adequate and be associated
with a lower rate of aspermia. Even
though clinical staging is imperfect,
it may be that a very closely moni
tored “wait and see” policy following
orchiectomy will spare an appreciable
number of these patients extensive
(and therapeutically unnecessary) op
erations. Provided early detection of
metastatic disease is assured, these
patients may do as well with delayed
chemotherapy as those whose man
agement is based upon surgical stag
ing. Nevertheless, we believe that, at
present, complete, meticulous lym
phadenectomy is the single most im
portant factor in providing definitive
therapy and a guideline for the ad
juvant management of patients with
nonseminomatous germ cell testicular
tumours.
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Control of Postoperative Renal Hemorrhage
by Embolization with a Gianturco Coil
G.

John A nkenman ,

A 35-year-old woman underwent a
left pyelonephrolithotomy for removal
of a staghorn calculus. Blood loss
was minimal for 5 days. Then there
was profuse bleeding from the left
kidney that did not respond to
conservative management. Angiographic
examination demonstrated
extravasation of contrast medium from
a minor intrarenal artery in the lower
pole of the kidney directly into
the pelvicalyceal system. An attempt
was made to embolize the bleeding
vessel with Gelfoam particles but
this failed because the Gelfoam
passed directly into the collecting
system. A Gianturco coil, however,
occluded the vessel and immediately
the hemorrhage ceased; the patient
had no further complications.
The authors emphasize that the
introduction of a steel coil to control
bleeding is advocated only when
the use of temporary occlusive agents
is unsuccessful.
Une femme de 35 ans a subi une
pyelonephrolithotomie gauche pour
I’ablation d'un calcul dendritique. On
observa pendant 5 jours un
epanchement sanguin minime. Puis,
il y eut alors une hemorrhagie abondante provenant du rein gauche qui ne
repondit pas a un traitement
conservateur. L’examen angiographique
revela une extravasation de la
substance de contraste a partir
d’une petite artere intrarenale
situee au pole inferieur du rein,
directement dans le systeme pelvicaliciel. On tenta d'obliterer le vaisseau hemorrhagique a I’aide de particules de Gelfoam, mais sans succes
puisque le Gelfoam fuit directement
dans le systeme collecteur. Une
spirale Gianturco permit toutefois
d’obliterer le vaisseau et d’arreter
immediatement I’hemorrhagie; la
patiente n'eut pas d'autre complication.

md , frcs[c]* and

John B. M urray,

Les auteurs insistent sur le fait
que I'emploi d’une spirale d'acier
pour maitriser un saignement n’est
recommande que lorsque les agents
d’obliteration temporaire ont echoue.

Pyelolithotomy for removal of a
staghorn calculus was performed suc
cessfully on a patient who presented
with recurrent urinary tract infec
tions. But 5 days later persistent renal
bleeding commenced. The patient did
not respond to conservative manage
ment and transcatheter segmental em 
bolization with Gelfoam was also
unsuccessful. However, when a steel
(Gianturco) coil (Cook Bloomington
Inc., Markham, Ont.) was introduced,
the bleeding ceased immediately.
Case Report

A 35-year-old female nurse underwent
investigation for recurrent urinary tract
infection. The right upper tract was
radiologically normal. On the left there
was a large staghorn calculus (Fig. 1).
A pyelonephrolithotomy was performed.
The kidney was cooled by the slush tech
nique and the renal artery clamped dur
ing operation. The calculus was removed

m b , frcr , F R C P [ c ] f

by an extended pyelolithotomy and smaller
nephrotomy incision. Subsequent roent
genograms confirmed complete removal
of the calculus. The 1000 ml of blood
lost during the procedure was replaced.
At closure, bleeding from the kidney
was minimal, so a fenestrated no. 10
feeding tube was inserted into the ureter
and brought out through the renal paren
chyma. A nephrostomy was not done.
The patient had no appreciable blood
loss for 5 days. Then the urine from
an indwelling Foley catheter in the blad
der became sanguineous. Blood replace
ment was not required until 10 days af
ter operation. Then, during the next few
days, she received 8 units of whole
blood, 2 units of packed cells and 6
units of fresh frozen plasma because of
progressive, profuse bleeding through
the Foley catheter.
When it was apparent that she would
not respond to conservative management,
angiographic examination was carried
out to identify the precise site of bleed
ing in the hope that selective trans
catheter embolization would stop the
bleeding.
Renografin-76 (12 ml) was injected
through a no. 6.5 F renal Gold catheter
into the main renal artery; the bleeding
site was demonstrated by focal accumu
lation of extravasated contrast medium
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FIG. 1—Plain film obtained at time
of retrograde pyelography showing
opaque staghorn calculus.
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FIG. 2— Selective renal arteriogram.
There is extravasated contrast medium
in lower pole.
269

The feasibility of transcatheter
renal infarction was initially evaluated
experimentally in animals by Lalli
and colleagues in 1969.1 Since then,

embolization of renal arteries has
been employed in a variety of clinical
situations,2'5 most notably as an ad
junct to nephrectomy for renal cell
carcinoma, but also to control hyper
tension caused by segmental renal
artery stenosis,6 to occlude intrarenal
aneurysms7 and spontaneous fistulas
associated with renal arterial disease,
and in congenital malformations.8
This method of control of post-trau
matic renal hemorrhage is gaining
acceptance with the increasing suc
cesses of “interventional” radiology.9
A variety of embolic materials
have been used in humans. Auto
logous blood clot and gelatin sponge
(Gelfoam) have proven the most
popular temporary occlusive agents
and with vascular hypernephromas
are frequently used in combination
with Gianturco steel coils for total
obliteration of the main renal arterial
supply.
In our case the catheter was ad
vanced as far as possible into the in
ferior pole vessel of the ventral
branch of the main renal artery in
an attempt subselectively to embolize
the bleeding vessel. Gelfoam particles
of increasing size were used initially,
to provide temporary occlusion, but
proved unsuccessful; the particles
passed freely into the adjacent calyx,

which was in direct communication
with the bleeding vessel. The Gian
turco coil was then placed as close
as possible to the bleeding site. The
major objective of avoiding a nephrec
tomy overshadowed the risk of seg
mental infarction and hypertension.
Immediate hemostasis was obtained.
As shown on the subsequent excretion
urogram, infarction of the lower pole
occurred, but satisfactory excretion
of contrast medium occurred from
the upper pole and the patient is now
normotensive 18 months later.
The best embolic agent would have
been Gelfoam, which produces a clot
that will last more than 24 hours,
whereas autologous clot lyses more
rapidly. A search of the literature
did not reveal a similar case in which
the use of Gelfoam particles was un
successful because they passed directly
into the renal collecting system. The
introduction of a 5-mm wide steel
coil was our alternative at the time
because the 3-mm coil was not com
mercially available. Our success in
this case may be unprecedented, but
we do not advocate the use of such
a coil unless temporary occlusive
agents are unsuccessful. Reoperation
and increased morbidity were avoided,
the iatrogenic infarction being the
only apparent sequela.

F IG .
3— Subselective
arteriogram
showing collecting system and proximal
ureter opacified by extravasated con
trast m edium containing blood clot (ar
row).

FIG . 4— G ianturco coil in place. C ath
eter w ithdrawn to m ore proximal posi
tion in ventral branch.

F IG . 5— Postcoil embolization; selec
tive arteriogram shows occlusion of
low er pole branch of ventral artery.

in the lower pole (Fig. 2). The catheter
was exchanged for a no. 6.5 F cobra
catheter which was easily passed into
the ventral branch of the main renal
artery close to the site of bleeding; 4
ml of the contrast medium was injected
and the pool of extravasated contrast
medium was shown to communicate di
rectly with the pelvicalyceal system,
which contained blood clot (Fig. 3).
With the catheter tip unaltered in its
position, multiple fragments of gelatin
sponge were injected in 2-ml increments
of Gelfoam-saline and Gelfoam-contrast
medium mixtures. Hemostasis was not
obtained because the fragments passed
through the vessel into the collecting
system.
A 5-mm wide steel (Gianturco) coil was
then introduced (Fig. 4), the catheter
tip withdrawn to the origin of the ven
tral branch and 8 ml of contrast medium
injected; complete occlusion of the
interlobar artery was achieved (Fig. 5).
There was no further bleeding. The
patient’s postoperative course thereafter
was smooth. Excretion urography done
3 months after operation showed con
traction of the lower renal pole consis
tent with infarction but with satisfac
tory function of the upper pole.
D iscu ssio n
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Renal Angiomyolipoma Not Associated
with Tuberous Sclerosis
J.L. C hin ,

Six cases of renal angiomyolipoma
not associated with the tuberous
sclerosis complex illustrate the
common presenting clinical picture of
this relatively rare hamartoma. The
authors discuss the traditional and
newer diagnostic studies used,
particularly ultrasonography and com
puterized axial tomography and their
applications in the diagnosis of
angiomyolipoma. Special emphasis is
placed on differentiation of renal
angiomyolipoma from renal cell
carcinoma. Although the newer imaging
techniques are valuable diagnostic
aids, treatment of these renal mass
lesions should not be based entirely
on results of such studies.
Six cas d'angiomyolipome renal non
relies a une sclerose tubereuse
complexe servent a illustrer le tableau
clinique habituel de cet hamartome
relativement rare. Les auteurs
commentent les techniques diagnostiques traditionnelles et plus recentes
utilisees, particulierement I'echographie
ultrasonique et la tomographie
transverse axiale avec ordinateur,
et leurs applications au diagnostic
de I'angiomyolipome. On insiste
specialement sur la differenciation
entre I'angiomyolipome renal et le
carcinome a cellules renales. Bien
que les nouvelles techniques de
visualisation soient des moyens

md and

J.K. Wyatt,

md, frcs [c], facs

diagnostiques utiles, le traitement de
ces masses renales ne doit pas
reposer entierement sur les resultats
de telles etudes.

Renal angiomyolipoma is a benign
hamartoma of mixed mesenchymal
origin. About 250 cases have been
reported. Although its association
with the tuberous sclerosis complex
is well known, about half the reported
cases are not associated with tuberous
sclerosis. Patients without signs of tu
berous sclerosis present a diagnostic
challenge in the differentiation of
renal angiomyolipoma from renal cell
carcinoma and a therapeutic chal
lenge in preserving renal tissue.
Clinically, tumours not associated
with tuberous sclerosis are often uni
lateral, solitary and large. There is
a female predominance1 and the peak
age range is the fifth to seventh
decade.2 The tumour involved the
right kidney in 80% of reported
cases.3 In contrast, patients with the
tuberous sclerosis type of tumour are
usually juveniles and there is no sex
predominance. The disease is usually
bilateral with multiple small tumours.
Patients

six patients had a space-occupying
lesion demonstrated on an excretory
pyelogram. Renal angiography done
in five patients showed abnormal
tumour vessels suggestive of renal
cell carcinoma. The sixth patient
presented with hypovolemic shock
from retroperitoneal hemorrhage and
was operated upon without under
going angiography. Renal ultrasono
graphy showed a characteristic solid
lesion in two patients. Radical ne
phrectomy was performed in five pa
tients because of the preoperative
diagnosis of renal cell carcinoma.
One patient with compromised renal
function had a partial nephrectomy
to preserve renal tissue.
Diagnosis

The diagnosis of renal angiomyo
lipoma is mainly radiologic. Renal
mass lesions are usually discovered
by excretory pyelography and, if
suspected from clinical presentation,
should be confirmed by infusion pye
lography with tomography. Grey-scale
ultrasonography differentiates true
cystic lesions from solid and partly
solid mass lesions. The simple cyst
can be accurately diagnosed by ultra
sonography and further investigation
or treatment is rarely required. For
all other renal masses renal angio
graphy more accurately outlines the
vascularity of the mass and aids in
planning the surgical procedures that
may be necessary. Angiographic ex
amination does not reliably differen
tiate between the neovascularity of
angiomyolipoma and the hypovascularity of renal cell carcinoma with
areas of central necrosis and tumour
infarction. The earlier attempts to dif
ferentiate angiomyolipoma from renal
cell carcinoma were based on sup-

Reprint requests to: Dr. L.K. Wyatt,
Chairman, Division of urology,
University of Western Ontario, Ste. 301,
111 Waterloo St., London, Ont.
N6B 2M4

Over the past 10 years, six patients
(four women, two men) with no signs
of tuberous sclerosis presented at our
centre with unilateral renal angiomyo
lipoma. Their ages ranged from 39
to 66 years (three were in their 50s).
All had left-sided tumours. As in
other reports, the commonest present
ing symptoms were severe flank pain
(five patients), hematuria (five) and a
palpable mass (two patients). Two pa
tients presented with the rarer pic
tures of retroperitoneal hemorrhage
and hypertension, respectively. All
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posedly characteristic angiographic
features of angiomyolipoma, such as
saccular aneurysmal dilatation of in
terlobar and interlobular arteries (Fig.
1), the “onion-skin” whorled pattern
in the capillary phase and the absence
of arteriovenous shunting. However,
the current consensus is that renal
angiography cannot be relied upon to
differentiate angiomyolipoma from
renal cell carcinoma, especially stage
A carcinoma.
Renal Ultrasonography
Recent developments in ultrasono
graphy help in establishing a more
accurate preoperative diagnosis. Nor
mal renal parenchyma is echo-free at

both low and high gain settings. Renal
cell carcinoma is usually echo-free
at low gain, but will show some in
ternal echoes at high settings, although
there are some highly echogenic ex
amples. Angiomyolipoma shows clus
ters of internal echoes at both low
and high gain settings,4 demonstrat
ing the disorganization and the nu
merous interphases among blood ves
sels, muscles, fat and connective tis
sues. Fig. 2 shows the typical ultra
sonographic picture of angiomyo
lipoma. We stress, however, that the
diagnostic accuracy of ultrasono
graphy is not such that the need for
a radical cancer surgery approach can
be dismissed, because we have en
countered renal cell carcinomas that
were highly echogenic at both low
and high gain settings.
Computerized Axial Tomography
We have used computerized axial
tomography in several cases of renal
cell carcinoma mainly for staging,
and there are recent reports5,6 of com
puterized axial tomography used as
an additional diagnostic tool for an-

FIG. 1—Renal angiogram of angio
myolipoma showing typical interlobar
and interlobular artery aneurysms.

giomyolipoma. Fat-dominant angiomyolipomas are clearly seen on the
tomogram (Fig. 3). These tumours
have very low attenuation coefficients
(—30) compared with other tissues be
cause of the low density of fat.5,6 Re
nal cell carcinoma does not contain fat
and therefore has a much higher at
tenuation coefficient (>0). Tumours
with necrosis or hemorrhage have in
termediate attenuation values (-10),
usually quite easily distinguishable
from angiomyolipoma.5,6 However,
not all angiomyolipomas contain fat in
the quantities that would display the
characteristic low density pattern on
the computerized axial tomogram.
Discussion

The first aim of treatment is to dis
tinguish angiomyolipoma front a
malignant tumour preoperatively. The
usual work-up for renal cell carcino
ma should be performed. Ultrasono
graphy and computerized axial tomo
graphy, if available, should be used
as adjunctive tools. As emphasized
earlier, these newer investigations can
not be depended upon completely to
rule out a malignant lesion. We must
therefore bear in mind when dealing
with certain solid and vascular renal
mass lesions that the tumour may
be benign. The second aim in treat
ment is to preserve normal renal tis
sue. However, since we have not
absolutely resolved the diagnostic
dilemma in patients with angiomyo
lipoma but no signs of tuberous scle
rosis, we cannot afford to break with
the radical cancer surgery approach
to justify preservation of renal tissue
except in special circumstances.
Fig. 3 is reproduced by courtesy of
John Wiley & Sons, Inc., New York,
from Lee TG et al: Ultrasound findings
of renal angiomyolipoma. JCU 1978; 6:
150-5
References

FIG. 2—Ultrasonogram showing kid
ney (as outlined by relatively sonolucent
perirenal fat) with dense internal echoes
reflecting disorganization and numerous
interphases among blood vessels, muscles,
fat and connective tissues that constitute
tumour.
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FIG. 3— Fat-dominant angiomyolipo
ma. Kenal angiogram (top) and com
puterized tomogram (bottom) showing
renal mass (arrow).
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Unilateral Renal Artery Embolism
Managed Conservatively
V. Srinivas,

Renal artery embolism presents a
diagnostic challenge because the
condition is rare and it often mimics
other more common abdominal
problems. A conservative approach is
favoured by most urologists but
management is still controversial.
The authors present a case of
unilateral renal artery embolism that
illustrates the difficulties and delay
in making a diagnosis. It also
highlights the efficacy of anticoagulants
in restoring adequate function in a
kidney that had been totally nonfunc
tioning and partially ischemic for
longer than
hours.

18

Le diagnostic de I'embolie d’une
artere renale presente un defi, du
fait que cette affection est rare et
qu'elle prend souvent les apparences
d'autres problemes abdominaux plus
frequents. La plupart des urologistes
favorisent une approche conservatrice
mais le traitement est toujours
sujet a controverse.
Les auteurs decrivent un cas
d'embolie u n ila te ra l d’une artere
renale qui illustre les difficultes de
diagnostic et les delais a y arriver.
II met egalement en lumiere I’efficacite
des anticoagulants a retablir une
fonction adequate dans un rein qui
avait ete completement non fonctionnel et partiellement ischemique
pendant plus de
heures.

18

Renal artery embolism is uncommon.
Patients with the lesion are usually
seen in the emergency department
and have flank and abdominal pain
that often mimics other, more com
mon, abdominal conditions.
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Whether the embolus should be
removed surgically1 or treated con
servatively with systemic anticoagu
lants2 is controversial. In a series of
24 cases of unilateral renal artery em
bolism, there were no deaths in pa
tients managed nonsurgically but 18%
of patients who were operated on
died. The rate of kidney preservation
in the two groups was 77% and 44%
respectively.3 Intra-arterial infusion
of streptokinase to dissolve the em
bolus has also been recommended as
an adjunct to systemic anticoagulant
therapy.4
We recently treated a patient with
left renal artery embolism who illus
trates the problems associated with
this uncommon condition.
Case Report

output from the left kidney. A renal
arteriogram showed that the renal vascu
lature was normal on the right; however,
the left renal artery was completely oc
cluded approximately 2 cm from its
origin (Fig. 1). A selective left renal
arteriogram revealed a few collateral
vessels and a lucency at the site of ob
struction (Fig. 2).
Heparin was given intravenously
(1000 U/h), and digoxin (0.125 mg/q6h,
intravenously, followed by 0.125 mg,
once a day, orally) was administered
to control her atrial fibrillation. Warfarin
therapy (5 mg once a day, then 2.5 mg
once a day) was started the next day and
the heparin was discontinued after 5 days.
The patient did well and at the time of

A 71-year-old woman was seen in the
emergency department with a 6-hour
history of left flank and lumbar pain of
acute onset. The pain was constant and
radiated to the umbilical region and left
groin. Her medical history was impor
tant in that she was taking insulin for
diabetes and medication for hypertension,
and she had ischemic heart disease with
mitral stenosis. Her blood pressure was
160/110 mm Hg, the pulse rate was
88 beats/min and was irregularly ir
regular, and the temperature was 37.5°C.
The abdomen was not distended, but
was tender throughout, particularly in
FIG. 1—Flush arteriogram shows
the left costovertebral angle and left normal right renal vasculature and com
lumbar region. Peripheral pulses were plete occlusion of left renal artery.
present and no bruit was heard over the
abdomen.
The hemoglobin level was 13.4 g/dl,
leukocyte count 10 X 109/1; urinalysis
showed 2 to 3 erythrocytes per highpower field, trace protein and 1 to 3
leukocytes per high-power field. The
blood sugar level was 263 mg/dl (14.6
mmol/1), blood urea nitrogen 14 mg/dl
(5 urea, mmol/1), serum creatinine 0.8
mg/dl (70.7 pmol/1), and serum elec
trolyte and amylase levels were normal.
The electrocardiogram revealed atrial
fibrillation with a controlled ventricular
response.
Intravenous pyelography on admis
sion revealed a normally functioning
right and a nonfunctioning left kidney
in the early and delayed films. Both
kidneys were of normal size. Cystoscopy
FIG. 2—Selective left renal arterio
under local anesthesia revealed a normal gram.
are several collateral ves
bladder and a left retrograde pyelogram sels andThere
lucency (embolus) (arrow) oc
appeared normal. There was no urine cluding left renal artery.
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discharge, 3 weeks later, the left kidney
was functioning well (Fig. 3).
D iscussion

Since the first case of renal artery
embolism was reported by Traube in
1856, a number of reports on this
condition have appeared in the litera
ture.2 Some of the important etiologic
factors in the development of renal
artery embolism are: atrial fibrilla
tion, myocardial infarction, subacute
bacterial endocarditis, surgery on the
abdom inal aorta, dislodgement of
plaques during angiographic proce
dures and blunt trauma.
The symptoms usually consist of
acute unremitting pain localized to
the lum bar region or spreading dif-

FIG. 3—Intravenous pyelogram after
3 weeks (15 minute film). There is good
function in left kidney.

fusely into the upper abdomen, some
times associated with nausea or ileus.
Invariably proteinuria and microscopic
hematuria are present. The serum lac
tic dehydrogenase concentration is
usually elevated and leukocytosis may
be present. The intravenous pyelo
gram shows a kidney of normal size
that is nonfunctional. Our patient
had similar clinical findings and the
characteristic pyelographic features,
which made us highly suspicious of
renal artery embolism. The lesion was
confirmed by renal arteriography.
Recent reports suggest that the
treatment of choice for unilateral
renal artery embolism is the adminis
tration of systemic anticoagulants
possibly with percutaneous transfemoral intra-arterial infusion of
streptokinase for quick dissolution of
the embolus.5 Anticoagulant therapy
prevents further propagation of clot
and occlusion of small cortical colla
teral vessels by platelet microthrom
bi.3 O ther supportive measures are
aimed at controlling the atrial fibril
lation and correcting the dehydration,
which are often present. Urinary in
fection is treated vigorously to pre
vent sepsis in the ischemic kidney.
Occasionally hemodialysis is required
for patients with acute renal failure
due to bilateral renal artery emboliza
tion or to an embolus in a solitary
kidney.
Although 18 hours had passed since
the first attack of pain and the left
kidney was completely nonfunctional
in our patient, she responded well to
systemically administered anticoagu

lants; function returned in that kidney
within 3 weeks. Perfusion of the
renal parenchyma via capsular and
peripelvic collaterals has been noted
to occur immediately after renal
artery occlusion;6 there is also mini
mal blood flow around the embolus.
These two factors are important for
preserving renal function in the pres
ence of total renal artery occlusion
as seen on angiography. This may also
explain the success of conservative
management using anticoagulants.
Adjuvant intra-arterial streptokinase
was not used in our patient because
we were afraid of dislodging athero
matous plaques.
It is essential to be aware of this
uncommon problem so that diagnosis
is made quickly and correct treat
ment is instituted before irreparable
damage occurs.
We thank Mrs. Cathy Breen for her
secretarial assistance.
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BOOK REVIEWS
ATLAS DE RADIOLOGIE DU PIED.
J. Montagne, A. Chevrot et J.-M.
Galmiche. 277 pp. Illust. Masson
Paris, 1980. Prix non mentionne. ISBN
2-225-48708-1.

This atlas on the foot, which has been
written in French and translated into
English, contains good-quality photo
graphs and has an excellent bibliography.
Each radiograph is succinctly described.
The authors consider first the radiologic
techniques and anatomy of the adult and
pediatric foot. Normal variants and mul
tiple radiologic measurements are de
tailed. The normal and abnormal bio
mechanics of the foot are also covered.
The chapters are divided according
to radiologic abnormalities, so that the
reader who is dealing with an unknown
282

picture can find the answer rapidly.
Each radiologic appearance is accom
panied by a description of the different
diseases that can produce this picture.
Multiple topics are covered such as local
or diffuse increased density, periostitis,
localized or generalized osteopenia, ex
pansile lesions, severe loss of bone,
osteonecrosis, arthritides and soft-tissue
abnormalities.
This is a well-organized and didactic
reference book which will be useful for
rheumatologists, orthopedic surgeons
and radiologists.
J.M. D u m a s ,

m d , f r c p [c ]

Department of diagnostic radiology,
Royal Victoria Hospital,
Montreal, PQ
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CONGENITAL DEFORMITIES OF
THE HAND. An Atlas of Their Sur
gical Treatment. W. Blauth and F.
Schneider-Sickert. 387 pp. Illust.
Springer-Verlag New York Inc., New
York, 1981. $230. ISBN 0-387-100849.

This impressive volume represents the
authors’ experience in over 1000 opera
tions for congenital hand deformity. It
is written for all practitioners of hand
surgery, who will find advice and an
swers on surgical technique and timing.
It has been translated from the original
German but, thanks to the able transla
tion of Ulrich Weil, one does not detect
this during reading.
continued on page 327
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Intestinal Bypass and Gastric Partitioning
for Morbid Obesity: a Comparison
MERVYN D e ITEL, MD, FRCS[C], FACS, FICS, FACG, FACN,*
M .A . B o j m , m d , frcs [ c ], M.D. A tin , b s c f and G.S. Z akhary ,

The authors have compared the results
of jejunoileal bypass and gastric
partitioning for the treatment of morbid
obesity in a consecutive series of
174 patients. All patients were more
than 45 kg overweight. There was a
high incidence of hypertension,
diabetes, respiratory distress, hyper
lipemia, debilitating arthritis and
stress incontinence, which where
relieved by weight loss after surgery
Thoracic epidural anesthesia was used.
In 64 patients who underwent
jejunoileal bypass, weight loss was
27% at 1 year and reached a plateau
of 33% at 2 years (range from 18%
to 53%). Liver biopsy specimens
obtained at operation showed fat in
the centrilobular area; postoperative
biopsy specimens showed worsening
of this condition at 9 months,
improvement at 18 months and a
normal appearance of the lobules at
30 months. The in-continuity section
of the bowel showed villous hyper
trophy with cellular hyperplasia and
the excluded bowel showed mucosal
atrophy. Sixteen patients required
From the department o f surgery,
University o f Toronto and St. Joseph’s
Health Centre, Toronto, Ont.
Presented at the 4th annual meeting
o f the Canadian Association o f General
Surgeons, Toronto, Ont., Sept. 17,
1981
* Associate professor o f surgery,
University o f Toronto
*Medical Research Council of Canada
summer scholarship student
tResearch fellow, St. Joseph’s Health
Centre Research Foundation
Accepted for publication Nov. 2, 1981
Reprint requests to: Dr. M . Deitel,
St. Joseph’s Health Centre Research
Foundation, 30 The Queensway,
Toronto, Ont. M 6R 1B5
VOLUME 25, N O . 3, M A Y

1982

/

replacement of electrolytes, 6 had
polyarthritis, which responded to
metronidazole therapy, and 5 had renal
stones, which resolved after the patient
was put on a low oxalate diet and oral
calcium was prescribed. Diarrhea
after 1 year was not a problem.
Gastric partitioning was carried out
on 110 patients, forming a pouch of
50-ml capacity. In the first 56 of these
patients the 1.2-cm diameter outlet
enlarged, reducing the effectiveness of
the operation. Weight loss at 1 year
was 21%, but at 30 months it was
only 16% (range from 0% to 36%).
In the next 54 patients, the 1.2-cm
outlet was reinforced about a
calibrating bougie by a circumferential
imbricating nonexpanding suture. In
this group weight loss was 31% at
1 year.
In neither series have there been
any deaths. Jejunoileal bypass gives
acceptable weight ioss, but patients
require continued surveillance.
Gastric partitioning provides effective
weight loss if enlargement of the
outlet can be prevented.
Les auteurs ont compare parmi une
serie de 174 patients consecutifs,
les resultats obtenus par derivation
jejuno-ileale et par cloisonnement
gastrique dans le traitement de
I'obesite pathologique. Tous les
patients avaient plus de 45 kg en
trop. On notait une forte incidence
d'hypertension, de diabete, d'insuffisance respiratoire, d'hyperlipemie,
d’arthrite debilitante et d'incontinence
a I’effort, que la perte de poids apres
chirurgie a ameliores. On eut recours
a I'anesthesie thoracique epidurale.
Chez 64 patients qui avaient subi
une derivation jejuno-ileale, la perte
de poids etait de 27% apres 1 an
et elle atteignit 33% apres 2 ans

mdJ

(ecart de 18% a 53%). Les biopsies
hepatiques pratiquees au moment
de I'operation montraient du tissu
graisseux dans la region centrolobulaire; les biopsies postoperatoires
revelerent une deterioration apres 9
mois, une amelioration apres 18 mois
et des lobules normaux apres 30
mois. La section anastomosee de
I'intestin montrait une hypertrophie
villeuse avec hyperplasie cellulaire
alors que la partie de I’intestin mise
au repos presentait une atrophie de
la muqueuse. Seize patients ont
necessity une recharge electrolytique,
6 ont souffert d'une polyarthrite qui
repondit au metronidazole, et 5 ont
eu des calculs renaux qui disparurent
iorsque les patients recurent un
regime alimentaire a faible teneur en
oxalate et qu’on leur administra du
calcium par voie orale. Apres 1 an,
la diarrhee n’etait plus un probleme.
Un cloisonnement gastrique par
formation d'une poche de 50 ml fut
pratique chez 110 patients. Chez 56
de ces patients, I'orifice de 1.2 cm de
diametre s'elargit reduisant I'efficacite de I'operation. La perte de poids
apres 1 an etait de 21%, mais elle
n'etait plus que de 16% apres 30
mois (ecart de 0% a 36%). Chez les
54 patients suivants, I’ouverture de
1.2 cm fut renforcie autour d'une
bougie d’etalonnage par une suture
circonferentielle, imbriquee et non
expansible. Dans ce groupe, la perte
de poids etait de 31% apres 1 an.
Aucun deces n’a ete enregistre dans
I’une ou I'autre des series. La
derivation jejuno-ileale assure une
perte de poids acceptable mais les
patients necessitent une surveillance
continue. Le cloisonnement gastrique
entraine efficacement une perte de
poids en autant qu’on puisse prevenir
I'elargissement de I'ouverture.
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Diets, drugs, psychotherapy, behavi
oral and exercise programs, injec
tions, hypnotherapy, acupuncture and
tooth-wiring have all been espoused
for weight loss in morbidly obese in
dividuals, but none has proven reli
able over the long term. Surgical ap
proaches have therefore evolved as a
last resort in an attempt to provide
effective, lasting weight loss (Fig. 1).
We review the development of these
procedures and compare our experi
ence with jejunoileal bypass and gas
tric partitioning.

FIG. 1—Patient before and after sur
gery.

Historical Background

To allow food to bypass the major
absorptive areas of the small bowel,
Payne and colleagues1 and Lewis and
colleagues2 experimented with the
end-to-side jejunotransverse colostomy
(Fig. 2), but the sequelae of elec
trolyte imbalance, occasional excess
loss of weight and liver failure were
too hazardous. Payne then popular
ized the end-to-side jejunoileal by
pass3"5 (Fig. 2); his initial measure
ments of 37.5 to 12.5 cm were asso
ciated with late weight gain in some
patients, so were changed to 35 to 10
cm. These precise measurements from
the ligament of Treitz along the me
senteric border of the bowel were
found to allow the weight loss to be
maintained after adaptation of the
functioning small bowel. The jejunal
stump was tacked to the root of the
transverse mesocolon to prevent in
tussusception. Because some patients
did not lose enough weight because of
reflux occurring a short distance into
the bypassed bowel,6 other procedures
were devised.
Scott and colleagues,6"8 Salmon9 and
Buchwald and associates10 developed
the end-to-end jejunoileal bypass,
draining the bypassed and isolated
bowel into the transverse colon, sig
moid or cecum (Fig. 3), to discourage
reflux into and absorption by the by
passed bowel. Palmer and Marliss11
modified the Payne bypass by using
a Y-shaped anastomosis (Fig. 3) to
direct food to the cecum without re
flux; furthermore, they simply tacked
the jejunal stump to the adjacent
ileum.
To avoid the undesirable sequelae
of intestinal bypass, Mason and asso
ciates12'13 pioneered the gastric bypass

FIG. 2—Left: Jejunocolic bypass after Payne and col
leagues4 and Lewis and associates.2 Right: End-to-side jejuuoileostomy (T-shaped anastomosis) popularized by Payne.3"5
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(Fig. 4), dividing the proximal 10%
of stomach with a Billroth II-type
retrocolic, short-loop, gastrojejunos
tomy, using a stoma 12 mm in diame
ter. The limited gastric functional
capacity and narrow outlet necessi
tated decreased food intake. Alden11
simplified this difficult procedure by
a staple-line partitioning the stomach
(which was not transected) and by an
antecolic gastrojejunostomy to the
proximal segment of 60-ml capacity.
Griffen and colleagues15,16 used a
retrocolic Roux-en-Y jejunal loop
anastomosed to a proximal 50-ml seg
ment of divided stomach in order to
avoid bile reflux, lessen the hazard
from anastomotic leakage and facili
tate moving jejunum in a retrocolic
fashion to a high position (Fig. 5).
Pace and coworkers17'18 described the
simpler technique of gastric parti
tioning (Fig. 6), removing three cen
tral staples before a single application
of the TA90 stapler (United States
Surgical Corp., Stamford, Conn.)
leaving a 9-mm opening, but Cohn
and associates,19 using this method,
had a mean weight loss of only 20%
at 10 and 16 months.
Patients and Methods

Between Sept. 26, 1973 and Sept.
1, 1981 at the St. Joseph’s Health

FIG. 4— Original gastric bypass of
Mason.12

FIG. 3—Left: End-to-end jejunoileal bypass; Scott and
associates6'8 and Salmon9 drained bypassed bowel into trans
verse (A) or sigmoid (B) colon; Buchwald and colleagues10
chose cecum (C). Right: Modification of Payne bypass by
Palmer and Marliss.11 Appendix is removed in all jejunoileal
bypasses.
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Centre in Toronto, 174 consecutive
patients underwent surgery for mor
bid obesity, according to established
criteria (Table I). The first 64 patients
underwent jejunoileal bypass. From
1973 to 1975 patients underwent the

Table I—Criteria for Operation
Presence of morbid obesity, i.e., more than
45 kg overweight or twice the ideal
weight for more than 5 years
Failure of conservative treatment for more
than 5 years
Stable life pattern
Absence of endocrine disorder
Cooperative
Acceptable operative risk
Absence of alcoholism*

Scott jejunoileal procedure (Fig. 3,
left). In the University of Toronto col
laborative group, however, Palmer’s
patients had a similar weight loss, so
from 1975 on we used his simpler
method (Figs. 3 and 7). In patients
who underwent jejunoileal bypass, the
mean weight was 135 kg (range from
94 to 178 kg), the mean height was
156 cm (range from 125 to 186 cm)
and the mean age was 36 years

(range from 15 to 61 years). The
female to male ratio was 15:1. To
wards the end of the study period
the Gomez-type20 of gastric partition
ing was becoming popular as a sim
pler and safer alternative to gastric
bypass, so our next 110 patients
underwent
this
procedure.
In
these patients the mean weight was
127 kg (range from 90 to 207 kg), the
mean height was 157 cm (range from
126 to 188 cm) and the mean age
was 33 years (range from 18 to 63
years). The female to male ratio
was 14:1.
Results

Jejunoileal Bypass

‘ Because of potential hepatic complies
tions following operation.

FIG. 7—Payne jejunoileal bypass
modified by Palmer and Marliss.11 Roent
genogram after barium meal at 2 years
shows rapid transit to cecum. Reflux into
bypassed ileum is negligible.

FIG. 5—Extension of Griffen Rouxen-Y gastric bypass.

FIG. 8—Weight loss following Scott
jejunoileal bypass. Number at each fol
low-up point is number of patients. Ar
rows indicate time at which two patients
required further resection.

In the nine patients who underwent
the Scott jejunoileal bypass, the mean
weight loss was 35% (range from
22% to 52%) and had not risen at
96 months postoperatively (Fig. 8).
However, two early patients who had
slightly excessive measurements at
operation required a further resec
tion, at 22 and 37 months respect
ively, to achieve adequate weight loss.
In patients who had a modified
Payne jejunoileal bypass with Yshaped anastomosis, the weight loss
after 72 months was 33% (range
from 18% to 53%) and has not
risen (Fig. 9). There has been no
excessive weight loss.
The effects of the weight loss on
the side-effects of morbid obesity
are shown in Table II. Blood pressure
fell from an average of 180/120 mm
Hg with wide cuff to 140/90 mm Hg
at 12 months (Fig. 10).
The early postoperative complica
tions are shown in Table III and the
late sequelae in Table IV. Hypoka
lemia was treated by Slow K or Kaon
elixir,10'21 hypomagnesemia by Magnesium-Rougier and hypocalcemia by
Calcium-Sandoz.22 Polyarthritis was
eliminated by metronidazole.10,23 Renal
calcium oxalate stones were treated
by a low oxalate diet (avoiding choco
lates, cola drinks, tea, carrots, celery,
spinach, gelatin, nuts, plums and
strawberries)22 and by giving calcium
carbonate orally.10,24 Excess “gas” re
solved with metronidazole.
Only one jejunoileal bypass in our
series has so far been reversed. The
patient was a woman who weighd 123
kg and was 156 cm tall. She suffered
from dyspnea, diabetes, osteoarthri
tis, urinary stress incontinence and
recurrent varicose veins. A Payne
jejunoileal bypass in March 1976
reduced her weight to 58 kg and the
associated problems subsided. How-

FIG. 6— Gastric partitioning with
TA90 (4.8-mm staples) after Pace and
associates.17

FIG. 9—Weight loss following Payne
jejunoileal bypass with Y-shaped ana
stomosis.
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ever, she had recurrent oxalate
nephrolithiasis and would not coop
erate with respect to diet and drug
therapy. She underwent reversal of
the bypass elsewhere November 1980
and is fighting weight gain.
The adaptation of the functioning
small bowel consisted of dilatation
and lengthening as well as prominence
of the valvulae conniventes, shown
by roentgenograms after barium in
gestion, and marked elongation of
villi associated with cellular hyper
plasia (but not cellular hypertrophy)
as in Fig. 11. This figure shows the
histologic features in the bowel of
the patient who required further re
section at 37 months because of in
adequate weight loss.25 Bypassed
bowel showed mucosal atrophy.
Of the 174 patients in the study,
168 had liver biopsy at the time of
operation (Table V). Patients showed
hepatic steatosis varying from severe
to mild. The principle area of fattv
distribution was centrilobular (37% )
and diffuse (34%) (Fig. 12). The nor
mal livers (10%) tended to be present
in the younger patients.
After jejunoileal bypass, some serial
liver biopsy specimens appeared worse
at 9 and 12 months, but generally
were improved by 30 months over
the biopsy taken before operation
(Fig. 13). There were transient eleva
tions of serum glutamic oxalocetic
transaminase or alkaline phosphatase,
or both, which generally returned
to normal after 24 months. These
elevations in hepatic enzyme levels
frequently did not correlate with the

liver biopsy findings. All serum bili
rubin levels remained normal. All
patients were routinely given pre
digested protein capsules (3 cap
sules tid) containing the lipotropic
factor L-methionine (3.9 mg/capsule),
and larger doses were prescribed
when the results of liver function
tests or biopsy findings were abnor
mal. Patients were also given multiple
vitamins and instructed regarding a
high-protein, low-fat diet.26,27 There
have been no instances of liver failure.
Diarrhea after 1 year was not a
problem. Indiscretions in dietary in
take, such as of greasy or oily foods,

H y p e rte n s io n
D ia b e te s
R e s p ir a to r y d is tre s s
H y p e rlip e m ia
O s te o a r th r itis (k n e e s ,
a n k le s , lo w b a c k )
F a t t y liv e r
S ta s is u lc e rs and e d em a
V a r ic o s e v e in s
T h r o m b o p h le b itis
C h o le c y s titis

U r in a r y s tre s s
in c o n tin e n c e
In t e r t r ig o
P s y c h o s o c ia l and
e c o n o m ic p ro b le m s

Fig. 14 shows the procedure we
used. The left triangular ligament of
these fatty livers was not divided.
The upper portion of the Polytract
retractor with the Gomez hand
(Narco Pilling, Downsview, Ont.)
placed over the padded liver facili
tated exposure. A Penrose drain
about the esophagus identified the
cardia. The TA90 stapler was applied
twice, high on the stomach, after four

C o m p lic a tio n

N o.

W ou nd in fe c tio n
S erom a
D e e p v e in th ro m b o s is
P u lm o n a ry e m b o lis m

1
2
2
0*

*2 p a tie n ts h ad p re v io u s h is to r y o f p u lm o n a ry e m b o li.

FIG. 10— Mean blood pressure ac
companying weight loss. Circles repre
sent systolic pressure, triangles represent
diastolic pressure.

B e fo r e
45 (s e v e r e in 1 6 )
36 (fr a n k in 8, m ild
in 22, la t e n t in 6 )
40 (s e v e r e in 1 7 , 2 w ith
P ic k w ic k ia n s y n d ro m e )
15 (ty p e II in 2,
ty p e IV in 1 3 )
46 (s e v e r e in 22,
d e b ilita tin g in 9 )
57 (m a r k e d in 1 7 )
4
11
4
27 (p r e v io u s c h o le c y s te c to m y
in 19, p r e s e n t c h o le c y s te c to m y
in 8 )

E ffe c t o f
w e ig h t loss
R e s o lv e d in 24
N o h y p e rg ly c e m ia
R e s o lve d

T a b le IV — L a te C o m p lic a tio n s
a f t e r J e ju n o ile a l B y p a s s
C o m p lic a tio n

N o.

P e rs is tin g e le c tro ly te a b n o r m a lity
H y p o k a le m ia
H y p o m a g n e s e m ia
H y p o c a lce m ia
P o ly a r th r itis
R e n a l (c a lc iu m o x a la t e ) s to n e s
E xcess fla tu s a n d b lo a tin g
In c is io n a l h e rn ia
M e c h a n ic a l o b s tru c tio n o f b y p assed
ile u m
In tu s s u s c e p tio n o f je ju n a l s tu m p

16*
9
4
3
6
5
11
6

It
It

‘ R e q u ir in g r e p la c e m e n t.
(S a m e p a tie n t ( F ig . 1 1 ).

R e s o lv e d
S trik in g im p ro v e m e n t
in 43
(S e e t e x t )
H e a le d in 3

T a b le V — S ta tu s o f L iv e r a t O p e ra tio n

—
—

P rin c ip a l a re a of
f a t d is tr ib u tio n

—‘

35 o f 60 w o m e n
31

R e s o lv e d in a ll b u t 1
R e s o lv e d *

33

G e n e ra l im p ro v e m e n t

*2 0 u n d e r w e n t s u b s e q u e n t lip e c to m y .
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Gastric Partitioning

T a b le I I I — E a rly C o m p lic a tio n s
a f t e r J e ju n o ile a l B yp ass

T a b le I I — S id e -E ffe c ts o f M o rb id O b e s ity in 64 P a tie n ts
W ho U n d e r w e n t J e ju n o ile a l B yp ass

S id e - e f f e c t

still caused rapid transit21 with stea
torrhea and anal irritation in a few
patients, and Lomotil was occasional
ly used.20 Lomotil was also used when
an abnormality was found in the
electrolyte levels or results of liver
function tests, to delay transit and
prevent electrolyte and protein loss.

VOLUME 25, NO. 3, MAY 1982 /

C e n tr ilo b u la r
D iffu s e
C e n tr ilo b u la r-m id z o n a l
M id zo n a l
P e r ip o r ta l
O th e r
N o rm a l

% o f p a tie n ts
( n = 168)
37.4
34.4
9.8
3.7
1.2
3.1
10.4
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staples had been removed from the
greater curvature side of the instru
ment before each application, leaving
a 50-ml pouch and a greater curvature
channel. A no. 18 F nasogastric tube
was placed through the outlet at the

Fig. 11a

end of the operation to decompress
both sides of the partition.
This procedure (Fig. 14, left) was
performed on 56 patients. The staple
lines were secured with through-andthrough polypropylene sutures at the
corners. The mean weight loss (Fig.
15) was 21% at 12 months but only
16% (range from 0% to 36%) at
30 months, due to stomal enlarge
ment. Two patients weighed the same
and two weighed more than preoperatively. After many months there was
uninhibited emptying of the proximal
pouch and enlargement of the stoma.
The next 54 patients underwent
a similar procedure (Fig. 14, right),
but a circumferential, seromuscular,
imbricating, running, polypropylene
suture was inserted against a no. 38 F
Maloney bougie, to produce a nonexpandable outlet 1.2 cm in diameter.
A large clip on the lesser curvature

prevented disruption of the line of
staples. We found use of a no. 32
F bougie (10.2 mm opening) unsatis
factory because we had to reoperate
4 to 6 weeks postoperatively to en
large the outlet in five patients. The
mean weight loss with the reinforced
nondistensible channel (Fig. 15) at 12
months was 31%, and there has been
no weight gain in the five patients
now followed up for 15 months.

Fig. 13a

Fig. l i b

Fig. l i d

Fig. 13b

Fig. 11c
FIG . 11— (a) N orm al jejunum during
Scott jejunoileal bypass, (b) At 24
months after bypass, while pregnant, pa
tient had obstruction of bypassed bowel,
which had been drained into sigmoid
colon; segment of ileum was resected.
Mildly atrophic m ucosa can be seen
in bypassed bowel 25 cm from sigmoid.
Patient subsequently had full-term n o r
mal delivery.25 (c) A t 37 m onths, she
had resection of in-continuity bowel for
further weight loss. Elongated villi with
hyperplasia of cells are seen as adapta
tion to short bowel, (d) At 47 months
there was intussusception o f jejunal
stump, which was resected. M ucosa is
markedly atrophic (hem atoxylin and
eosin, reduced by 49% from X 25).

F IG . 12— Severe diffuse fatty m eta
morphosis (> 7 5 % of liver infiltrated).
Some portal areas are spared (hem a
toxylin and eosin, reduced by 49%
from X 25).
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Fig. 13c
F IG . 13— (a) L iver biopsy shows dif
fuse fatty in filtration at operation, (b)
Same patient 12 m onths after jejunoileal
bypass shows im provem ent ( < 2 5 % of
liver occupied by fat), (c) At 36 m onths
liver is norm al (hem atoxylin and eosin,
reduced by 55% from x 100).
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These patients can eat only very small
soft meals, chewed well, slowly. Fig.
15, right, includes three of our pa
tients, and one from elsewhere, who
had undergone previous gastric parti
tioning with no control over the chan
nel and who subsequently had the
channel narrowed and circumfer
entially imbricated over a bougie.
The postoperative complications in
the 110 patients are shown in Table
VI. The five patients requiring re
operation had circumferential imbrica
tion initially against a no. 32 F bougie
and were guilty of dietary indiscre
tion despite instructions to take tiny
liquid meals (e.g., from a 30-ml plas
tic medicine glass) for 8 weeks postoperatively.18 At reoperation, the
through-and-through and circumferen
tial sutures about the channel were
removed; closure of the channel and
gastrogastrostomy over a bougie
would likely be the procedure in
later cases. There was no diarrhea
since the vagal trunks were preserved,
but constipation occurred occasionally
in the first 2 months, because of lack
of dietary residue.
Fourteen patients had cholecystec
tomy for cholelithiasis at the time
of gastric partitioning (28 had had
previous cholecystectomy), and 4 un
derwent repair of a hiatal hernia using
the Hill technique.
When excess trauma occurred in
the stomal area during operation, a
gastrostomy was placed in the lower
stomach for effective decompression
and possible later feeding. This was
done in 19 patients. A drain was
placed in each patient. There have
been no leaks or subphrenic abscesses.
There have been no metabolic com
plications after the procedure. The
liver has not shown the abnormalities
that occasionally occurred after
jejunoileal bypass, but has improved
directly with the weight loss.

If an epidural catheter is to be in
serted, minidose heparin can only
be started postoperatively, but pa
tients went to the operating room
wearing compression stockings. There
were no instances of pulmonary em
bolism.
Jejunoileal bypass produced satis
factory weight loss, but obligates the
patient to years of medical surveil
lance. Scott and associates6 showed
that as the length of bowel is short
ened, metabolic complications in
creased. On the other hand, increas
ing bowel length permits future
weight gain after bowel adaptation;
this is anticipated because of the
transport capability of the millions of
intestinal absorptive cells involved.
The adaptations that maintain the
weight as it stabilizes consist of villus
hypertrophy in the in-continuity bow
el and also in the immediately ad
jacent bypassed ileum where intestinal
contents reflux.30,31 We22 and others32
have found mucosal atrophy in the re
maining bypassed bowel. Friedman
and associates33 found villus height in
the proximal jejunum to be almost
identical to that before jejunoileal by
pass, but others30'32 have not found
this.
The major cause of liver deterio
ration after jejunoileal bypass is be
lieved to be protein malabsorption,
especially of methionine and choline,
in the first 2 years.10'11,22 The lack of
this complication in our patients may
be due to the liberal use of pre
digested protein capsules. It is known
that infusions of amino acids given
intravenously or into bypassed jeju
num if exteriorized will rapidly re
verse the liver changes.
In gastric partitioning, a small
pouch to give the sensation of satiety34
and a small calibrated outlet that will
not expand are important.20 Double
application of the stapler is necessary
to prevent staple-line disruption.18

Circumferential Marlex mesh about
the outlet has been proposed, but has
been followed by delayed progressive
scarring and stenosis.11 Buried nonreactive circumferential Silastic tub
ing may be advantageous.35 Tech
niques have been described to leave
a centrally located opening in the par
tition.17 However, it is difficult to re
inforce this central channel posteriorly
to prevent its ultimate enlargement.
Furthermore, with a central outlet,
one may be unsuccessful in applying
the stapler twice with the two open
ings coinciding to permit a channel.
We believe that if suture reinforce
ment is used along the entire length
of the partition, this can be difficult
and hazardous. Oblique partitions
with the outlet on the lesser curva
ture side have been proposed,35 but
it is known that food tends to pass
readily down the lesser curvature
Magenstrasse so that weight loss may
be unsatisfactory; furthermore, a fundal pouch for distension and to give
a sensation of fullness is helpful.
The procedures are in a state of de
velopment, and many improvements
will likely be devised in the next
decade. Comparisons of new tech
niques are now being reported.36
Lately, in patients who are unac
ceptable operative risks, we have used
an intragastric balloon inserted trans-

1

-c

'

■«

V

V
Table VI Complications after
Gastric Partitioning

4
Complication
Early
Transient outlet obstruction
Persistent outlet obstruction
requiring reoperation
Wound seroma
Late
Ventral hernia

No.

5

«

5
11
8

Discussion

y

To our knowledge all 174 patients
who underwent surgery for morbid
obesity are alive. Thoracic epidural
anesthesia, supplemented by a light
general anesthetic, was usually used,
and the patients were awake and extubated at the end of the operation.28
The epidural was maintained for
analgesia up to 3 days after operation
Patients were able to breath and
move with ease, and did not require
intramuscular narcotics, which have
a respiratory depressant effect. F ur
ther, there is evidence that nitrogen
balance is improved with epidural
analgesia.29
288

4

k.

■»
FIG . 14— Left: gastric partitioning as
performed on first 56 patients with no
control over outlet; this led to stomal
enlargem ent. Right: gastric partitioning
with nonexpandable outlet performed in
last 54 patients.
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F IG . 15— W eight loss following gas
tric partitioning w ithout reinforcem ent
of outlet (left) and with reinforcem ent
by nonexpandable imbricating Prolene
suture about outlet (right).
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nasally (Fig. 16). Control over the
volume of air in the balloon has been
maintained by a fine nasogastric tube
taped externally over the ear. How
ever, the weight loss will likely be

limited to the period that the balloon
is in situ.
12.

C onclusions

Jejunoileal bypass, using critical
measurements, has provided accepta
ble and lasting weight loss, but the
sequelae require prolonged surveil
lance. Gastric partitioning with a
pouch capacity of 50 ml is not asso
ciated with long-term complications
but provides unreliable weight loss
due to the expanding outlet. The
procedure may provide as effective
weight loss as jejunoileal bypass if a
secure technique is used to prevent
subsequent enlargement of an outlet
of 1.2 cm or less.

13.
14.
15.

16.
17.

18.

Addendum

After a further 6 months of follow-up,
the mean percentage weight loss after
gastric partitioning with the reinforced
channel is 34% in the 14 patients who
have passed 18 months. There continues
to be a variation in the percentage
weight loss in different patients, despite
the calibrated operation. Experience with
a further 43 patients suggests that the
no. 36 F bougie may give optimal results
in the procedure performed.

Fig. 16b
FIG. 16—Patient with (a) intragastric
balloon in place to provide early satiety,
(b) This man lost 44 kg in 5 months
with resolution of stigmata o f morbid
obesity.
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Because “biphasic infection”
threatens to complicate surgery
of the large bowel...

control sepsis with
an antibiotic to arrest primary
gram-negative aerobic infection
in combination with
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Treatment Outcome and Efficiency in Surgery
T.H. B rian H aig,

Health gains for patients treated on
the surgical service of the University
Hospital in Saskatoon have been
measured using an illness index
matrix and these gains have been
related to financial costs. Although
many patients benefited, 46.5% did
not, either because they suffered
self-limiting complaints or because
their diseases were beyond the
surgeon's ability to help. This 60-bed
surgical service generated costs of
$8 million in 1979, of which about S3
million were for services from which
there was little or no gain for the
patient. Since 72% of expenditures
were for basic bed, board and nursing
costs, more exacting use of hospital
beds holds the greatest potential
for increasing efficiency. There is
evidence, too, that our use of medical
manpower may be improvident.
Les benefices pour la sante chez les
patients traites dans le service de
chirurgie de I’Hopital Universitaire
de Saskatoon ont ete mesures a
I'aide d’une grille d’indices de maladie,
et ces benefices ont ete rattaches
a leurs couts financiers. Bien que
plusieurs patients aient profite des
traitements, il n’en a pas ete de
meme pour 46.5%, soit parce qu’ils
souffraient d’affections qui evoluent
spontanement vers la guerison, soit
que leur maladie depassait la capacite
d intervention du chirurgien. En 1979,
ce service chirurgical de 60 lits a
entraine des couts de S8 millions dont
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S3 millions sont alles pour des services
n'offrant que peu ou pas de benefices
pour le patient. Comme 72% des
depenses passent pour des couts de
base tels que le gite, le couvert et
le personnel infirmier, la meilleure
facon d'ameliorer I'efficacite serait
de faire un usage plus parcimonieux
des lits d'hopitaux. II existe aussi des
indices d'une utilisation abusive des
effectifs medicaux.

ment in hospital and to tabulate the
cost of that treatment; then we cal
culated the dollar cost of each incre
ment of benefit to give a measure of
efficiency. We did this for a random
sample constituting 20% of all pa
tients treated on the adult general
surgery service of University Hospital
in Saskatoon during 1979, using hos
pital charts as the sole source of
information.
Working from concepts espoused
In 1979, Canadians spent $18 579 959
by Williams14 and by Patrick and col
000 on health care.1 Of this sum
leagues,15 we first defined illness as
90% went towards personal services
having three components — discom 
for patients, leaving less than $2 000
fort, dysfunction and prognosis. In
000 000 for health promotion through
dependent
assessments of discomfort
social and community interventions.
and dysfunction were made for the
Since, to a very large extent, the
first day each patient entered the
determinants of health lie outside the
surgical ward in 1979. The discomfort
sphere of therapeutic medicine,25 one
component was measured using a 10must question the disproportionate
point ordinal scale having three
allocation of expenditures towards
levels of severity and three levels of
therapy, even in a developed country
frequency, with the absence of dis
like Canada. Indeed, McKinlay and
McKinlay6 contended that despite cur comfort and death, as the two ex
tremes. For dysfunction we used the
rent levels of health and longevity in
cardinal scale developed and tested
the United States, about 92% of all
by Bush and colleagues,15"17 but we
health gains over the past 100 years
simplified it to a 10-point scale by
occurred before the surge in medical
grouping entries wherever preference
spending began in the mid-1950s. The
same picture emerges from Britain.7 values tended to cluster. We then had
two coordinates — one a measure of
Still, medical care has contributed
discomfort
and the other a measure
to the health of our population over
the past 50 years,8 as it has to com of dysfunction — descriptive of each
patient s condition on the day of ad
forting the sick for much longer than
mission to hospital. We plotted these
that. What is perhaps less apparent,
coordinates
on an illness index matrix
but more disturbing, is that we seem
upon
which
indifference curves had
to be putting more and more of our
been drawn as described by Williams14
limited resources into interventions
and by Culyer;18 each indifference
from which expectations of gain are
curve was assigned the preference
least.9"18
value ascribed to the corresponding
What we lack is a good way of
dysfunction value. This simplification
measuring the health gains that do
was considered satisfactory for an
accrue from medical interventions and
initial
study of the method and gave
of determining the cost of each in
us
the
desirable attribute of prefer
crement of gain. Without this knowl
ence
values
on a cardinal scale. Ill
edge we cannot judge how the manv
ness index measurements of like char
components of medical care compare
acter were then made for each dav
with alternative ways of allocating
after the patient’s admission for 1
resources to improve health. This
year and a time profile curve was
work reports on one set of techniques
that can be used for measuring thera drawn that was descriptive of the
peutic outcome and relates the out patient’s course for this 1 year. A
second curve was then drawn for
come to cost.
each patient, as outlined by Williams1’
and by Culyer,18 descriptive of that
Material and Methods
patient’s probable course had treat
Our approach was to measure the
ment not been undertaken. For this
improvement in health experienced
information we went to various
by individuals as a result of treatsources in the medical literature,
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drawing particularly heavily upon
Eiseman’s recent study19 o f prognosis
in surgical disease. Using Williams’
technique of subtracting the area un
der the curve depicting the course
with treatment from that under the
curve delineating prognosis in the
absence o f treatment, we derived a
value descriptive o f the gain that the
patient achieved from therapy. We
call this the social utility value be
cause it describes the benefits derived
by that person as a social being and
not simply as a patient with a specific
medical diagnosis.
Costs o f hospital care, too, were
tabulated individually for each pa
tient, but no attempt was made either
to assess social costs or to convert
these dollar equivalents. The hospital
business office gave us a per diem
bed cost for each bed, including
hostelry, dietary and nursing costs;
this base figure was used for each
hospital day. T o it was added the
physicians’ fees, and costs o f drugs,
laboratory and radiologic services and
operating room facilities; fo r these
categories each patient was treated
individually by listing, then costing
out, all o f the services and materials
applied to that patient while in hos
pital.
Efficiency was defined as the dol
lar cost of each social utility unit
and was calculated by dividing the
total cost of treatment by the social
utility value derived from that treat
ment.
Results

The

distribution

of

social utility

values plotted against costs is illus
trated in Fig. 1; it shows a skewing
to the positive benefit side, but also
shows a heavy clustering towards
zero. Positive social utility values
were attained by 53.5% o f patients.
For the 46.5% o f patients who de
rived zero or negative benefits, 40.6%
o f the total resources were expended.
This, projected to the whole service,
would amount to about $3 205 855
out o f a total expenditure o f $7 895
918 for the general surgical service
in 1979. Thirty-six (11.4% ) patients
in the sample had. costs exceeding
$10 000 and consumed a total o f
$566 472, which amounted to 36%
o f the total resources for this sample.
These patients were a decade older
than average and their mean gain
was about half that o f the whole
sample, but 61% o f them did benefit.
Table I shows that basic bed costs
accounted for 72% o f the total, while
investigative services cost about 8%
and therapeutic materials and services
took almost 2 0 % . The proportion
attributable to basic bed costs was
somewhat greater for those who did
not benefit, as were the investigative
costs, while therapeutic services were
proportionately a little higher for the
group achieving positive health bene
fits from their stay in hospital.
Table II records the age and sex
distribution for the sample as it was
divided, somewhat arbitrarily, into
disease categories. The mean social
utility value for the entire sample
was + 5 6 .9 8 , and for 16 o f the 18
disease categories the social utility
value was positive. The magnitude
o f benefit did vary substantially be
tween disease categories, but there
was little constant relation between
the degree o f benefit and either age
or sex. The proportion o f patients
who benefited varied appreciably be
tween disease categories as well, but

in 13 o f the 18 categories more
people benefited than did not, with
an average o f 7 5% having a positive
social utility value.
Few patients with benign breast
or endocrine disease benefited, prin
cipally because o f the relatively trivial
nature o f their illnesses. Treatment
outcome was disappointing also for
those with disease o f the lungs or
thorax, exclusive of carcinoma, but
in these cases it was usually because
they suffered from serious diseases
for which little could be done. While
many patients with peripheral arterial
disease did gain substantially from
treatment, a relatively large propor
tion o f persons with these chronic,
disabling diseases gained nothing.
O f all patients treated on this
service, 4 5% had complaints referable
to the gastrointestinal system, exclu
sive o f cancer. Most who suffered
from the common specific diseases —
cholelithiasis,
anal
and
perianal
disease, hernia, bowel obstruction
and appendicitis — gained substan
tially from treatment. However, 40%
o f this large group had a variety o f
more nebulous complaints and only
a quarter o f these were helped as a
result o f their hospital treatment;
often the cause was not discovered.
Efficiency in this group, as in almost
all others, was substantially greater
in those patients who were operated
on. This reflects the fact that overall,
more could be achieved when opera
tion was possible.
Table III catalogues the total cost
o f treatment per patient for each dis
ease category and shows the deriva
tion o f these costs. Overall expendi
tures generally reflect the complexity
o f therapeutic requirements, so ill
nesses requiring sophisticated tech
nology, highly skilled nursing and
ancillary care and very specialized
medical procedures cost most. In all

Table I—Costs

Costs
Total, $
Bed/board/nursing, $ (% )
Investigation, $ (% )
Laboratory
Radiology
Miscellaneous
Therapy, $ (% )
Physicians
Drugs
Operating room/
miscellaneous
F IG . 1— Scattergram showing cost —
benefit coordinates for each o f 316 pa
tients.
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Total sample
(N = 316)

Positive SUV*
(n = 169)

Negative SUVt
(n = 147)

1 579 183
1 146 791 (72.62)

938 012
(71.75)

641 171
(73.89)

69 512 (4.40)
43 142 (2.73)
10 343 (0.66)

(4.40)
(2.55)
(0.64)

(4.40)
(3.00)
(0.67)

168 378 (10.66)
76 007 (4.81)

(11.17)
(4.97)

(9.93)
(4.59)

64 961 (4.11)

(4.50)

(3.54)

♦Patients who derived a social utility value (SUV) greater than zero.
(Patients who derived a social utility value of zero or less.
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categories, however, b^sic bed costs
accounted for by far the largest ex
penditure and investigative procedures
the smallest. For most groups of pa
tients the tabulations reflect quite
well the entire dollar cost of treat
ment for the particular illness. This

would not be true for cancer patients,
however, as some will have received
intensive courses of chemotherapy
or radiotherapy after leaving hos
pital. Similarly, expenditures for
cardiac patients will be biased to
wards the low side because virtually

all these patients were investigated
on the cardiology service during an
admission before, and distinct from,
their admission to the surgical service.
These services would add from
$1000 to $2000 to the overall costs
generated by each of these patients

*
Table II

w

Category of
disease

*

v

(
>

Cholelithiasis
Anal/perianal
Groin hernia
Small bowel obstruction
Appendicitis
Peptic ulcer disease
Other gastrointestinal/
abdominal§
Trauma
Coronary artery disease
Valvularheart disease
Other cardiac disease
Peripheral artery disease
Venous disease
Carcinoma
Soft tissue tumour
Breast/eridocrine!
Lung/thorax§
Renal§
Total sample

i
4

Demographic and Efficiency Characteristics

Age, yr*

Sex ratio
male : female

Social utility
value*

% deriving
positive social
utility value

Efficiency/

46(20)
54 (16)
55(15)
45(22)
25 (13)
52 (19)

2:17
9 :6
13:0
5:8
8 :4
11:1

84.14 (85.66)
68.35 (68.25)
101.19 (101.52)
95.30 (94.62)
167.46 (148.63)
67.92 (119.72)

68
80
77
77
75
42

44.12
41.58
20.33
60.96
12.55
56.65

95
93
85
54
100
25

44.14
40.34
19.54
52.13
12.55
40.52

58
28
17
13
8
34
9
36
3
18
9
3

52 (24)
41 (21)
51 (8)
57 (16)
72 (13)
67 (12)
52 (17)
65 (16)
46(18)
49 (11)
57 (11)
75 (15)

24:34
22 :6
14 :3
8 :5
5 :3
29:5
3:6
20 :16
1 :2
0:18
6:3
1 :2

(61.82)
(90.32)
(72.65)
(97.55)
(54.23)
(101.84)
(70.97)
(60.95)
(71.85)
(41.82)
(6.87)
(69.17)

26
64
71
54
100
47
56
58
100
11
22
100

176.10
84.45
93.64
137.00
39.48
169.52
61.23
148.97
8.26
N/A||
N/A
98.73

36
71
100
92
88
88
44
75
100
83
44
67

117.63
82.01
93.64
133.69
33.59
164.85
29.19
138.41
8.26
N/A
N/A
101.30

316"

53 (19)

179:137

56.98 (89.38)

54

87.69

72

79.60

No. of
patients
19
15
13
13
12
12

21.32
74.64
77.85
57.92
98.24
45.92
58.46
46.77
139.70
-22.84
-3 .6 5
95.34

Efficiency
for
% undergoing
operation
operation!

‘Mean ( ;t standard deviation).
tEfficiency = mean total c o s t + mean social utility value = the mean dollar cost for purchase of each social utility unit.
/Efficiency calculations confined to those patients in this category who underwent operation.
^Excluding malignant neoplasms and renal transplants.
*! Total sample slightly less than total for categories because a few lesions fell neatly into more than one category.
||This calculation is meaningless when social utility value is zero or less.

Table II I — Distribution of Costs within Illness Categories
Bed costs/
Category of
disease

Total cost/patient,
5*

$*

Investigation costs/

Therapeutic costs§
r

%

V

Cholelithiasis
Anal/perianal
Groin hernia
Small bowel obstruction
Appendicitis
Peptic ulcer disease
Other gastroi ntestinal/
abdominalf
Trauma
Coronary artery disease
Valvularheart disease
Other cardiac disease
Peripheral artery disease
Venous disease
Carcinoma
Soft tissue tumour
Breast/endocrine*
Lung/thorax*!
Renal*!

3712 (1328)
2841 (2374)
2058 (859)
5810 (3535)
2102 (1161)
3848 (2666)

2864 (1109)
2212 (1909)
1541 (632)
4532 (2701)
1534 (898)
2984 (2250)

77.16
77.8
74.87
78.01
72.98
77.55

158 (87)
87 (68)
78 (66)
367 (447)
103 (133)
316 (173)

4.26
3.05
3.80
6.32
4.88
8.21

690
541
448
930
464
548

(195)
(427)
(230)
(619)
(139)
(373)

18.58
19.04
21.77
16.01
22.07
14.24

3721 (3221)
6303 (5608)
7290 (5807)
7935 (3728)
3879 (1936)
7784 (7444)
3579 (5591)
6967 (5659)
1154 (183)
1866 (1265)
5472 (5724)
9413 (3792)

2996 (2638)
4176 (3496)
4593 (4993)
4373 (2683)
2908 (1593)
5718 (6208)
3057 (5169)
5321 (4339)
877 (117)
1259 (805)
4203 (4419)
6945 (2413)

80.51
66.25
63.01
55.11
74.97
73.45
85.41
76.38
75.93
67.47
76.81
73.78

237 (243)
652 (785)
642 (332)
1346 (900)
216 (153)
471 (549)
91 (53)
534 (633)
44 (31)
121 (162)
403 (463)
703 (343)

6.37
10.35
8.81
16.96
5.59
6.05
2.55
7.67
3.81
6.47
7.37
7.47

491
1446
2053
2239
755
1595
431
1109
234
486
866
1765

(468)
(1560)
(537)
(805)
(403)
(1281)
(417)
(919)
(148)
(346)
(900)
(1166)

13.21
22.94
28.17
28.21
19.46
20.49
12.04
15.92
20.25
26.06
15.82
18.75

Total sample

4997 (4884)

3629 (3737)

72.62

389 (312)

7.79

979 (607)

19.58

%

%

*Mean ( ± standard deviation).
tBed, dietary, nursing and related support costs.
/Laboratory, radiologic, electrocardiographic and related costs
^Physicians’ fees, drugs, operating room and related costs.
11Excluding malignant neoplasms and renal transplants.
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and since they are not included in
our figures, efficiency calculations
for both of these groups is some
what overstated.
Discussion

The crux of this work is the meas
urement of treatment outcome. Over
the past three or four decades several
methods have become available to
accomplish this; some are useful,
though of restricted applicability.
Culyer18 discussed a number of these
in some depth and delved into the
conceptual difficulties encountered
with them. In addition, Sullivan20 and
Torrance 21 pointed out problems in
herent in developing health status
indices of the sort used in this study.
Certainly the obstacles are real, but
they must be overcome if we are
to measure the benefits provided by
our therapeutic interventions. The
method used in this work lacks polish,
but it has two outstanding virtues.
First, it is applicable to all categories
of illness and to all types of therapy,
and second, its measurements are
blind to medical diagnoses. This latter
attribute has several important im
plications. Complications and other
unsought outcomes are accounted
for easily and their effects weighted
no differently from the primary com
plaints. Moreover, when the method
ology is refined sufficiently for pro
spective studies, nonmedical personnel
will be able to take the required
measurements, thereby reducing costs
and, perhaps more important, shield
ing patients from medical influence in
making their assessments of outcome.
Of greatest concern with the
methodology is our rudimentary abil
ity to predict the natural history of
untreated disease. For short-term
analyses, such as in this study, the
medical literature supplemented by
first-hand experience works reason
ably well, but is less rigorous than
one would wish. For long-term esti
mates, the literature seems inadequate
and personal experience unreliable.
Some alternative tactic may be neces
sary. The assignment of preference
values requires more study and refine
ment, too, for while the dysfunction
scale of Bush and his colleagues1 5 1 7
is a tested and very good starting
point, it is not comprehensive enough,
and it was calibrated using healthy
young people rather than a patient
population. The discomfort scale we
used is crude and has not been
rigorously tested. The cost calcula
tions are undoubtedly subject to some
error as well, particularly with refer
296

ence to the per diem component for
bed, board and nursing services:
there is bound to be some variation
in requirements between patients. By
sequestering and independently tabu
lating investigative and therapeutic
costs, however, we have fairly ac
curately calculated the real costs en
gendered by each patient studied.
While recognizing and accepting
the above caveats, we can learn sev
eral useful things from this first run
at measuring treatment outcome and
efficiency. First, it is evident that
bed costs are by far the greatest of
the cost components and investigative
costs the smallest. So, in considering
cost containment, keeping people who
do not need acute care out of hos
pital would be by far the most effec
tive way of reducing the expense of
medical care. Given our system of
publicly funded personal medical
services, however, incentives for pa
tients, for physicians and for hos
pitals all tend to increase rather than
to limit hospital use. On our particu
lar service the miscellaneous cases of
gastrointestinal and abdominal disease
are those for which we might improve
our performance most in this regard
Second, limiting laboratory and radiologic investigations likely has merit in
protecting patients from unnecessary
discomfort and harm, but the eco
nomic impact of these efforts will
be modest. A third observation is
that therapeutic services, including
the professional component, were
much less intensely applied to the
usual general surgery patients than
they were to trauma patients — now
largely taken over by subspecialists
— and to patients with cardiac and
arterial disease. While it is recognized
that a tertiary care hospital is a poor
reflection of the larger community,
this observation must make us won
der whether very expensive medical
manpower is being as well used as
it should be or whether our general
surgeons are being overtrained and
underused.
Conclusions

The measurement of therapeutic
outcome in surgery is possible and
can be combined with cost analysis to
evaluate efficiency. The application
of a prototype measure of this sort
allows us to see that we can probably
improve the use we make of hospi
tals and of medical personnel.
The help of Miss Emma Lew, a senior
medical student who undertook the
tabulation of costs, and that of Miss
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Gastric Variceal Bleeding Due to
Occlusion of Splenic Vein in Pancreatic Disease
R oger G. K eith , md,
R obert A. M ustard, j r „ b sc, md *

Nine patients with gastric varices
secondary to occlusion of the splenic
vein, which resulted from pancreatic
disease, were treated by the authors
between 1973 and 1981. Profuse
hemorrhage, recurrent bleeding and
hypochromic anemia were investigated
by endoscopy, gastrointestinal
roentgenography and selective angio
graphy. Pancreatic disease was
defined by ultrasonography, endoscopic
retrograde pancreatography and
operation. There were three cases of
chronic pancreatitis, three of
pancreatic abscess, two of pseudocyst
and one of carcinoma of the pancreas.
Definitive control of upper gastro
intestinal bleeding from gastric
varices was achieved by combining
splenectomy with selective pancreatic
surgical procedures. Two patients did
not undergo operation. One death
resulted from an unresectable carci
noma. Bleeding did not recur in six
patients followed for up to 8 years
after operation.
Entre 1973 et 1981, les auteurs ont
traite neuf patients atteints de
varices gastriques secondaires a une
occlusion de la veine splenique
causee par une maladie du pancreas.
Une hemorragie abondante, des
saignements repetes et une anemie
hypochrome etaient investigues par
endoscopie, radiographie gastrointestinale et angiographie selective.
La maladie pancreatique etait precisee
par echographie ultrasonique,
pancreatographie endoscopique
retrograde et a I’operation. On
identifia trois cas de pancreatite
chronique, trois d'abces pancreatique,
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deux de pseudo-kyste et un cancer
du pancreas.
L’arret definitif des hemorragies
gastro-intestinales superieures dues
a des varices gastriques fut obtenu
par une splenectomie associee a des
interventions chirurgicales selectives
du pancreas. Deux patients n’ont pas
subi d’operation et un deceda d'un
cancer non resecable. II n'y eut pas
de recidives des saignements chez
six patients suivis jusqu'a 8 ans
apres I'operation.

Upper gastrointestinal hemorrhage is
one of the most common reasons for
emergency admission to a gastroin
testinal service. Endoscopy facilitates
early identification of the source of
bleeding in most patients. However,
in a minority no active bleeding site
is identified. The cause of the hemor
rhage is frequently attributed to gas
tritis. Such gastric bleeding may be
associated with pancreatic disease.
Varices may result when splenic vein
occlusion occurs from the extrinsic
effects of such disease. This represents
a form of localized, or left-sided,
portal hypertension. The management
of gastric variceal bleeding from this
cause is quite different from that re
lated to cirrhosis. In this paper we
discuss the etiology, diagnosis and
management of this unusual cause of
gastrointestinal hemorrhage.
Patients and Treatment

The series comprised nine patients,
seen between 1973 and 1981 (Table
I). Five presented with frank upper
gastrointestinal bleeding, three with
hypochromic, microcytic anemia and
one was found incidentally to have
gastric varices at operation for chronic
pancreatitis. All had pancreatic con
ditions documented by ultrasono
graphy, endoscopic retrograde pan
creatography and operation. Disease
included pancreatic abscess, pseudo
cyst, chronic pancreatitis and carci
noma of the pancreas.
Gastrointestinal
roentgenography
was not diagnostic of gastric varices
in eight patients who underwent this
investigation. Endoscopy similarly

FRCP[c]f

was nondiagnostic (Table I). Celiac
angiography diagnosed the condition
in the seven patients who were
studied, and in two cases the diagnosis
was established at operation.
Six patients had definitive surgical
procedures and have had no recur
rence of their gastrointestinal bleeding
during follow-up from 6 months to 8
years. One patient (no. 9, Table I)
with extensive carcinoma of the body
of the pancreas underwent a palliative
gastroenterostomy and died 5 months
later.
Two patients did not have defini
tive treatment. One patient (no. 8,
Table I) had only hypochromic
anemia and refused operation. The
second (no. 5), aged 75 years, had
moderate bleeding that ceased spon
taneously. Because of age and asso
ciated illnesses, she was managed
conservatively and splenectomy will
be performed only if bleeding recurs.
Discussion

Many disease processes may cause
occlusion of the splenic vein with
preservation of flow in the remaining
portal venous system. The causes mav
be intrinsic or extrinsic. Intrinsic
causes, which are extremely rare, in
clude myeloproliferative disorders and
umbilical vein catheterization.1-2 Ex
trinsic causes relate to structures con
tiguous to the splenic vein — the pan
creas anteriorly and the retroperitoneum posteriorly. Rarely, retro
peritoneal fibrosis, lymphoma or
hematoma may produce compression
of the splenic vein resulting in throm
bosis.2,3 More commonly, the pan
creatic lesion obstructs flow. Pan
creatic diseases include chronic pan
creatitis, congenital cyst, pseudocyst,
abscess and carcinoma.2,4-6 Splenic
vein thrombosis is not uncommon
with chronic pancreatitis. Rignault and
colleagues7 described 20 patients with
chronic pancreatitis who underwent
percutaneous splenic portography; 8
were found to have isolated splenic
vein thrombosis. Similar results have
been reported by Salam and asso
ciates.8
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Table I— C linical Features of Nine Patients Presenting w ith Gastric Varices

Patient Age,
no.
yr Sex
i

43

M

2

47

F

3

43

M

4

55

M

5

75

F

6

37

M

7

59

F

8

57

F

9

69

F

Clinical
presentation

Previous
surgery

Pancreatic
disease

Endoscopic
findings

Angiographic
findings

ND

ND

SVT

Vagotomy and
pyloroplasty

Recurrent
Abscess
bleeding
Profuse
Abscess
hemorrhage
Recurrent
bleeding
Bleeding

Gastro
intestinal
radiologic
findings

ND

Pseudocyst
Abscess

Pseudocyst
Profuse
hemorrhage
Chronic
Pain
pancreatitis
Anemia
Chronic
pancreatitis
Anemia
Chronic
pancreatitis
Carcinoma
Anemia,
cachexia

Vagotomy and
pyloroplasty
Cystojejunostomy

ND

ND

SVT

ND

ND

SVT

Cystogastrostomy

ND

ND

SVT

—

ND

ND

External drainage
of pseudocyst
Pancreaticojejunostomy
—

ND

ND

SVT

ND

ND

SVT
SVT

ND
~

Surgical
treatm ent

Follow-up,
mo

Splenectomy

96

Distal pancrea
tectomy and
splenectomy
Cystogastrostomy
and splenectomy
Distal pancrea
tectomy and
splenectomy

60
60
18
8

75% pancreatectomy
and splenectomy
75% pancreatectomy
and splenectomy

8
6
6

Gastroenterostomy

Dead,
5

N D = nondiagnostic, SVT = splenic vein thrombosis.

Once the splenic vein has become
occluded, the venous flow may take
various routes (Fig. 1). The short gas
tric veins may drain to the gastro
epiploic arcade or across the fundus
of the stomach to the left gastric vein
(coronary vein). The fundal veins
may drain through the esophageal
venous plexus, producing portosys
temic collaterals, which may also form
between the spleen and the retroperitoneum. Previous operation may have
altered the venous anatomy, producing
additional collateral pathways. Burbige and associates9 described a case
of bleeding from colonic varices when
thrombosis of the splenic vein from
chronic pancreatitis occurred after
previous gastrectomy had disrupted
gastric collateral vessels.
Variceal hemorrhage secondary to
splenic vein occlusion should be con
sidered in any patient with pancreatic
disease who presents with upper gas
trointestinal bleeding (Table II). On
physical examination, splenomegaly in
the absence of other signs of portal
hypertension or cirrhosis may be
noted in about 50% of patients.10 A

pancreatic lesion may be confirmed
promptly by abdominal ultrasono
graphy, enhanced by grey scale and
real time scanning. Endoscopic retro
grade pancreatography will define any
abnormalities of the pancreatic ducts.
Air contrast roentgenography after
barium ingestion will rarely confirm
the diagnosis. Gastric fundal varices
may assume either a localized poly
poid configuration or produce multi
ple rounded submucosal projections,
which may simulate tumour or hyper
trophic rugal folds (Fig. 2).11'13 En
doscopy is extremely accurate in dem
onstrating esophageal varices but
usually cannot identify gastric varices
because of the thickness of the gastric
mucosa. Endoscopically, gastric var
ices may mimic the appearance
of hypertrophic folds. In the absence
of ulcer, gastritis or other causes
of upper gastrointestinal bleeding,
the endoscopist should suspect gastric
varices.
Celiac arteriography is the defini
tive procedure for identifying gastric
varices and splenic vein occlusion.
Any patient with upper gastrointes-

FIG. 1—Collateral venous return from
spleen may become varicose following
thrombosis of splenic vein.

Table ll— lnvestigations Recommended fo r Bleeding
from Suspected Gastric Varices
Gastric bleeding
Pancreatic disease
Splenic vein occlusion
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Endoscopy
A irco n tra st upper gastrointestinal roentgenography
Ultrasonography or computerized axial tomography
Endoscopic retrograde pancreatography
Operation
Selective arteriography and venography
Measurem ent of hepatic venous pressures
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FIG. 2—Gastric barium roentgeno
gram shows fundal varices which simu
late polyps or hypertrophic gastric
rugae.
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tinal bleeding of unknown cause
should undergo angiography.
The venous films, following selec
tive splenic artery injection, will
demonstrate filling of the splenic
parenchyma but not of the main
splenic vein (Fig. 3). Subsequently,
the collateral venous flow will be
seen. Usually this flow is to the portal
vein by way of the gastroepiploic or
coronary veins. The contributing
varices in the gastric fundus will be
easily identified, contrasted against
an air-filled stomach (Fig. 4). Venous
phase films after injection of the su
perior mesenteric artery can be used
to demonstrate the anatomy of the
portal vein and rule out extrahepatic
obstruction of the portal vein. The
gastric and esophageal collateral veins
will not be opacified by this injection.
Measurement of wedged and free
hepatic venous pressures will give
normal results, ruling out portal hy
pertension from chronic liver disease.
This procedure should always be
completed at the time of angiography
except when profuse hemorrhage
necessitates emergency operation.

FIG. 3—Venous phase angiography
shows complete occlusion (arrow) of
splenic vein at hilum with collateral re
turn through gastroepiploic veins (ar
rows).

Pancreatic disease may cause either
gastric variceal bleeding from occlu
sion of the splenic vein, usually at a
nonexsanguinating rate, or brisk ar
terial hemorrhage from rupture of a
pseudoaneurysm. Patients with chron
ic pancreatitis are particularly at risk,
because splenic vein occlusion is com
mon in this group. Moreover, 10%
of these patients have pseudoaneu
rysms of pancreatic arteries (splenic
artery, gastroduodenal artery second
ary to pseudocyst formation).14
In patients with severe upper gas
trointestinal bleeding who undergo
emergency surgery, the diagnosis of
splenic vein occlusion may be estab
lished at operation. The operative
findings have been described by
Salam and associates.8 The triad of
dilatation of the gastroepiploic vein,
enlargement of the spleen and a nor
mal liver, associated with gastric or
gastroesophageal varices, is highly
suggestive (Fig. 5). The diagnosis may
be confirmed by demonstrating pan
creatic disease and by finding a nor
mal portal vein pressure. Portal
manometry and venography can be
carried out by threading a catheter
into a tributary of the superior
mesenteric vein.
Once the diagnosis of bleeding
varices secondary to splenic vein oc
clusion is established, the definitive
surgical procedure is splenectomy.
There may be extensive portosystemic
collaterals in the perisplenic liga
ments, so it is wise to ligate the
splenic artery before mobilizing the
spleen. Little and Moossa15 described
an anterior gastrotomy for oversewing
the varices, because in their series
active bleeding was not stopped by
simple splenectomy. This has not
been our experience and rebleeding
has not been a problem in other pub
lished series.4,8,16'18
Patients with pancreatic disease as
sociated with occlusion of the splenic

vein may require splenectomy com
bined with selective pancreatic sur
gery. Occlusion associated with a pan
creatic pseudocyst has been reviewed
by Salam and associates.8 Cystogastrostomy should be avoided because
of possible hemorrhage from the
stomach. Roux-en-Y cystojejunostomy
is the procedure of choice for drain
ing the pseudocyst. Pseudocyst de
compression alone will rarely relieve
splenic vein occlusion, so splenectomy
should also be carried out, if tech
nically feasible. When the spleen
forms part of the wall of the pseudo
cyst, the surgeon should consider
splenectomy with external drainage
of the pseudocyst or possibly distal
pancreatectomy including splenec
tomy.
Management of peripancreatic ab
scess producing splenic vein occlusion
may present difficult technical prob
lems. With disease limited to the body
or tail of the gland, distal pancrea
tectomy with splenectomy would be
the procedure of choice. However,
this procedure may be compromised
by the severity of subacute and chron
ic inflammation. Resection under such
circumstances may contribute to post
operative complications such as
hemorrhage, pancreatic fistula or
subphrenic abscess. Debridement and
external drainage of the necrotic,
peripancreatic tissue combined with
splenectomy will control bleeding
from the gastric varices and will limit
septic complications of the pancreatic
abscess. If the patient is not actively
bleeding, splenectomy should be re
served for a second operation follow
ing control of peripancreatic sepsis.
Patients with chronic pancreatitis
and gastric varices present a complex
problem, combining acute gastroin
testinal blood loss and a chronic pain
syndrome. If bleeding is the sole prob
lem, splenectomy alone should suf
fice. If the pain of chronic pancrea
titis is associated with bleeding from
the varices, then resection including
splenectomy should be considered,
based on the extent of disease affect
ing the gland. Obliteration of surgical
planes posterior to the gland occurs
in such cases and vascular anatomy
can be substantially altered. Care
should be taken to prevent injury
to the celiac axis and hepatic artery.
Carcinoma of the pancreas pro
ducing splenic vein occlusion and
bleeding gastric varices presents an
almost hopeless situation because the
carcinoma is invariably unresectable.
The surgeon must consider the course
of the malignant disease and the
severity of the bleeding when decid-

FIG. 4—Massive fundal varices drain
to portal system through coronary
(black arrow) and gastroepiploic (white
arrow) veins.

FIG. 5—Dilated gastroepiploic veins
coursing through gastrocolic ligament.
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ing whether splenectomy is indicated.
In these patients there may be a
place for simple ligation of the splenic
artery or percutaneous embolization
of the artery. The risks of splenic in
farction with subsequent sepsis or
revascularization with rebleeding have
not been reported.
Conclusions
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The Conduct of Cholecystectomy: Incision, Drainage,
Bacteriology and Postoperative Complications
R.T. L ew is , m b , frcs [c ], facs ,* C.M. A llan , md , frcs [c ], F A C s ,f R.G. G oodall, md , frcs [c ],
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The benefits of some ancillary
techniques of cholecystectomy are
exaggerated by retrospective study
of selected patients. Therefore, the
authors performed a prospective,
randomized study of 100 consecutive
patients who underwent simple
elective cholecystectomy for chronic
cholecystitis and cholelithiasis. No
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patient was excluded because of
incomplete hemostasis or fear of bile
leakage. The frequency of pulmonary
complications and wound infections
was independent of the type of
incision — vertical or subcostal.
Peritoneal drainage was found to be
unnecessary. Short-term drainage may
increase the frequency of postoperative
fever, but did not increase pulmonary
complications or wound infections.
In these patients, intra-abdominal
sepsis is rare; wound infections were
uncommon and the gallbladder bile
was usually sterile and not the cause
of postoperative infection.
Les etudes retrospectives chez des
patients choisis exagerent les avantages de certaines techniques
auxiliaires de la cholecystectomie.
Les auteurs ont realise une
etude prospective et randomisee de
100 patients consecutifs qui ont subi
une cholecystectomie simple non
urgente pour cholecystite chronique
et cholelithiase. Aucun patient ne
fut exclu en raison d'une hemostase
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incomplete ou d'une fuite de bile
apprehendee. La frequence des
complications puimonaires et des
infections de plaie n’etait pas influencee par le type d'incision (verticale
ou sous-costale). Le drainage
peritoneal fut juge inutile. Le drainage
de courte duree peut augmenter la
frequence de la fievre postoperatoire
mais il n'a pas augmente le nombre
des complications puimonaires ou
des infections de plaies. Chez ces
patients, les infections intraabdominales sont rares; les infections de
plaies furent peu frequentes et la
bile dans la vesicule biliaire etait
habituellement sterile et elle ne causa
pas d'infections postoperatoires.

Although cholecystectomy is the sec
ond commonest major operation per
formed today,1 the ideal ancillary
procedures have not been settled. In
1882, Carl Langenbuch devised the
technique of cholecystectomy by care
ful cadaver dissection and performed
the first such procedure on a living
person.2 He opened the abdomen

THE CANADIAN JOURNAL OF SURGERY

through a vertical lateral rectus in
cision with a subcostal T-extension;
after removing the gallbladder, he in
serted a peritoneal drain before clos
ing the abdomen. Thirty-one years
later, a group of German surgeons
introduced the “ideal” cholecystec
tomy;3 it is usually performed through
a subcostal incision, and includes
“subserous” cholecystectomy4 and ab
dominal closure without peritoneal
drainage.5,6 Sporadic reports since
then have claimed for that technique
greater patient comfort, a shorter op
erating time and hospital stay,7'9
fewer wound infections and respira
tory complications,10 and even lower
operative mortality.11 However, since
few careful prospective studies have
been done, we designed a study to
examine the effect of the type of in
cision and the insertion or omission
of peritoneal drains on the frequency
of postoperative complications after
simple elective cholecystectomy and
to review the nature of infectious
complications after routine cholecys
tectomy.
Patients and Methods

Starting in December 1979, 100
consecutive patients underwent elec
tive cholecystectomy for chronic
cholecystitis. Patients with acute
cholecystitis or jaundice and those
requiring exploration of the common
bile duct or an additional procedure
on the stomach or colon were not
included. However, no other exclu
sions, such as fear of bile leakage or
incomplete hemostasis, were permit
ted. The patients were randomly as
signed by sealed envelope technique
to one of three groups: no drain,
Penrose drain, or closed suction
(Hemovac drain). A subcostal or a
vertical abdominal incision was em
ployed depending on the usual prac
tice of the surgeon. Forty-nine proce
dures were performed by four sur
geons through subcostal incisions and
51 operations by three surgeons
through vertical abdominal incisions.
The age, sex, weight and height
of each patient and the duration of
operation were noted. Ideal weight
for height and body build values
were obtained from standard tables.12
A risk index of wound infection was
calculated as suggested by Davidson
and associates.13 This index relates
the risk of postoperative wound in
fection to the age of the patient, dura
tion of operation, wound class and
presence or absence of organisms on
culture of the subcutaneous fat at the
VOLUME 25, NO. 3, M A Y 1982
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end of operation. The total blood
lymphocyte count was obtained preoperatively by multiplying the total
leukocyte count by the percentage of
lymphocytes seen on differential
smears. Determinations of the serum
bilirubin, alkaline phosphatase, gluta
mic pyruvic transaminase (SGPT)
and lactic dehydrogenase (LDH)
were made preoperatively and 2 and
4 days postoperatively by standard
methods using the Bichromatic Autoanalvser (Abbott Laboratories, Diag
nostics Division, Toronto, Ont.). The
normal values for total serum bili
rubin are 0.3 to 1.4 mg/dl (5.13 to
23.9 yu.mol/1), alkaline phosphatase
90 to 280 IU/1, SGPT 4 to 25 U /l
and LDH 52 to 142 U/l.
At operation, the degree of wound
contamination was noted. The cystic
duct was doubly ligated by ligature
and metal clip, and the serosa of the
gallbladder bed in the liver was closed
by continuous catgut suture. A cul
ture was obtained from the inner
surface of the gallbladder and from
the subcutaneous fat of the abdomi
nal wall before skin closure.
Patients were carefully followed
postoperatively for development of
wound or intra-abdominal complica
tions and for the development of non
specific pulmonary or urinary tract
infections. A wound infection was
diagnosed when pus drained from the
wound and a sample of the pus was
then sent for culture. Wounds that
were indurated, reddened or tender
were followed until the condition re
solved or there was drainage. A fur
ther report was obtained 1 month
after operation from the patient’s
physician. The volume of daily drain
age from the suction drain was re
corded. Drains were removed on the
second postoperative day unless the
volume of drainage was excessive.
Oral temperatures were recorded
every 6 hours and a fever index was
calculated for each patient as the
number of postoperative days that

the temperature was higher than
37.5°C after the first 24 hours.
Statistical evaluation was carried
out where indicated by Student's ttest and y2 analysis.
Results

There were no deaths in the series
and no patient required reoperation.
One patient, operated upon through
a vertical incision and closed with
out peritoneal drainage, sustained in
traoperative injury to the portal vein.
This injury was identified and the
vein repaired. Transient intra-ab
dominal bleeding occurred postoper
atively necessitating blood transfusion
before vital signs were stabilized on
the day of operation.
The 49 patients who underwent op
eration through subcostal and 51
through vertical abdominal incisions
were compared with respect to mean
age, sex, preoperative blood lympho
cyte count, percentage of ideal weight
for height and the Davidson risk index
of wound infection (Table I). The
groups were evenly matched. Post
operative complications were equally
frequent in patients with subcostal
incisions and those with vertical in
cisions. The mean postoperative fever
indices were 2.2 ± 0.26 and 1.98 ±
0.20 days respectively (P > 0.1, t =
0.79); seven patients had pneumonia
(four with subcostal and three with
vertical incisions) and wound infec
tions developed in one patient with a
subcostal incision and three with ver
tical abdominal incisions (P > 0.1,
X2 = 0.96).
Patients with and without peri
toneal drainage were compared with
respect to mean age, sex, preopera
tive blood lymphocyte counts, the
percentage of ideal weight for height
and the Davidson risk index of wound
infection (Table II). These groups,
too, were well matched. Postoperative
complications between the groups
are compared in Tables III and IV.

T a b le 1— C o m p a ris o n o f P a t ie n ts A c c o rd in g to
T y p e o f In c is io n *
T y p e o f in c is io n
F a c to r
A ge, yr
S e x ,m a le /f e m a le
N o . o f ly m p h o c y te s ,/m m 3
W e ig h t, a c tu a l/id e a l ( % )
R is k i n d e x , %

S u b c o s ta l
(n = 4 9 )
5 1 .3

± 2.5
5 /4 3
1715 ± 9 2
1 1 9 .8 ± 3 .2
15
± 2 .6

V e r tic a l
( n = 51)
50.5

± 2 .2
8 /4 3
1782 ± 1 0 0
140.9 ± 19.8
17
± 2.44

tv a lu e !
0 .2 2
—

0 .4 9
1.1 6
0 .5 3

“M e a n v a lu e s -+- s ta n d a rd e r r o r o f th e m e a n .
t N o t s ig n ific a n t.

THE CANADIAN JOURNAL OF SURGERY

305

Postoperative fever occurred more
frequently in patients with peritoneal
drainage, but no significant differ
ence in fever index was observed
between patients with (1.8 ± 0.23)
and those without (2.3 ± 0.23) a his
tory of chronic obstructive pulmonary
disease and cigarette smoking; post
operative pneumonia was equally
common in patients with drainage
and those without. Wound infections
were slightly more frequent in pa
tients with drainage than in those
without, but the difference was not
statistically significant. The frequen
cy and level of increase of postoper
ative serum bilirubin between patients
with and those without peritoneal
drainage, and between patients with

Penrose and those with Hemovac
drains did not show any significant
differences.
The striking results of cultures ob
tained at operation from the gall
bladder and subcutaneous fat of the
wound and from the wounds of the
four patients who had wound infec
tions were the low frequency of posi
tive cultures of the gallbladder bile
and the lack of correlation of the
gallbladder organisms with those
found in the subcutaneous fat and
in infected wounds (Fig. 1). No pa
tient was given antibiotics prophylactically. The Davidson risk index of
wound infection was significantly
higher (P < 0.02) in the four patients
who had wound infections than in

Ta b le II -C o m p a ris o n of P atien ts
According to U se of D rainage

NS (0 .4 8 )
NS
NS (0 .1 5 )
NS (0 .4 5 )
< 0.1 (1 .3 )

51.5

± 2 .7
8/42
1744 * 8 4
121.6 ± 3.3
17.7 ± 2.5

49.8

± 2 .2
6/44
1764 ± 1 0 8
123.3 ± 3.8
13.3 ± 2.2

A ge, y r
S ex, m a le /fe m a le
N o. o f lym phocytes,/m m ’
W e ig h t, a c tu a l/id e a l ( % )
R isk in d e x , %

P v a lu e
(t v a lu e )

N o d ra in
(n = 50)

D ra in
(n = 50)

F a c to r

NS = n o t sign ific a n t.

T a b le I I I — D ra in vs. No D ra in
P o s to p e rative C om plications

F a c to r
P o s to p e rative fe v e r index, d
> 3 8 .5 ° C
W ound in fe c tio n , no.
P o s to p e rative pneum onia, no.

F a c to rs associated
w ith b iliru b in e m ia

D ra in s reta in ed m ore than
2d
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No drain
(n = 50)

P v a lu e

2.5 ± 0 . 2
3 (2 H em ovac,
1 P en ro s e )
4

1.7 ± 0.2
1

< 0 .0 1 ( t = 2.28)
> 0 .3 (y - — 1.04)

3

NS

D isc u ss io n

Although much has been written
on the effect of ancillary techniques
of cholecystectomy on postoperative
complications, few prospective studies
have been done. Our study examines
the problem in a prospective, con
trolled manner. The allocation of in
cisions was not truly random, but
the matching of patients was.
Which Incision is Preferable?
Some surgeons14 report fewer com
plications and others'5 more pulmo
nary complications with subcostal in
cisions than with vertical abdominal
incisions. In keeping with the spirometric studies of Williams and Brenowitz16 we found no difference in the
frequency of postoperative pneumonia
or in the fever index between the
two incisions. Haight and Ransom1'
have reported similar results.
Is It Safe to Omit Peritoneal
Drainage?
Our results indicate that peritoneal
drains may be omitted safely in
cases of uncomplicated elective
cholecystectomy. There were no op-

P o s to p e rative B iliru b in e m ia vs. D rainage

T a b le IV

A b n o rm a l postoperative
s e ru m b iliru b in , no.
P re o p e ra tiv e serum
b iliru b in , m g/dl
P o s to p e rative serum
b iliru b in , m g/dl
P o s to p e rative increase
b iliru b in , m g /d l
W ith Hem ovac d ra in , m g/dl
(n = 25)
W ith P en rose d ra in , m g/dl
(n = 25)
C o rresp o n d in g h epatic
b ile , ml
C orrespond in g p eritoneal
flu id , ml
H em ovac d rainage, ml

D ra in
(n = 50)

those who did not, but the factors
constituting the index did not show
similar differences (Fig. 2).

D rain (n = 50)

No drain
(n = 50)

F IG . 1— B acteriology: gallb lad d er, su b 
cu tan eo u s fa t, infected w ounds.

P v a lu e
( t v a lu e )

11

NS

0.56 ± 0.04

0.45 ± 0.03

< 0 .0 5 (1 .9 4 )

0.92 ± 0.09

0.87 ± 0.08

NS (0.56)

0.36 ± 0.08

0.42 ± 0.08

NS (0.50)

9

0.24 ± 0.05
NS (0.30)

0.42 ± 0.15
94

110

940
59.2 ± 12.3
(m edian 30, ran ge 0 450)

1100

5 (2 H em ovac, 3 P e n ro s e )
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F IG . 2— R isk index: factors in w ound
infections.
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erative deaths and no patients re
quired reoperation. Glenn18 has stated
that subhepatic accumulations occur
after the majority of cholecystectomies
and are of clinical importance in
7% to 10% of cases. We should
therefore have expected at least three
instances of such accumulations in
50 cholecystectomies that were not
drained. None was suspected or diag
nosed.
Does Any Less Obvious Morbidity
Result from Omitting a Drain?
Edlund and associates19 found a
transient abnormal increase in serum
bilirubin levels after undrained chole
cystectomy and attributed this to re
sorption of bile that would otherwise
have been discharged by the drain.
Our results show that an abnormal
postoperative bilirubin level was
equally common in patients with and
without drains. The extent of the
postoperative increase in serum bili
rubin level was also similar in the
drained and undrained groups. Based
on the average concentration of bili
rubin in hepatic bile and peritoneal
drainage fluids,20 large amounts of
bile would have to be lost and fluid
resorbed to produce this postoperative
increase in serum bilirubin level. It
is therefore unlikely that this me
chanism alone explains the increase.
Nor is pericholangitis21 a satisfactory
explanation, for no significant changes
occurred in the concentrations of
SGPT, LDH and serum alkaline
phosphatase.
Polk22 has recommended sump
suction drainage of the subhepatic
space after cholecystectomy. Sump
drains without bacterial filters, al
though more efficient than Penrose
drains,23 entrain more organisms from
the patient’s skin, dressings and en
vironment.24 If drainage is required,
closed suction seems preferable, but.
surprisingly, van der Linden and asso
ciates25 recently found that closed
suction drains impair rather than en
hance intraperitoneal drainage. We
found no difference between our pa
tients who had Penrose drains and
those who had Hemovac drains. In
deed, since patients without drains
did as well as those with drains, we
would expect little difference between
the two types of drains.
Are There Any Advantages to
Omitting the Drain?
We found increased frequency of
postoperative fever in patients with
peritoneal drains. Maull and asso
ciates26 reported similar results, but
VOLUME 25, NO. 3, MAY 1982
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two other prospective studies19,27 found
no increase.
No significant increase in wound
infection occurred in patients with
peritoneal drains. In contrast to the
findings in numerous retrospective
studies, no prospective controlled
clinical trial has demonstrated such
an association.
What Is the Frequency and Source
of Postoperative Infection in
Uncomplicated Elective
Cholecystectomy?
In our study there were four wound
infections, all due to Staphylococcus
pyogenes; there was no intra-abdomi
nal sepsis. Only 11 % of gallbladder
cultures grew organisms and none of
them S. pyogenes. The light growth
of Staphylococcus epidermidis from
the subcutaneous fat of 20% of oper
ative wounds was probably insignifi
cant. The lack of correlation between
the results of cultures of the gall
bladder, subcutaneous fat and in
fected wounds suggests that in the
truly “low-risk” patient28 with uncom
plicated cholelithiasis who undergoes
elective operation, culture of the
gallbladder bile and subcutaneous fat
is not useful. Since cultures obtained
from the nasal mucosa and skin of
two of these four patients were nega
tive for S. pyogenes, it is unlikely
that they were carriers of this organ
ism. These findings are in sharp con
trast to what occurs in “high-risk” pa
tients.28 There, the source of post
operative infection is endogenous,
usually from the streptococcal or coliform bacteria in the bile, and post
operative intra-abdominal infection
occurs more frequently. These differ
ences have not been adequately em
phasized, but have been noted previ
ously by Stone and associates.29
Conclusions

In simple elective cholecystectomy
for chronic cholecystitis and choleli
thiasis the choice of abdominal inci
sion, vertical or subcostal, does not
influence the development of post
operative pulmonary or infectious
complications. Peritoneal drainage
may be omitted safely without in
creasing morbidity.
Postoperative
fever occurs less often when no drain
age is used but the frequency of
respiratory complications and wound
infections is not altered. Gallbladder
bile is usually sterile and is not the
source of wound infection.
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Management of Duodenal Diverticula
C.H. Scudamore,

md , frcs[c],

Duodenal diverticula are not un
common. Uncomplicated diverticula
require no treatment. In the period
1970 to 1980, 104 patients with
symptoms presented at the Vancouver
General Hospital and the Swedish
Hospital in Seattle. Of these, 26%
presented with pain and 24% with
anemia. Malabsorption and benign
tumours were noted infrequently. Fifteen
patients were treated surgically for
pain, perforation, hemorrhage, tumour,
blind loop syndrome and obstruction
of the duodenum, biliary tract or
pancreatic duct. Two patients died.
The second part of the duodenum
was involved in 82% and the third part
in 10%. Anatomical variations are
common in the area of the ampulla;
these should be anticipated before
operation. Surgical procedures in the
area may be technically demanding and
associated with high mortality and
morbidity. The choice of procedure
depends on the urgency and nature of
the complication of the diverticulum.
Endoscopic retrograde cholangio
pancreatography can play a role in
evaluating the possible significance of
the diverticulum and the anatomy
of the area. In some cases endoscopic
sphincterotomy may be possible.
In some situations diverticulectomy
is contraindicated.
II n'est pas rare de rencontrer des
diverticules duodenaux. Lorsqu’il n’y
a pas de complication, ils ne necessitent pas de traitement. Durant la
periode allant de 1970 a 1980, 104
de ces patients souffrant de symptdmes ont ete recus au Vancouver
General Hospital et au Swedish
Hospital de Seattle. Parmi ceux-ci,
26% manifestaient de la douleur et
24% etaient anemiques. De la diarrhee
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et des tumeurs benignes etaient
rarement observees. Une intervention
chirurgicale fut pratiquee chez 15
patients presentant de la douleur,
une perforation, une hemorrhagie,
une tumeur, un syndrome de I'anse
borgne ou une obstruction du duo
denum, des voies biliaires ou du
canal pancreatique. Deux patients
sont decedes.
II y avait atteinte de la seconde
partie du duodenum dans 82% des
cas et de la troisieme partie dans 10%.
Les variations anatomiques de la re
gion ampullaire sont frequentes et elles
devraient etre anticipees avant (’ope
ration. Les interventions chirurgicales
pratiquees dans cette zone peuvent
etre techniquement difficiles et elles
sont associees a un fort taux de
mortality et de morbidite. Le choix
du type d’intervention depend de
I'urgence et de la nature des com
plications reiiees au diverticule.
La cholangiopancreatographie
endoscopique retrograde peut jouer
un role quand il s'agit d’evaluer
(’importance du diverticulum et I'anatomie de la region. Dans quelques
cas, la sphincterotomie est possible.
Dans certaines situations, la
diverticulectomie est contre-indiquee.

Duodenal diverticula are found in
2% to 5% of all individuals who
undergo upper gastrointestinal con
trast studies.1’2 The duodenum is the
second most frequent location for
gastrointestinal diverticula after the
colon.3 Symptoms attributed to duo
denal diverticula are nonspecific and
seldom severe, and it is difficult to
identify the diverticulum as the source.
The usual presentation of acute com
plicated duodenal diverticular disease
is that of a surgical emergency in an
elderly patient, with either an acute
abdomen or an active gastrointestinal
hemorrhage. The diagnosis is seldom
considered preoperatively. The condi
tion is difficult to manage surgically
and is associated with appreciable
morbidity and mortality.2,4‘6
The majority of reports dealing
with complicated duodenal diverticula
were published before the era of mod
ern fiberoptic endoscopy. The investi
gation and treatment of duodenal
diverticular disease has been altered
by the use of the side viewing duodenoscope and endoscopic retrograde

T.T. W hite ,
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cholangiopancreatography.7’8 It now
may be possible to investigate and
treat some nonemergent complica
tions of duodenal diverticula entirely
endoscopically.7
Emergent complications must be
recognized early and dealt with by
a surgeon who is familiar with the
complex anatomical relations of the
diverticulum that may be obscured by
inflammation or bleeding.
Patients and Method

The records of patients seen at
the Vancouver General Hospital for
complications arising from duodenal
diverticular disease were reviewed for
the 10-year period 1970 to 1980.
Those who had treatment or surgical
procedures for coexisting conditions
and were found incidentally to have
duodenal diverticular disease were ex
cluded. Two cases from the Swedish
Hospital in Seattle, Washington were
also included. There were 104 pa
tients in all.
Case Reports

The following four cases from the
Vancouver General Hospital are
presented to illustrate the problems
of the behaviour, diagnosis and treat
ment of complicated duodenal diver
ticula.
Case 1

An 85-year-old man complained of
generalized abdominal pain, which had
started suddenly in the right upper
quadrant and flank 4 hours earlier.
Examination revealed generalized ab
dominal tenderness, bowel sounds were
absent and the abdominal wall was rigid.
His temperature was 37.4°C, blood
pressure 140/90 mm Hg, pulse rate 90
beats/min and irregular. The leukocyte
count was 8.9 X 10V1 with 39% poly
morphonuclear cells and 58% lympho
cytes, the total serum bilirubin level was
1.4 mg/dl (23.9 umol/l), serum alkaline
phosphatase was 122 IU/1 (normal to
125 IU/1), serum amylase was 140 IU/1,
(normal to 80 IU/1). The prothrombin
time was normal. Roentgenogram of the
abdomen showed multiple air—fluid
levels throughout the large and small
bowel. There was air in the retroperi
toneal space.
A diagnosis of a ruptured viscus was
made; supportive measures were insti
tuted and antibiotics given. At laparo
tomy the common bile duct was found
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to be dilated and a greenish staining
was noted in the periduodenal tissues.
The duodenum was kocherized. A per
foration was noted in a duodenal diver
ticulum that measured 3 cm. The com
mon bile duct was explored, stones were
removed from it and a probe was passed
through into the duodenum. The duo
denum was opened and the gallstones
were removed from the diverticulum.
The diverticulum was totally resected
and the duodenum closed primarily. A
T-tube was placed in the common duct.
The patient had previously had a cho
lecystectomy.
The postoperative course was com
plicated by mild pancreatitis. A T-tube
cholangiogram obtained 7 days after
operation appeared noimal.
Case 2
An 87-year-old Caucasian woman with
no history of abdominal complaints had
acute epigastric pain beginning several
hours before admission. The pain was
steady, generalized and radiated to the
back. She had vomited bile-stained fluid
twice. She had had a normal bowel
movement that morning. The blood
pressure was 180/100 mm Hg, the
pulse rate was 100 beats/min and regular
and the temperature was 38°C. Bowel
sounds were absent and her abdomen
was distended and rigid. No abnormality
was found on rectal examination. Ab
normal laboratory results included a
leukocyte count of 8.7 X 109/1, 25%
polymorphonuclear cells, 63% lym
phocytes and occasional metamyelocytes.
The blood glucose level was 249 mg/dl
(13.7 mmol/1). (The serum bilirubin,
creatine phosphokinase, glutamic oxalo
acetic transaminase and lactic dehydro
genase levels were all normal.) The serum
albumin level was 2.7 g/dl, calcium
9.8 mg/dl (2.43 pmol/l), phosphate 2.6
mg/dl (0.85 mmol/1) and amylase 471
IU/1. The urine amylase level was 1624
IU/1. The prothrombin time was 70%
of normal. Abdominal roentgenograms
did not reveal free air or retroperitoneal
gas shadows. An abdominal tap pro
duced cloudy fluid in copious quantities.
On Gram-staining the fluid was found
to contain Clostridium sp. and large
numbers of leukocytes and erythrocytes
and had an amylase concentration in
excess of 5000 IU/1.
A diagnosis of perforated or infarcted viscus was made. Supportive
measures were instituted and antibiotics
given. At laparotomy the periduodenal
tissues were bile-stained and a perforated
diverticulum of the second part of the
duodenum was found. The biliary sys
tem was normal to palpation.
The diverticulum was patched with
omentum, a large T-tube was brought
out through the lateral duodenal wall
as a controlled fistula, and a gastro
stomy and feeding jejunostomy were
fashioned. A Salem sump was placed in
the subhepatic space near the diverticu
lum.
Postoperatively she had prolonged
312

bile-stained drainage from the controlled
duodenal fistula site. This closed after
approximately 1 month.
Case 3
An 84-year-old man complained of
epigastric pain and weakness. His ap
petite was diminished and he had noted
a weight loss of 6 kg over the previous
4 months. His pain was intermittent,
worse between meals, most severe in the
epigastrium and radiated to the back.
He had noted black stools on and off
for a few weeks. He had had his gall
bladder removed 15 years before. He
was a thin, pale man in no acute dis
tress. His blood pressure was 160/90
mm Hg supine and 140/70 mm Hg sit
ting, accompanied by faintness and a
pulse rate of 110 beats/min. Tenderness
but no mass was noted in the epigas
trium. Abnormal findings on laboratory
studies were a hypochromic microcytic
anemia, blood urea nitrogen value of
50 mg/dl (18 urea, mmol/1) and serum
creatinine value of 1.2 mg/dl (106
umol/1). The serum amylase level was
normal and the prothrombin time was
90% of normal. The aspirate from the
nasogastric tube was bile-stained. Upper
gastrointestinal roentgenography after
barium meal demonstrated a large duo
denal diverticulum. Two days after ad
mission the patient’s blood pressure
dropped to 90/60 mm Hg and his heart
rate climbed to 140 beats/min. Bright
red blood appeared in a nasogastric
aspirate. At operation a bleeding duo
denal diverticulum was found with a
large enterolith in its lumen. The re
maining duodenum was normal. The
common duct was probed and was nor
mal. The stone was removed and the
ulcer in the diverticulum, which was ac
tually bleeding, was oversewn. The pa
tient did well postoperatively.
Case 4
A 74-year-old woman presented with
a long history of intermittent epigastric
and right upper quadrant pain, usually
postprandially. On occasion she would
vomit bile-stained material which fre-

quently brought relief of her symptoms.
Antacids were of no help. She was
slightly obese but in no acute distress.
The findings on abdominal examination
were normal. Laboratory values included
a hemoglobin level of 13.7 g/dl, leuko
cyte count of 6.7 X 10°/1 with 70% poly
morphonuclear cells and 12% lympho
cytes, serum alkaline phosphatase 120
IU/1, prothrombin time 85% of normal,
total serum bilirubin of 1.4 mg/dl (23.9
pmol/l) and direct value of 0.6 mg/dl
(10.3 umol/1). The serum glutamic oxalo
acetic transaminase, lactic dehydro
genase and amylase levels were normal.
Upper gastrointestinal roentgenograms
after barium meal showed a diverticu
lum in the medial portion of the second
part of the duodenum and the oral
cholecystogram, showed nonfunctioning
gallbladder after a double dose of con
trast material. Endoscopic retrograde
cholangiopancreatography demonstrated
the duodenal diverticulum with com
pression of the bile duct. Stones were
demonstrated in the gallbladder and
common duct. An endoscopic sphinctero
tomy was done and stone extraction was
carried out with a balloon catheter (Fig.
1). The patient remains free of symp
toms and has not had to have her gall
bladder removed.
Results

Our experience was essentially the
same as that of others. The male to
female ratio of the 104 patients was
2:3. The average age was 71 years
(range from 27 to 96 years). Multiple
duodenal diverticula were found in
22% of the patients. The first part
of the duodenum was involved in
6% , the second in 82% , the third
in 10% and the fourth in 2% ; lateral
ly projecting diverticula were found
in 2% . Active associated diseases that
could be responsible for presenting
symptoms were frequently found
(Table I). The presenting signs and
symptoms were pain in 26% (with no
associated disease in 4% ), hemor
rhage in 10% (with no other source
in 4% ), anemia in 24% (with no other
source in 6%) and diarrhea in 4% .
Once the associated diseases were

Table 1—Associated Disease

Disease

Fig. la
Fig. lb
FIG. 1—(a) Duodenal diverticulum
obstructing common bile duct, (b) Fol
lowing endoscopic sphincterotomy and
stone removal.
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Biliary tract
Hiatus hernia
Peptic ulcer disease
Myocardial disease
Diverticula elsewhere
in gastrointestinal tract
Gastric carcinoma
Pancreatitis
Aortic aneurysm

% of
patients
24
20
20
18
16
3
2
2
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ruled out as a cause for their com
plaints, only about 25% of these pa
tients still had unexplained symptoms.
Only 15 of the 104 patients un
derwent operation and for varying
indications (Table II). Two patients
died in hospital, one of sepsis and
pulmonary embolism and the other of
sepsis and pancreatitis. The hospital
stay was prolonged in two patients
because of high enterocutaneous fis
tulas.
Discussion

Diverticular Types

Duodenal diverticula may be true
(full thickness) or false (mucosal).
True diverticula may be congenital
or be acquired traction diverticula
secondary to chronic peptic ulcer dis
ease. False diverticula usually occur
on the medial or pancreatic aspect of
the second part of the duodenum8
(Table III). Much less frequently they
are found in the third or fourth part
or at multiple sites. The usual posi
tion for second-part diverticula is
intimately related to the entrance of
the common bile duct into the duo
denum. Most open within 2.5 cm of
this point, hence the name “pervaterian”.1,9 These are the diverticula
associated with most complications
and that cause the most problems for
both patients and surgeons.2’6 The
commonly accepted theory explain
ing this position is the presence of a
congenital weakness in the duodenal
wall allowing the entry of the pan
creatic and common bile ducts into
the duodenal lumen. Entrance of
larger penetrating blood vessels may
provide a similar weakness.10

Table II— Indications for Operation
in 15 Patients

Indication
Pain
Hemorrhage
Localized perforation
Free perforation
Enterolith
Malabsorption

No. of
patients
5
3
3
1
1
2

Location

%
85
8
4
10
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There are two situations that give
rise to most diverticular complications
(Table IV): stones passing down the
common duct may become trapped in
the lower end of the common bile
duct or in the diverticulum itself and
enteroliths can form in the amuscular
diverticular pouch from food and
stasis.11,12 Obstructive complications
include jaundice, pancreatitis and,
rarely, duodenal obstruction. Stones
in the diverticular lumen can erode
through the thin wall causing bleed
ing or perforation, but they need not
be present for perforation to occur 2,5,13 Large diverticula have a
tenuous blood supply, and according
to Laplace’s law the diverticulum is
the vulnerable point if intraluminal
duodenal pressures rise.
Perforation of the diverticulum
usually presents as sudden pain in
the right upper quadrant or epigas
trium radiating to the back. This pain
progresses rapidly and there is gen
eralized abdominal rigidity. Accom
panying these findings are those of
toxicity.10,13 The important differen
tial diagnoses include biliary tract dis
ease, pancreatitis, a perforated viscus
and mesenteric infarction.5'14 The pa
tient is obviously very ill and often
profoundly hypovolemic. Plain radiologic studies may demonstrate retro
peritoneal gas shadows but seldom
free air.15 Contrast studies demon
strate the presence of the diverticulum
but may fail to show the perforation.
The most reliable operative clue is
that of a bile-stained periduodenal
phlegmon.2 The perforation can be
demonstrated after careful kocherization of the duodenum. Diverticulectomy with primary closure of the duo
denal wall, followed by periduodenal
drainage, has lowered the morbidity
and mortality rates compared with
drainage alone because the diverti
culum may become necrotic or the
source of a high enteric fistula.2 Be
fore wide kocherization or diverticulectomy is performed, care must be

Table IV — Complications
Stomal obstruction
Duodenal obstruction
Bleeding
Perforation
Enterolith — secondary small
bowel obstruction (rare)
B iliary obstruction
Pancreatitis
Malabsorption
Tum our (ra re )

Table I II— Location of False D iverticula

Periampullary
Lateral (torsion commoner)
Posterior
M ultiple

Complications and Treatment

/

taken to identify the pancreatic and
common bile ducts. Rarely, they may
enter the diverticulum itself and thus
would become disconnected at the
time of resection. This would be
disastrous.16 Lateral drainage of the
duodenum itself as a controlled fistula
is not usually necessary; it resulted in
a duodenal fistula of long duration in
our case 2.
Elective surgical treatment of
periampullary diverticula is seldom re
quired.17 In the past, elective diverticulectomy for nonspecific indica
tions resulted in a mortality as high
as 20% and persistent symptoms in
as many as 50% .10 For patients with
serious unexplained symptoms, such
as those from a dilated common duct
or recurrent pancreatitis, we advocate
endoscopic retrograde cholangiopan
creatography to delineate the ductal
anatomy and to detect the presence
of stones in the ducts or diverticulum
once the usual contrast studies of the
biliary tree and upper gastrointestinal
tract have been performed.
It is important to know that the
majority of pancreatic and common
bile ducts come together and gain en
trance into the duodenum at the su
perior margin of the diverticulum.
Although conventional contrast stud
ies may give the impression that the
ducts are entering the diverticular
dome, this is exceptional but impor
tant.1 Sphincterotomy will permit
drainage of the common duct which
is compressed by the diverticulum.8
Sphincterotomy and endoscopic ret
rograde
cholangiopancreatography
should not be done when there is
poor patient cooperation, when there
are medical contraindications, when
the duct enters the dome and when
perforation is suspected. Acute pan
creatitis is a relative contraindication.8,17,18
If the ampulla enters the dome of
the diverticulum when there is com
mon duct obstruction, diverticulectomy is contraindicated and choledochoduodenostomy is much preferred.
Reimplantation of the ducts carries
a mortality rate of more than 3 0 % .16
There are three rare situations when
the common bile duct, pancreatic
duct or ampulla must be divided.
The first is when there is a tumour
in the diverticulum whose prognosis
is worse than the expected mortality
of duct repair. The others are when
life-threatening hemorrhage and per
foration are present and they cannot
be managed by other means. If dis
connection is essential or if the dam-
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age is done inadvertently the com
mon duct and pancreatic duct should
be reconstituted by separate anas
tomoses into a Roux-en-Y loop.
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Resection and Primary Anastomosis for
Diverticulitis with Perforation and Peritonitis
E dw ard F ark o uh ,
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Primary resection is the treatment of
choice for diverticulitis of the colon
with perforation and generalized
peritonitis. Although there has been
controversy concerning the manage
ment of the bowel ends after
resection, for the last 20 years
immediate anastomosis has been
gaining increasing support.
Between 1970 and 1981, at the
Hopital du Sacre-Coeur in Montreal,
15 patients having diverticulitis with
perforation and diffuse spreading
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peritonitis who fulfilled specific
criteria w ere treated by primary
resection of the perforated segment
of bowel and immediate anastomosis.
The criteria for operation were: (a)
the bowel must not be distended;
(b) the bowel should be empty of
feces; (c) edema of bowel wall at
the resection site must be minimal;
(d) the distal segment of colon
should be above the peritoneal
reflection; (e) there should be no
fecal contamination; (f) the patient’s
general condition should be reasonably
good. If these criteria were met, the
procedure was safe and gave
satisfactory results. In the authors’
series, postoperative hospital stay was
reduced considerably (it averaged
11 days). There was one anastomotic
leak and one death from acute
pulmonary edema.
La resection primaire constitue le
traitement de premier choix dans
les cas de diverticulite du colon
avec perforation et peritonite generalisee. Bien que la conduite a tenir
apres la resection avec les deux bouts
de I'intestin ait fait I'objet d’une controverse, I'anastomose immediate s'est
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gagnee de plus en plus d’appuis au
cours des 20 dernieres annees.
Entre 1970 et 1981, a I’Hopital du
Sacre-Coeur a Montreal, 15 patients
qui souffraient de diverticulite avec
perforation et peritonite diffuse envahissante, et qui rencontraient certains
criteres specifiques ont ete traites
par resection primaire du segment
intestinal perfore et anastomose
immediate. Les criteres retenus
pour I'operation etaient les suivants:
a) absence de distension de I'intestin;
b) absence de feces dans I'intestin;
c) oedeme minime de la paroi intestinale au lieu de resection; d) le
segment distal doit etre situe au-dessus
de la reflexion peritoneale; e)
absence de contamination fecale;
f) etat du patient raisonnablement
bon. Quand chacun de ces criteres
etait rempli, I'operation se revela
sure et donna des resultats satisfaisants. Chez la serie de patients
traites par les auteurs, la duree du
sejour a I’hopital fut reduite
considerablement (une moyenne de
11 jours apres I'operation). II y eut
une fuite d'anastomose et un deces
cause par un oedeme pulmonaire
aigu.
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Perforation with diffuse peritonitis is
a rare but serious complication of
diverticular disease of the colon. Its
incidence in most published reports
is about 2 % .' Although infrequent,
this condition, once diagnosed, must
be treated as an emergency. Hughes
and associates2 in 1963 and Hinchey
and associates3 in 1978 recognized
four clinical stages of diverticular
disease with perforation: stage I —
pericolic abscess, confined by the
mesentery of the colon; stage II —
pelvic abscess, resulting from local
perforation of a pericolic abscess;
stage III — diffuse generalized peri
tonitis that usually results from the
rupture of either a pericolic or pelvic
abscess into the peritoneal cavity;
stage IV — fecal peritonitis, usually
secondary to perforation of a diver
ticulum, with feces escaping from the
lumen of the colon into the peritoneal
cavity. This report is concerned with
patients belonging to stage III (those
who had diverticulitis with perfora
tion and diffuse spreading peritonitis).
We intend to demonstrate the safety
of resection and primary anastomosis
in managing this serious complication,
provided that the patients are carefully
selected and certain criteria are ful
filled.
Patients and Methods

At the Hopital du Sacre-Coeur in
Montreal, we reviewed all patients
with acute diverticulitis of the colon
seen between Jan. 1, 1970 and Aug.
31, 1981. Fifty-one had diverticular
disease with perforation, 26 with
generalized peritonitis (stages III and
IV) and 25 with localized peritonitis
(stages I and II).

Of the 26 patients with generalized
peritonitis, 15 underwent primary re
section of the perforated segment of
bowel with immediate anastomosis, 4
had primary resection and no anas
tomosis (Hartmann procedure), while
7 patients were treated by a threestage procedure (proximal colostomy,
resection, closure of colostomy).
Of the 15 patients treated by resec
tion and primary anastomosis (Table
I), 6 were men and 9 were women.
The average age was 57 years (range
from 33 to 77 years). In some cases,
emergency laparotomy was indicated
from the start, either because the
patient was admitted with features of
diffuse generalized peritonitis or, on
rare occasions, because the flat plate
of the abdomen showed a pneumo
peritoneum (Fig. 1). However, most
of the patients were admitted with
clinical features suggestive of localized
peritonitis of the left iliac fossa. They
were initially managed by a medical
regimen consisting of nasogastric suc
tion, intravenous administration of
fluids and antibiotics. Operation be
came imperative if, despite this regi
men, the general condition of the pa
tient continued to deteriorate or signs
of spreading peritonitis appeared.
Thus, the time of observation before
operation during which the patient
was kept on medical treatment varied
from a few hours to a few days
(maximum 10 days).
In general the leukocyte count was
elevated and only a few patients had
a count lower than 10 X 10V1. At
laparotomy the perforated segment
of the colon was resected, followed
by immediate end-to-end anastomosis
of the bowel, using the one-layer
technique, with 3-0 Prolene sutures.

Lavage of the peritoneal cavity with
large amounts of isotonic saline solu
tion was carried out before the abdo
men was closed; Penrose and sump
drains were inserted. We did not
perform a proximal colostomy. All
our patients received antibiotic thera
py. We used a combination of clin
damycin and gentamicin. The former
is effective against anaerobic bac
teria, while the latter is especially
effective against gram-negative aero
bes. Occasionally we added a third
antibiotic, either penicillin or ampicillin, for the control of the grampositive aerobes.
Results
The results of resection and primary
anastomosis in our series were satis
factory. There was only one com
plication, a colocutaneous fistula, in
dicating a small anastomotic leak.
This healed spontaneously without
the need for a proximal colostomy.
Wound infection was not a problem
since delayed wound closure was
used. There was one death (6.6%)
from acute pulmonary edema, which
was confirmed by autopsy. The aver
age period of hospital stay after oper
ation was 11 days (range from 7 to 15
days).

Table 1— Diverticulitis of the Colon with Perforation in
15 Patients Treated by Primary Resection and Anastomosis

Sex

Age,
yr

Leukocyte count,
X 109/1

Time before
operation, d

M
F
F
M
F

47
54
73
55
77

17.7
23.0
18.0
7.9
7.5

1
1
3
3
10

M
M
M
F
F
F
F
F
F
M

56
69
55
68
65
72
45
33
47
56

15.5
19.2
21.7
15.9
14.6
7.4
9.4
18.4
9.6
15.6

5
1
<1
2
6
3
5
1
3
5
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Complication
Fistula
—

Death

_
—

—

—

—

—

—

Acute
pulmonary
edema

—

_
_

—

—

—

—
—
—

—

_
_

—

—

—

_

—

—

Hospital
stay, d
8
12
12
10
15
14
9
14
10
12
10
10
7
13
11

Fig. lb
FIG. 1—(a) Upright position, (b)
lateral supine position. Arrows point to
free air in peritoneal cavity.
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Discussion

Controversy has existed for many
years concerning the best procedure
for the treatment of diverticulitis with
perforation. There are two types of
procedure: the three-stage procedure
and primary resection with or without
anastomosis.
Traditional teaching favoured the
three-stage procedure. In the first
stage proximal colostomy is done
with drainage of the perforated seg
ment of bowel; the diseased segment
is resected 2 to 6 months after the
colostomy and a third operation is
done to close the colostomy. Although
the three-stage procedure was the
standard treatment for diverticulitis
with perforation and peritonitis for a
long time, the mortality, about
30% ,1,4-7 is unacceptable.
We believe, as do many others,711
that resection of the perforated seg
ment of bowel should be the primary
goal of therapy, since it removes
the source of peritoneal contami
nation. Whether to do an imme
diate anastomosis or a colostomy with
delayed anastomosis remains con
troversial. Because of the high risk
of anastomotic leak, some1214 dis
agree with the trend to perform pri
mary anastomosis on unprepared
bowel in the presence of diffuse peri
tonitis. After resection of the per
forated segment of colon, many sur
geons prefer either to establish a
proximal colostomy with a mucous
fistula, or to do the Hartmann proce
dure — proximal colostomy and in
tra-abdominal closure of the rectal
stump. In both cases anastomosis of
the bowel ends is postponed until
the conditions are more favour
able.7’10,15’16
The results obtained in our series
suggest that primary colonic resection
T a b le I I — R e p o rte d D e a th s fro m P rim a r y
R e s e c tio n and A n a s to m o s is in P a tie n ts
w it h D iv e r tic u litis o f th e C o lo n w ith
P e r fo r a tio n

A u th o r s

No. of
p a tie n ts

No. of
d e a th s

with immediate anastomosis as ad
vocated by Madden and Tan1 has its
place in the management of diverti
culitis with perforation and diffuse
peritonitis. Occasionally a proximal
colostomy may be performed if the
integrity of the anastomosis is in
doubt. In our series no colostomies
were done.
Since Gregg17 in 1955 reported his
series on diverticulitis with perfora
tion, primary resection of the diseased
segment of bowel with immediate
anastomosis has gained increasing
support. Although most of the pub
lished series4’18-23 are small, the results
in general are quite satisfactory. Of
73 patients reported only 6 died, a
mortality of 8.2% (Table II).
Although it is tempting to perform
this procedure more often, it should
be emphasized that it is only suitable
for patients in whom the following
criteria are fulfilled: (a) the bowel
should not be distended; (b) the bowel
should be empty of fecal material;
(c) there should be minimal edema of
the bowel wall at the site of resection;
(d) the distal segment of the colon
should be above the peritoneal re
flection; (e) there should be no fecal
contamination of the peritoneal
cavity and (f) the patient should be
in fairly good general condition.
If all these criteria are respected,
primary colonic resection with im
mediate anastomosis is a safe and
satisfactory alternative for the man
agement of the perforated diverticular
colon with spreading peritonitis.
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Iatrogenic Bile-Duct Strictures
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Management of iatrogenic stricture
of the bile ducts is difficult and is
associated with substantial morbidity
and mortality. At the Toronto General
Hospital, 61 patients with strictures
following operative trauma underwent
a total of 75 repairs. The overall
success rate was 8 0 % . End-to-end
duct repair is preferred when feasible;
8 of the 61 patients were treated
this way, with success in 7. In the
majority of patients, however, extensive
duct scarring and shortening preclude
its use, necessitating Roux-en-Y
hepaticojejunostomy, done in 53
cases. If the anastomosis is adequate,
with good mucosal approximation, a
stent is not essential and of 12 such
operations, 10 were successful. Even
when the mucosa-to-mucosa apposition
is less than optimal, the use of a
straight-tube stent or changeable
U-tube stent may produce a satisfactory
end result. Of 41 such operations, 31
were successful.
Since iatrogenic bile-duct strictures
lead to high morbidity and frequent
recurrence despite seemingly adequate
repair, continued emphasis should be
placed on prevention of injury,
especially during routine cholecystec
tomy. Experience, careful dissection,
knowledge of anatomic variations and
good judgement concerning the
performance of a cholecystostomy
in difficult situations, should all
reduce this complication to a
minimum.

md , frcs [c ], facs and

B. L anger ,

preferee chaque fois qu'elle est
possible; 8 des 61 patients furent
trades de cette facon, dont 7 avec
succes. Toutefois, chez la majorite
des patients un tissu cicatriciel
etendu ou en raccourcissement du
canal en empeche le recours et
necessite une hepatico-jejunostomie
de Roux-en-Y. Cette operation fut
pratiquee dans 53 cas. Quand
I'anastomose est adequate et que
le rapprochement des muqueuses est
bon, un gabarit n'est pas essentiel
et sur 12 operations de ce genre, 10
ont reussi. Meme quand I’apposition
des muqueuses n'est pas ideal,
I'emoloi d’un tube droit ou d'un tube
en U variable comme gabarit peut
donner des resultats satisfaisants.
Sur 41 operations de ce genre, 31 ont
ete couronnees de succes.
Comme le retrecissement iatrogene
des voies biliaires entraine une forte
morbidite et de frequentes recidives
en deoit de reparations aoparamment
adequates, I'accent doit etre mis de
facon soutenu sur la prevention des
lesions, particulierement durant les
cholecystectomies ordinaires.
L'experience, une dissection soigneuse,
la connaissance des variations
anatomiques et un bon jugement
concernant la realisation des cholecystostomies dans les situations
difficiles devraient reduire cette
complication au minimum.

A benign, extrahepatic stricture of
the
bile duct presents one of the most
Le traitement des retrecissements
difficult
management problems in
iatrogenes des voies biliaires extraabdominal surgerv. It is associated
hepatiques est difficile et ii est
with high morbidity and appreciable
relie a une morbidite et une mortality
mortality. The commonest cause is
importantes. Soixante-et-un patients du
surgical
trauma to the bile duct dur
Toronto General Hospital qui
ing
operations
on the biliary tract,
souffraient de retrecissement
stomach
or
pancreas.
secondaire a un traumatisme operatoire
Numerous techniques of recon
ont subi un total de 75 reparations.
struction have been described. The
Le taux global de reussite a ete de
long-term results are far from satis
80%. Une reparation bout-a-bout est
factory, as many patients require mul
From the department of surgery,
tiple repairs. We review the operative
Toronto General Hospital and the
management of iatrogenic biliary
University of Toronto, Toronto, Ont.
strictures
in patients seen at the To
Presented at the 4th annual meeting of ronto General Hospital over a 15the Canadian Association of General
Surgeons, Toronto, Ont., Sept. 16, 1981 vear period.
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Patients and Methods

md , frcs [c ], facs

trauma were reviewed. Sixty-one pa
tients (43 men, 18 women) were
studied. The mean age was 49 years
(range from 17 to 79 years). Patients
were followed up either by the sur
geon or, for geographic reasons, by
the referring doctor. The follow-up
ranged from 3 to 144 months (mean
26.5 months, median 24 months).
The commonest procedure during
which bile-duct injury initially oc
curred was cholecystectomy (58 pa
tients). Ductal operation and gastrec
tomy were the causes in two and one
patient respectively. In the majority
of the original operative reports, the
cholecystectomy was reported as
“routine”. The injury was noted at
the time of original operation in only
15 patients (25%) and all underwent
immediate repair; 14 were operated
on at another institution and were
later referred to the Toronto General
Hospital for further assessment and
management. One primary repair at
the time of injury was performed at
this institution.
The sites of bile-duct injury are
depicted diagrammatically in Fig. 1,
which shows their relative frequency
in the intrahepatic, common hepatic
and common bile ducts and at the bi
furcation.
The 61 patients underwent 103
operative reconstructions, 75 of which
were performed at the Toronto Gen
eral Hospital. Twenty-eight (75%)
of the 37 patients admitted after the
original injury were seen within the
first 10 days, while the rest presented

FIG. 1—Location of injury; common
All patients operated upon between
duct (9), common hepatic duct (41),
1966 and 1980 for benign biliary bile
bifurcation (7) and right hepatic duct
strictures resulting from surgical (4).
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from 1 month to 20 years after injury
(mean 6 years). Jaundice (71%) and
biliary fistula (50%) were the most
common early signs of duct injury.
Patients whose first repair failed
usually presented later, at a mean
of 2 years after the previous recon
struction. Jaundice (84%) and cholan
gitis (67%) were found most com
monly in this group.
Investigations

The investigative techniques used
to diagnose the obstruction changed
over the course of the review. At
present, patients with a suspected
extrahepatic biliary obstruction ini
tially undergo ultrasonography to
check for dilated extra- and intrahepatic ducts (Fig. 2). If a bile fistula
is present, a sinogram is carried out.
If there is no bile fistula, percutane
ous transhepatic cholangiography is
performed, accurately demonstrating
the site of obstruction and the ana
tomy of the upper biliary tree (Fig.
3). A catheter may be left in place
after percutaneous transhepatic cho
langiography to decompress the proxi
mal ducts temporarily in preparation
for operation, and is sometimes neces
sary for drainage of an infected biliary
tree. Endoscopic retrograde cholan
giopancreatography can be useful in
determining the distal limit of the
obstruction (Fig. 4), as the stricture is
often long. It is also valuable in early
duct injuries when dilatation of the
intrahepatic ducts has not yet oc
curred, making percutaneous trans
hepatic cholangiography difficult to
perform.
These techniques have replaced
laparotomy and operative cholangio
graphy for diagnosis.

in the 75 reconstructive procedures
performed at this institution. Axial
(end-to-end) repair was favoured
when early reconstruction was car
ried out using healthy ducts with no
dilatation or loss of tissue. It was
possible in only nine cases.
Choledochojejunostomy or hepaticojejunostomy (listed as hepaticojejunostomy in Table I) using a Rouxen-Y loop of jejunum was used in
53 cases; stents were placed in 41.
Transhepatic U-tube changeable stents
were used in 17 instances and straight
tubes in 24 (Table II). In three
repairs with a straight tube, the
mucosal graft technique, to be
described in more detail, was used.
The U-tube stents were left in, with
replacement, for a mean period of 9
months. The straight-tube stents were

FIG. 3— Percutaneous transhepatic
cholangiogram from same patient as
in Fig. 2. Dilated intrahepatic ducts
narrow to obstruction of common he
patic duct at site of surgical clips
(arrow).

left in place for a mean period of 5
months. Simple dilatation with stent
ing and choledochoduodenostomy
were employed in 3 and 10 cases
respectively.
H e p a tic o jeju n o sto m y

Unstented.—At laparotomy, proxi
mal healthy duct is identified, cleared
and transected. Proximal duct is then
anastomosed, end-to-side, to a Rouxen-Y jejunal loop, using one layer of
interrupted, fine, catgut sutures. We
prefer catgut to silk because silk may
act as a nidus for the formation of
common bile-duct stones. If precise
mucosa-to-mucosa apposition is ac
complished using healthy duct, a stent
is not necessary. However, if severe
scarring of proximal duct prevents
such precise anastomosis, a U-tube
changeable stent or a straight rubber
transhepatic stent is used.
U-tube technique (Fig. 5).— After
the intrahepatic ducts have been dis
sected as far as safety allows, a mal-

FIG. 4— Endoscopic retrograde cholangiopancreatogram from same patient
shows obstruction of common bile duct
1 cm distal to surgical clips (arrow).

T a b le 1-- R e s u lts o f 75 B ile -D u c t R e c o n s tru c tio n s

R econstructive T echniques

Table I lists the types of repair used
O p e ra tiv e r e p a ir

N o.

S u c ce s s fu l
o u tc o m e , n o . ( % )

D ila ta tio n a n d s te n t
A x ia l r e p a ir
C h o le d o c h o d u o d e n o s to m y
H e p a tic o je ju n o s to m y

3
9
10
53

2 (6 7 )
8 (8 9 )
9 (9 0 )
41 (7 7 )

T o ta l

75

60 (8 0 )

T a b le I I — R e s u lts o f 53 H e p a tic o je ju n o s to m ie s

FIG. 2— Abdominal ultrasonographic
findings in 67-year-old woman with ob
structive jaundice, 5 months after
cholecystectomy for cholelithiasis. Ar
rows indicate dilated intrahepatic bile
ducts.
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S u c ce s s fu l
o u tc o m e , n o . ( % )

T e c h n iq u e

No.

U n s te n te d
S te n te d
S tra ig h t tu b e
U -tu b e

12
41
24
17

10
31
15
16

T o ta l

53

41 (7 7 )
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leable trochar is introduced into the ing exposed mucosa. A no. 18 red
had long or high strictures that re
left or right hepatic duct and brought rubber tube is placed transhepatically
quired hepaticojejunostomy using a
out through the anterior surface of as described for the U-tube technique.
Roux-en-Y loop. Forty-one (77%) of
the corresponding lobe of liver. A no. The end of the tube is then brought
18, long, red rubber catheter is then through a small opening in the ex 53 patients who underwent hepatico
tied to the end of the trochar, re posed mucosa and secured there with jejunostomy had a successful result at
a mean follow-up of 28 months
tracted back through the liver and a fine chromic catgut suture. With a
(range
from 3 to 144 months); 7
withdrawn from the open end of the combination of gentle manipulation
(13.5%) of these patients have occa
hepatic duct. The same procedure is of the jejunal loop from below and
sional mild symptoms that have not
then carried out for the other hepatic traction on the transhepatic tube
necessitated reoperation. In 12 pa
duct if necessary. The transhepatic above the liver, the exposed mucosa
tube is threaded into a Roux loop is gradually approximated to the in tients whose operation failed, recur
rent jaundice or cholangitis, or both,
through a small incision on the anti- trahepatic duct. This may be secured
necessitated
reoperation within a
mesenteric border, and leaves the loop in place as well, using interrupted
mean period of 13 months (range
through an additional opening ap fine catgut sutures between the sero
from 3 to 43 months).
proximately 15 cm from its entrance. muscular layer surrounding the mu
Hepaticojejunostomies were stented
The lower end of the stent is brought cosa and the scar tissue around the
with straight tubes in 24 cases (Table
through the abdominal wall to lie intrahepatic duct. The distal end of
II). Fifteen of these patients had
comfortably in relation to the Roux the tube sits free in the jejunal loop
satisfactory results. Sixteen of the 17
loop and the upper end is brought and the proximal end is brought out
patients
receiving U-tube stents have
out through a separate stab incision through a stab wound near the hepatic
done
well,
with a mean follow-up of
near the exit from the liver surface. exit. This technique provides mucosa38.8
months.
Twelve patients had un
Side holes are cut in the tube before to-mucosa apposition under very dif
stented
hepaticojejunostomies
and
positioning so that bile can drain from ficult circumstances and has the ad
10 of these have had good results
the bile duct into the Roux-en-Y loop vantage of requiring stenting for a
(mean follow-up of 17 months).
(an additional tube with identically shorter time than with the U-tube
located side holes is prepared at the technique.
Discussion
same time for future exchange). The
loop is then tacked to the undersur Results
The various causes of bile-duct ob
face of the liver with interrupted
struction were recently reviewed by
There were no operative deaths.
catgut sutures so that the jejunal
Smith.1 He reported on 3527 patients
mucosa abuts the intrahepatic duct One patient died of liver failure and
presenting with biliary obstruction
where the rubber tube enters the secondary biliary cirrhosis 2 months
between 1946 and 1977, operative
jejunum from the liver. This proce after his third biliary reconstruction.
trauma being the cause in 44% of
dure may be repeated for the other The overall complication rate follow cases. The preventable aspects of in
intrahepatic duct and the tube se ing these 75 operations was 24.3%.
jury to the extrahepatic bile ducts
cured at its jejunal exit with a fine Wound infection (33.3%) and per have been dealt with in several re
sistent bile leak around the drains ports.1'5 Fundamental knowledge of
catgut pursestring suture.
The advantage of U-tube stenting (22.2%) were encountered most fre normal anatomy and its variations as
in such high strictures with extensive quently.
well as good surgical judgement are
A repair was considered successful
scarring is that both ends of the tube
necessary to avoid operative bile-duct
lie outside the abdomen. If the if the patient was asymptomatic at trauma. As Smith summarized: “The
tube becomes blocked with sludge it follow-up or could be managed con more common causes of bile-duct in
servatively when mild, intermittent jury include an inadequate incision
can easily be replaced.
Mucosal graft technique.—This op symptoms were present. The result and poor exposure, poor illumination,
eration is a refinement of the U-tube was deemed unsatisfactory if reoper poor anaesthesia, poor assistance,
technique. Instead of a simple open ation was necessary.
ignorance of possible anatomic anom
Overall, 60 of the 75 repairs
ing in the antimesenteric border of
alies, and a failure to make certain
the Roux-en-Y loop, a 1-cm rim of (80%) were successful; 52 patients
identification of the anatomical
seromuscular layer is removed, leav- were asymptomatic and the remaining structures.”1 The injury may be ob
8 complained of only occasional mild
vious at the time of operation (in
symptoms. The mean follow-up in this 25% of our patients) or, if not recog
group was 27 months (range from 3 nized initially, may become evident
to 144 months). The overall failure
after a variable period.
rate was 20%. The mean period be
Bile-duct reconstruction is asso
tween operation and reoperation was ciated with moderate morbidity and
11 months (range from 2 to 42
mortality. Warren and lefferson5 re
months). Reoperation was prompted
ported 1552 such operations at the
by frequent recurrence of jaundice Lahey Clinic between 1940 and 1967,
or cholangitis, or both.
with a 25% morbidity and 13% mor
The success rate for each type of tality. The success of bile-duct re
reconstruction performed is shown
pair is often difficult to predict and
in Table I. Of the 22 short strictures,
depends on several technical factors,
3 were managed by dilatation and in including the location of the stricture,
tubation only, 9 by axial repair and
the number of previous attempted re
10 by choledochoduodenostomy. The
l7!!!- 5—U-tube technique. Single
pairs, and the presence of surround
replaceable U-tube stent is placed across
success rate of these procedures was
ing adhesions and acute inflammation.
hepaticojejunostomy at bifurcation.
86% overall. Most patients, however,
Poor mucosa-to-mucosa apposition
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usually results in recurrent stenosis.
Excess tension or overzealous mobili
zation of the ducts may impair blood
supply and result in stenosis. Other
factors, such as intrahepatic bile-duct
fibrosis, local infection, impairment
of hepatic function and the patient’s
overall clinical status, may also af
fect the result.
The procedure of choice for serious
bile-duct injury is axial repair (choledochocholedochostomy).
However,
this operation is only possible when
duct loss is minimal, such as at the
time of initial trauma, when both
proximal and distal ends are healthy.
We performed nine axial repairs and
eight were successful. In most cir
cumstances an end-to-end anastomosis
cannot be performed without tension.
In this situation, choledochoduodenostomy or hepaticojejunostomy is pre
ferred.
In our early experience, Roux-en-Y
hepaticojejunostomy was used only
for high strictures, but more recently
it has become the preferred type of
reconstruction for all injuries except
those amenable to primary axial re
pair. There are distinct advantages
with this technique: it can always be
performed without tension regardless
of the level of the anastomosis; an
anastomotic leak is less hazardous
with a Roux loop than with the duo
denum; there is virtually complete
protection against reflux of undi
gested intestinal contents into the
biliary tree and finally, if reoperation

is necessary, revision of hepaticojejunal anastomosis is far easier to
perform.
Bismuth and associates8 recently
reported their long-term results using
a Roux loop hepaticojejunostomy in
117 patients with benign strictures.
Eighty-six percent had no symptoms
attributable to biliary disease at fol
low-up (53.7% after 6 years). The
operative morbidity was 17.8%, large
ly from wound sepsis; there were no
deaths.
The technique of transhepatic
stenting of the biliary-intestinal anas
tomosis in order to prevent progres
sive stenosis was initially described
by Smith.7’8 Saypol and Kurian9 modi
fied this approach by bringing both
ends of the rubber stent through the
abdominal wall, facilitating tube re
placement. We reported our experi
ence with this technique in eight pa
tients and concluded that U-tube
stenting was particularly useful when
extensive scarring of the proximal
duct remnant made mucosa-to-mucosa
anastomosis to jejunum difficult.10
We currently have 17 patients who
underwent transhepatic U-tube stent
ing, and only 1 has required reopera
tion after 1 year. These patients were
intubated for a mean duration of 9
months.
The importance of long-term stent
ing is also emphasized in a number
of reports from the Lahey Clinic.4'5'11
For high strictures with appreci
able proximal duct scarring, an alter

native to the U-tube stent operation
is the jejunal-mucosal graft technique
described by Wexler and Smith12 that
we performed in three patients of
this series. Smith1 leaves his trans
hepatic tube in place for approxi
mately 4 months. He reported success
in 70% of patients who have under
gone the procedure.
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SESAP III Question
626. A 20-year-old man has a painless, smooth, firm unilateral scrotal mass of six weeks known duration.
It does not transluminate. The best management would consist of
(A)
(B)
(C)
(D)
(E)

Inguinal incision with orchiectomy if a tumor is found
administration of antibiotics and observation for two to four weeks
needle biopsy
scrotal incision to excise the mass
scrotal incision and open biopsy

For the incomplete statement above select the one answer that is best of the five given.
For the critique of Item 626 see page 340 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self-assessment Program
No. 3. For enrolment in the Surgical Education and Self-Assessment Program No. 3, please apply to the
American College of Surgeons, 55 East Erie St., Chicago, IT 60611.)
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The Sugiura Procedure for Bleeding Esophageal Varices:
a Modification
R.J. G insberg, md , frcs[c ], P.F. W aters, md , frcs[c ] and S .M . Strasberg , md , frcs [c ]

The Sugiura procedure is an operation
for control of bleeding esophageal
varices. Splenectomy, extensive
paraesophagogastric devascularization,
and transection and anastomosis of
the esophagus are performed
through two incisions. The modifica
tions described by the authors, such
as the single thoracoabdominal incision
and use of a stapler, simplify and
shorten the operation. Preliminary
results in nine patients are
encouraging.

m ony with our understanding o f their
zation, which then requires a p yloro
pathogenesis.
Portal
hypertension
plasty, and divides and sutures the
should be viewed as a beneficial re
esophagus by hand. It is in these areas
sponse to the block in blood flow to
that we have modified the procedure.
the liver due to cirrhosis, since portal
Sugiura’s description and diagrams o f
hypertension maintains liver b lood
the method used to preserve the
flow. When portal pressure reaches
paraesophageal shunt are schematic
about 20 cm saline, portacaval
and we have endeavoured to provide
shunts develop. A s the block in the
a description from our experience that
liver worsens, the shunts increase in
may be a more practical guide fo r the
size, and there is probably little or
surgeon.
no further increase in portal pres
sure. This concept is in keeping
Modifications
with the observation that portal pres
Incision
L operation Sugiura sert a arreter
sure and the degree o f shunting are
le saignement des varices oesophalargely unrelated.5 Portacaval shunts
A thoracoabdominal incision is
giennes. Une splenectomie, une
may develop in many areas, but the
used (Fig. 1). With the patient in the
devascularisation para-oeso-gastrique
most prominent and clinically im por
right lateral decubitus position, the
etendue et une dissection transversale
tant one is along and through the
incision is made in the seventh or
avec anastomose de I’oesophage sont
esophagus. Why this should be is un
eighth intercostal space (i.e., that
pratiquees a travers deux incisions.
known; however, the tendency to
which, if extended, would cross just
Les auteurs decrivent des modifications
form this shunt is great. Ablation o f
above the umbilicus). Posteriorly, the
telles qu'une incision thoracothis shunt, for example by classic
incision reaches the erector spinae,
abdominale simple et I’utilisation
portoazygous disconnection, is not
but anteriorly it extends only 3 to 5
d'une agrafeuse, qui simplifient
follow ed by compensatory dilatation
cm beyond the left costal margin and
•operation et en racourcissent le
o f other shunts that take over its role,
usually not beyond the edge o f the
temps. Les premiers resultats chez
but by a tendency for the shunt and
left rectus abdominis muscle. The
neuf patients sont encourageants.
for bleeding to recur. Selective d e
diaphragm is incised circumferentially
compression o f varices, which recog
at about 1.5 cm from its costal attach
The Sugiura procedure is a new tech
nizes the benefit o f portal hyperten
ment for a distance o f 2 to 3 cm on
nique for treating esophageal varices.
sion, is also follow ed by a substantial
each side o f the incision, although
It was developed in response to poor
incidence
of
recurrent
bleeding,
extensions may be made to facilitate
results obtained by standard porta
probably because the part o f the op er
exposure in short, thick-chested per
caval shunts.1'3 Starting initially with
ation that disconnects the main p o r
sons. The incision is closed in layers
esophageal transection as described
tal system from the varices eventually
starting with the diaphragm, which is
by Walker,4 the procedure was modi
fails.
resutured to its costal attachment with
fied by Sugiura in stages to include
The approach taken by Sugiura to
no. 1 Vicryl, beginning at the ex
an extensive paraesophagogastric de
deal with this situation is unique. He
tremity o f each incision and tying
vascularization and splenectomy. The
recognized that the shunt through
the sutures to each other and to that
results obtained by Sugiura3 have been
the hiatus has two parts, an intrao f the internal oblique-transversus ab
outstanding, with an actuarial survival
esophageal component and a para
dominis muscle layers. T he costal
rate o f 8 3 % , more than double that
esophageal component. The Sugiura
margin is not sutured, but the ribs are
for standard shunts.
operation obliterates the intraesophaapproximated by pericostal sutures.
W e were attracted to the operation
geal shunt, while carefully preserving
C om m ent.— This incision provides
not only by the results reported by
the paraesophageal shunt. Theoreti
superior access to the left upper quaSugiura, but also by the fact that the
cally, the paraesophageal shunt is suf
operation approached the problem o f
ficient to satisfy the need for a shunt
varices in a manner that was in harthrough the hiatus and the intraesophageal shunt does not reform. N o
other operation incorporates this ra
From the department o f surgery,
tionale.
Toronto Western Hospital, Toronto, Ont.
The Sugiura operation has three
Presented at the 4th annual meeting of
parts: splenectomy, extensive para
the Canadian Association o f General
Surgeons, Toronto, Ont., Sept. 15, 1981
esophagogastric devascularization and
division and suture o f the eso
A ccepted for publication Dec. 16, 1981
phagus. Sugiura performs the opera
Reprint requests to: Dr. S.M. Strasberg,
tion through separate thoracic and
Rm. 1224, Playfair Research Wing,
Toronto Western Hospital, 399
abdominal incisions, does a selective
FIG . 1— Incision used for modified
Bathurst St., Toronto, Ont. M 5T 2S8
vagotomy as part o f the devasculari
Sugiura procedure.
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drant of the abdomen (Fig. 1). Re
moval of any spleen, particularly a
large spleen with body wall adhesions,
is considerably easier than through
a midline incision. The esophagogas
tric junction and intra-abdominal eso
phagus, which are the focal points of
the subdiaphragmatic portion of the
operation, are easy to see and to
reach. Little retraction is needed, as
the liver, even when large, sinks down
to the right. Access to the intrathoracic esophagus up to the inferior
pulmonary vein is ample and one
may simply and quickly inspect the
esophagus on both sides of the dia
phragm, an important advantage when
completing the devascularization right
at the hiatus. Closure of the incision
is straightforward, preserves dia
phragmatic function and results in
few problems as long as the costal
cartilages are not sutured.
Subdiaphragmatic Portion
o f the Operation
Splenectomy is performed by
standard techniques. Sugiura does
not state explicitly how far down the
greater curvature the gastric devas
cularization is carried, but it appears
from his diagrams that only the
short gastric vessels are taken,1,3 al
though the omentum may be opened
below the gastroepiploic arcade.
Sugiura also states that the upper half
of the stomach is stripped of venous
collaterals.3 We have used this as
a guide and removed gastroepiploic
branches from the upper half of the
greater curvature.
The remainder of the devasculariza
tion is best viewed as if making a
longitudinal incision on one side of
a banana, then lifting the skin in
front and behind, exposing and divid
ing attachments between pulp and skin

FIG. 2— Completion of abdominal dis
section. Esophagus has been cleared
from left to right and highly selective
vagotomy performed, clearing lesser
curvature to “crow’s foot”. Large vein
(lifted forward), usually seen posterior
to plane of lesser omentum, is major
portoazygous connection. It is probably
continuation of coronary vein.
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until the whole midsection of the
pulp is free and exposed. To do this
the left lateral portion of the eso
phagus is exposed and the nerves,
vessels, peritoneum and fat are lifted
off the esophagus in front and behind
as two flaps, and only those branches
that directly enter the muscle of the
esophagus or bare area of the stomach
posteriorly are ligated and divided.
Eventually, the right lateral border of
the esophagus is reached and cleared,
and the flaps of nerves, fat, perito
neum and vessels fall away to the
right. At this point the large paraeso
phageal veins (now completely de
tached from the esophagus) can be
seen running up to the hiatus. This
portion of the operation is completed
by the technique used in highly selec
tive vagotomy to clear the lesser cur
vature down to the “crow’s foot”
(Fig. 2). Again it is essential to stay
on the gastric wall to avoid injur
ing the longitudinal veins.
Comment.—Sugiura’s diagrams in
the 1973 and 1977 papers3,3 differ
slightly. In his latter paper it appears
that the major paraesophageal vein
is a continuation of the venous ar
cade along the lesser curvature (i.e.,
right gastric and left gastric veins that
appear to drain into the portal vein
by way of the right gastric vein). We
believe that the major shunt is by way
of the coronary vein, since following
completion of the abdominal portion
of the operation we have been able
to see a large vein passing through
the hiatus on the right side of the
esophagus in a plane posterior to the
lesser curvature of the stomach (Fig.

“crow’s foot” since we wish to pre
serve pyloric function.

Thoracic Portion of the Operation
(Fig. 3)
The inferior pulmonary ligament is
divided up to the inferior pulmonary
vein. A longitudinal incision is made
in the mediastinal pleura over the
esophagus. The esophagus is devascularized by the technique described
above, first exposing the left lateral
edge and peeling the esophagus away
from its covering of veins, fat, nerves
and pleura, dividing only those vessels
that directly enter the muscle. The
dissection of the anterior and posterior
flaps is carried from the hiatus to the
inferior pulmonary vein (12 to 18
cm). This is facilitated by dissecting
the midportion first and passing a
Penrose drain around the first sec
tion of cleared esophagus. Again great
care is taken to preserve the longitu
dinal veins. The final portion of the
devascularization is performed at the
hiatus. Working from both sides the
surgeon can free the esophagus from
all venous attachments, often without
destroying
the
phrenoesophageal
membrane. If the dissection is per
formed from one side only, this is
difficult to accomplish.
Comment.—Although Sugiura ob
viously intends the paraesophageal
venous plexus to be preserved, it is
our impression that this is not well
understood and that coronary and
other longitudinal veins have been
ligated in the course of a “Sugiura
procedure”. It is possible that preser
vation of the paraesophageal longi
tudinal veins is not necessary. How
2) .
Sugiura continues the devasculari ever, in reporting results it is im
zation for 7 cm along the lesser cur portant to indicate whether or not
vature from the esophagogastric junc the longitudinal plexus was preserved,
tion. Our point of reference is the since the results may be different, as
would be the rationale for the opera
tion.
As in the abdominal part of the
operation it is possible to see the large
longitudinal paraesophageal vein,
which is usually posterior and just to
the right of the esophagus; Sugiura
also shows a left longitudinal vein in
the thorax, but in our experience this
is far less prominent.
In both abdominal and thoracic
portions of the operation, the two
technical features that are most im
portant are careful hemostasis and
meticulous development of the flaps,
otherwise longitudinal veins will be
FIG. 3—Thoracic portion of proce
interrupted.
dure. Veins entering esophageal wall are
ligated. Longitudinal veins are preserved.
Large longitudinal vein shown is con
tinuation of that in Fig. 2.
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Division and Repair of the Esophagus
The circular stapler (EEA Auto
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Stapler, Auto Suture Company, Divi without postoperative encephalopathy
sion of United States Surgical Corp., and surprisingly small changes in
Stamford, Conn.) is inserted through
liver function. At the time of writ
a small gastrotomy and an absorbable ing there has been no hemorrhage,
suture used to tie down the esophagus during a follow-up that has ranged
(Fig. 4). The point of transection is 2 from 1 to 22 months. Several patients
to 3 cm above the esophagogastric have complained of dysphalgia to solid
junction. After removal of the instru food at 4 to 6 weeks and have re
ment a D-tube is carefully guided quired one or two dilatations with a
through the anastomosis into the stom Maloney bougie. In one patient dilata
ach. The gastrotomy is closed and the tion resulted in a small leak at the
operation is completed by a loose anastomosis 6 weeks after operation;
Nissen fundoplication.
the leak was managed conservatively
C om m ent .—The circular stapler with total parenteral nutrition for 2
makes a difficult procedure easy and weeks. Repeated dilatations (i.e., more
quick. The Nissen wrap is used to than two) have not been required. One
protect the anastomotic line and as patient who complained of epigastric
an antireflux procedure. It must be pain was found to have a duodenal
loose.
ulcer 6 months after operation. This
patient was treated with cimetidine
Results
for 6 months and has now been free
To determine the scope of this of ulcer and off medication for 6
procedure, we decided to accept for months.
operation all patients referred with
In two patients emergency opera
proven varices that had bled. All pa tions were performed. Both were
tients had serious variceal hemorrhage bleeding actively despite pressure of
requiring transfusion of several units a Blakemore tube with gastric bal
of blood. The term emergency was loon inflated. Both were encephaloapplied to those patients in whom pathic, deeply jaundiced and had
bleeding was active at the time of coagulopathies, one of which was
operation, and the term elective to all severe. One patient had massive
other patients, including those who ascites and muscle wasting. Both pa
had stopped bleeding only 24 hours tients died in the postoperative period,
before operation and who had a one on the first postoperative day of
Blakemore tube still in position (two an uncontrollable coagulopathy, and
patients).
the other at 14 days, of a combination
Five patients had alcoholic cir of sepsis and liver failure.
rhosis and four had cirrhosis due to
Comment
other causes.
Seven elective procedures were per
The Sugiura procedure is a new
formed over 22 months. One patient
and
logical approach to the problem
had had two previous procedures, a
of
bleeding
varices. We have modified
Warren shunt and a splenectomy.
several
aspects
of the procedure; these
Operations were performed in combi
modifications
will
increase the ease,
nation by two surgeons, a thoracic sur
speed and safety of the operation. The
geon and an abdominal surgeon with a
major interest in liver disease. The results in our series of nine patients
are preliminary and permit no object
operating time was about 3 hours
ive
statements about the efficacy of
and the blood loss about 1500 ml. All
patients had an excellent recovery, the procedure. However, these results
are sufficiently encouraging that a
controlled trial is planned.
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B O O K R E V IE W S
continued from page 282

The 16 chapters are systematically
laid out in numbered subheadings and
each chapter basically follows the same
format. A reference and subject index
follows at the end of each chapter.
Everything that one would want to
know about a particular operation is
detailed, including initial comments on
anesthesia, positioning, exsanguination
and skin preparation. The book con
tains 425 figures, most in colour, all of
which are artist’s drawings. The figures
are clear and concise.
The basic techniques used and de
scribed are familiar to all practising
hand surgeons and illustrations of their
application are numerous; for example,
on syndactyly alone there are 58 pages
with half of that number dedicated to
illustrations, on right-hand pages, of all
types and degrees of syndactyly and the
left-hand pages related to a textual de
scription with timely advice regarding
the particular procedure.
This book is an atlas of the tech
niques found most useful by the au
thors and no time is wasted on exten
sive discussion of alternative techniques.
Omitted are references to the role
of microvascular surgery of free tissue
transfers because this text is a result
of work done before this development.
I found very little in this book to
argue with except perhaps the use of
the tubed pedicle in restoring or recon
structing a web space, but even this
was restricted to one particular situa
tion.
This is a classic atlas and a must
as a reference for anyone doing hand
surgery particularly that involving con
genital deformities.
D.J. C la sse n , dds , m d , f r c s [c ]
Plastic and reconstructive surgeon,
Assistant professor of surgery,
University of Saskatchewan,
Saskatoon, Sask.
GASTROINTESTINAL
H E M O RRHAGE. Edited by Richard G. Fiddian-Green and Jeremiah G. Turcotte.
429 pp. Illust. Grune & Stratton, Inc.,
New York; Academic Press Canada
Ltd., Don Mills, Ont., 1980. $57.85.
ISBN 0-8089-1267-4.

This book resulted from a symposium
on gastrointestinal hemorrhage held at
the University of Michigan. The clinical
evaluation and investigation of gastroin
testinal hemorrhage provides a good
introduction. A separate chapter is de
voted to bleeding in infants and chil
dren. The section on chronic gastroin
testinal blood loss features an easy-tofollow “diagnostic flow chart”. Diag
nostic endoscopy and angiography are
discussed thoroughly and the chapter
on angiography details several typical
radiologic findings that would be of par
ticular interest to the non-radiologist.
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NOW IN STROKE
The Advantages of ENTROPHEN
with reduced risk
of stomach upset

To reduce the risk
of stroke

When you prescribe
ASA for long-term use,
it is important not to create
additional problems for
your patients.

Now, ENTROPHEN* is
indicated for reducing the risk
of recurrent transient ischemic
attacks or stroke in men w ho
have had transient ischemia
of the brain due to fibrin
platelet emboli. At present
there is no evidence that
A S A is effective in reducing
transient ischemic attacks
in wom en, or is of
j
benefit in the treatment
of com pleted strokes
in m en or women.
Inhibition of platelet
fl
cyclooxygenase activity
M
b y a single dose of
ENTROPHEN*-10
was comparable to
M
that of plain ASA,
although the effect was
||®?
delayed, reflecting the
delayed appearance of
A S A in the plasma.1

While they may benefit
from the therapeutic
effect of ASA, there is
still a potential for
gastric irritation and
upset, particularly
when the regimen calls
for continuous daily
dosage.
Clinical experience
has shown that
ENTROPHEN*, coated
with POLYMER 37*
reduces gastric distress
in long-term treatment
with high doses of ASA.

entrodheri

i.
To reduce
the risk of stroke
with reduced risk
of stomach upset

’ $8etylsalicylic acid taB|jfe . USP)
HHKnc-coated with PC|||§§1ER 37

C H A R L E S E. F R O S S T 4 C O .

n, et al.: Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin,
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TABLETS

entrophen
(acetylsalicylic acid tablets, USP)
Enteric-coated with POLYMER 37*
Anti-inflammatory—Analgesic Agent
Platelet Aggregation Inhibitor
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain
ing acetylsalicylic acid coated with POLYMER 37*.
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA) has analgesic, anti
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and
antipyretic effects are useful, the major purpose
for which ASA is used is to reduce the intensity of
the inflammatory process. Inhibition of prosta
glandin synthesis may be involved in the anti
inflammatory action of ASA.
ASA also alters platelet aggregation and release
reaction by inhibiting prostaglandin synthesis
Thromboxane A2 is an essential step in platelet
aggregation. ASA prevents Thromboxane A2 for
mation by acetylation of platelet cyclooxygenase.
This inhibition of prostaglandin synthesis is
irreversible and affects platelet function for the
life of the platelet.
The POLYMER 37* coating substantially resists
disintegration in aqueous fluids having a pH lower
than 3.5 for a period of at least 2 hours and is
capable of disintegrating in aqueous fluids having
a pH of at least 5.5 in from 10 to 30 minutes. Thus,
POLYMER 37* coating effectively inhibits the
release of ASA in the stomach, whilst allowing the
tablet to dissolve in the upper portion of the small
intestine for absorption from the duodenal area.
Clinical experience has shown that POLYMER 37*
coated acetylsalicylic acid diminishes or eliminates
gastric distress during long-term treatment with
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs
and symptoms of the following:
Osteoarthritis
Rheumatoid arthritis
Spondylitis
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the
risk of recurrent transient ischemic attacks or
stroke in men who have had transient ischemia of
the brain due to fibrin platelet emboli. At present
there is no evidence that ASA is effective in
reducing transient ischemic attacks in women, or
is of benefit in the treatment of completed strokes
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients
Active peptic ulcer
Patients who had a bronchospastic reaction to
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of
accidental poisoning in toddlers and infants.
ENTROPHEN* should, therefore, be kept well out
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution
to patients with asthma and other allergic condi
tions, with a history of gastrointestinal ulcerations,
with bleeding tendencies, with significant anemia
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid
function tests.
Acute hepatitis has been reported rarely in
patients with systemic lupus erythematosus and
juvenile rheumatoid arthritis with plasma sali
cylate concentrations above 25 mg/100 mL.

Patients have recovered upon cessation of
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic
effects. ASA has been found to delay parturition
in rats. This effect has also been described with
non-steroidal anti-inflammatory agents which
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy
may lengthen the gestation and parturition time.
Because of possible adverse effects on the
neonate and the potential for increased maternal
blood loss, ASA should be avoided during the last
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN*
and anticoagulants are prescribed concurrently, as
ASA may potentiate the action of anticoagulants.
Salicylates may potentiate sulfonylurea hypo
glycemic agents. Large doses of salicylates may
have a hypoglycemic action, and thus, affect the
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric
agents, smaller amounts may depress uric acid
clearance and thus decrease the uricosuric
effects of probenecid, sulfinpyrazone and
phenylbutazone.
Sodium excretion produced by spironolactone
may be decreased in the presence of salicylates.
Salicylates also retard the renal elimination of
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting,
diarrhea, gastrointestinal bleeding and/or ulcera
tion. Ear reactions: tinnitus, vertigo, hearing loss.
Hematologic reactions: leukopenia, thrombo
cytopenia, purpura. Dermatologic and Hypersen
sitivity reactions: urticaria, angioedema, pruritus,
various skin eruptions, asthma and anaphylaxis.
Miscellaneous reactions: acute reversible hepatotoxicity, mental confusion, drowsiness, sweating
and thirst.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE
Symptoms
In mild overdosage these may include rapid and
deep breathing, nausea, vomiting (leading to
alkalosis), hyperpnea, vertigo, tinnitus, flushing,
sweating, thirst and tachycardia. (High blood
levels of ASA lead to acidosis.) Severe cases may
show fever, hemorrhage, excitement, confusion,
convulsions or coma, and respiratory failure.
Treatment
Treatment is essentially symptomatic and sup
portive. Administer water, universal antidote and
remove by gastric lavage or emesis. Force fluids
(e.g., salty broth) to replace sodium loss. If the
patient is unable to retain fluids orally, the alkalosis
can be treated by hypertonic saline intravenously.
If salicylism acidosis is present, sodium bicar
bonate intravenously is preferred because it
increases the renal excretion of salicylates.
Vitamin K is indicated if there is evidence of
hemorrhage. Hemodialysis has been used with
success.
Respiratory depression may require artificial
ventilation with oxygen. Convulsions may best be
treated by the administration of succinylcholine
and artificial ventilation with oxygen. Central
nervous system depressant agents should not
be used.
Hyperthermia and dehydration are immediate
threats to life and initial therapy must be directed
to their correction and to the maintenance of
adequate renal function. External cooling with
cool water or alcohol should be provided quickly
to any child who has a rectal temperature over
104°F.
DOSAGE AND ADMINISTRATION
Analgesic: antipyretic
Up to 2.925 g daily as necessary.
Anti-inflammatory
Because the suppression of inflammation in
creases with the dose of salicylate even beyond
the point of toxicity, the therapeutic objective is
to employ as large a dose as possible short of
toxicity. Most patients will tolerate blood salicylate
levels in the range of 20 to 25 mg per cent. The
most common reason for failing to obtain a
therapeutic response to ASA is the administration
of inadequate doses.

The generally accepted way to achieve effective
anti-inflammatory' salicylate blood levels of 20 to
25 mg per cent is to titrate the dosage by starting
with 2.6 to 3.9 g daily, according to the size, age
and sex of the patient. If necessary, the dosage is
then gradually adjusted by daily increments of
0.65 g until symptoms of salicylism e.g., auditory
symptoms, occur. Then, the dosage is decreased
by 0.65 g daily until these symptoms disappear
and maintained at that level as long as necessary.
In adults the median dose at which tinnitus
develops is 4.5 g per day, but the range extends
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients
should be advised not to vary the dose from day
to day depending on the level of pain because
that often fluctuates independently of the intensity
of the inflammation. A continuous regimen of
0.65 g four times daily is considered to be
minimum therapy for adults. ENTROPHEN*
should be administered four times daily. For night
time and early morning benefits, the last dose
should be given at bedtime.
O nce m a in te n a n ce dose is e sta b lis h e d ,
ENTROPHEN*-15 may be useful to encourage
patient compliance.
Optimally, salicylate therapy should be monitored
by periodic blood salicylate level determinations.
If this is not practical, the appearance of auditory
symptoms in the form of tinnitus or deafness are
acceptable as an indication of the maximum
tolerated salicylate dose.
There is an inverse relation between blood
salicylate levels at which auditory symptoms
appear and the age of the patient. In the young
adult, this is usually in the range of 20 to 30 mg
per cent. In children, however, the level may be
much higher, or the effect apparently absent.
Because salicylate toxicity may appear without
such warning in children, the usual practice is to
give ASA in a daily dose of 50 to 100 mg per
kilogram of body weight and to follow blood levels
aiming for a concentration of about 30 mg per cent.
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of
body weight administered in divided doses to
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472—ENTROPHEN*-15 tablets containing
975 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Oval, pale yellow, film-coated
tablets with the FROSST name engraved on one
face and 472 on the other and supplied in bottles
of 100 and 500.
No. 470—ENTROPHEN*-10 tablets containing
650 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Oval, orange, film-coated tablets,
with the FROSST name engraved on one face
and 470 on the other and supplied in bottles of
100, 500 and 1,000.
No. 4 38—ENTROPHEN*-5 tablets containing
325 mg of acetylsalicylic acid USP, coated with
POLYMER 37*. Round, brown, film-coated tablets,
with the FROSST name engraved on one face
and 438 on the other and supplied in bottles of
100, 500 and 1,000.
FULL PRODUCT MONOGRAPH AVAILABLE
ON REQUEST.
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VOLUNTARY CONTRIBUTIONS

Unicameral Bone Cyst
K.S. M orton ,

A 28-year experience with 76
unicameral bone cysts is reviewed
and compared to other large series
and recommended treatments recorded
in the English literature. Particular
attention is paid to the importance
of recurrence in relation to the need
for secondary operations and in
contrast to the disability caused
by enforced restriction of activity.
Evidence is presented suggesting
that, in spite of residual radiologic
changes, the disability is frequently
insufficient to warrant a second
operation. Most unicameral bone
cysts probably run their own course,
not always greatly affected by
treatment, with very satisfactory
end results.
L’experience de 28 annees portant
sur 76 kystes osseux uniloculaires est
analysee et comparee aux autres
grandes series et aux traitements
recommandes dans la litterature de
langue anglaise. Une attention
particuliere est accordee a I'importance des recidives en rapport avec
la necessity de nouvelles operations
et en comparaison de I'incapacite
rencontree lorsqu'une restriction des
activites est imposee. Les constatations presentees indiquent qu'en
depit de changements radiologiques
residuels, I'incapacite est frequemment
insuffisante pour justifier une
deuxieme operation. La plupart des
kystes osseux uniloculaires se
resolvent probablement spontanement,
sans etre bien souvent affectes
par le traitement et avec un resultat
final fort satisfaisant.

From the division of orthopedics and
the Bone Tumour Registry, University
of British Columbia, Vancouver, BC
Accepted for publication Dec. 3, 1981
Reprint requests to: Dr. K.S. Morton,
Division of orthopedics, 2740 Heather
St., Vancouver, BC V5Z 3J4
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Unicameral bone cyst has been a
well-known but little understood en
tity since it emerged from a conglo
merate of cystic and fibrous lesions
of bone discussed by authors such as
Bloodgood1 and Elmslie.2 Jaffe and
Lichtenstein3 established the entity
more securely, but as recently as 1977
Cohen,4 in an excellent summary of
the subject, pointed out the continu
ing gaps in the knowledge of this
fairly common clinical problem, par
ticularly in the areas of pathogenesis
and treatment.
Cohen’s article prompted us to
examine our experience of 76 cases
of unicameral bone cyst registered
with the University of British Colum
bia Bone Tumour Registry over the 28year period from 1951 to 1978. It was
immediately apparent that no statis
tical analysis could be undertaken
because of the limitations Cohen de
scribed: the changing patterns of
management, the relatively small
numbers in relation to age of patient
and bone involved and, inevitably,
the inadequate follow-up information.
Nevertheless, certain observations
are valid and conclusions justified.

ment rather than our current prac
tice, for these patients were treated
over a period of almost three decades.
The most common procedure was
curettage and bone grafting (45 cases),
in earlier years with frozen bank bone
and often accompanied by cautery.

Patients

Our 76 patients (51 male, 25 female)
all had solitary lesions (Fig. 1). When
first seen they ranged in age (Table
I) from 2 to 57 years. The common
est age was 12 years and the majority
were within the first two decades of
life. The common sites were the upper
humerus (25 patients) and upper
femur (22 patients), but 8 cysts occur
red in the humeral shaft and 21 were
widely distributed in all bones but
the skull.
Of the 76 patients, 64 were treated
operatively; in 12 no operation was
carried out so a pathologic diagnosis
was not made. The type of operation
(Table II) reflects the timing of treat
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FIG. 1— Typical radiologic appear
ance of unicameral bone cyst of proximal
shaft of humerus in 14-year-old girl.

Table 1— Age D is trib u tio n of 76 Cases
of U nicam eral Bone Cyst

y

No. of
patients

0-10
11-20
21-30
31-40
>40

37
24
6
7
2

Age group,
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Later, autografts were used. The most
recent surgical procedure has been
subtotal, subperiosteal excision with
or without subperiosteal bone graft
ing (two cases).

these second operations were done in
the 1956 to 1967 period. Another pa
tient had two osteotomies for correc
tion of varus deformity from a cyst in
the trochanteric region of the femur.

Results

Shortening and Deformity

On the whole the results were satis
factory in that we have recognized no
disability, no loss of limb and no
associated malignant conditions. The
validity of this conclusion can be
judged in part by examination of our
follow-up figures (Table III), with on
ly 28 patients followed up for 4 years
or more and 37 patients followed up
for less than 2 years.

Three patients, all with cysts of the
upper humerus, demonstrated up to
5.1 cm of shortening of the involved
bone on follow-up 3 to 9 years after
pathologic fracture and operation.
Though angular deformity sometimes
occurred, usually in humeral cysts,
it did not persist and was not a com
plaint in any patients followed up for
4 years or longer. One patient
with a cyst in the trochanteric region
of the femur required osteotomy for
varus deformity on two occasions, at
the age of 6 and 7 years. Three years
later the cyst had healed and the*
result was described as satisfactory
though there was some valgus de
formity at the hip.

Fracture and Refracture
Forty-four of 76 patients presented
with a fracture through, into or near
the cyst. The fracture ranged from
a fine crack through thinned cortex
to, less often, comminuted and dis
placed fractures requiring treatment.
Eleven patients were known to have
suffered a second fracture; 1 of these
had three and another four fractures.
Reoperation
Six patients underwent two opera
tions. In all instances the initial pro
cedure was curettage and grafting with
banked bone. In three patients the sec
ond operation was the same while the
remaining three had autografts. All

Restricted Activity
Perhaps the greatest problem in
these patients is the sometimes lengthy
and possibly unnecessary period of
restricted activity because of fear of
pathologic fracture. We are con
vinced that any treatment that leads
to strengthening of the bone and
hence shortening of this period of
relative inactivity is to be recom
mended.
Discussion

T a b le I I — T y p e o f O p e r a tio n P e r fo r m e d in
64 C ases o f U n ic a m e r a l B o n e C y s t

In spite of our apparently good
results we are aware first that de
formity, particularly from injudicious
surgery, is a potential problem. This
is illustrated by the findings from one
patient too recent to include in the
current series. Curettings from a uni
cameral bone cyst of the ankle show

N o . of
p a tie n ts

O p e ra tio n
C u re tta g e
C u re tta g e and b a n k e d b o n e g r a ft
C u re tta g e a n d a u to g e n o u s g r a ft
S u b p e rio s te a l re s e c tio n
O th e r
N o t de s c rib e d

13
29
16
2
1
3

T a b le I I I — L e n g th o f F o llo w -u p in
76 C ases o f U n ic a m e r a l B o n e C y s t

F o llo w -u p , y r

°i
4-1

1 -2
2 -3
3 -4
4 -5
5-10
>10

No. of
p a tie n ts
23
5
9
10
1
8
15
5
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FIG. 2—Curettings from treated uni
cameral bone cyst showing organized
cartilage of epiphyseal plate (hematoxyliii
and eosin, reduced by 52% from X 125).

/

epiphyseal plate damage that is ex
pected to produce progressive growth
deformity (Fig. 2).
Neer and associates5 defined recur
rence of unicameral bone cyst as
“continuing expansion and thinning
of the cortex” requiring reoperation.
On this basis they reported failure
rates of initial curettage and grafting
as 30% in the upper humerus and
17% in the upper femur.
In another large series, Spence and
associates6,7 categorized any residual
cystic defect as a recurrence and
found that 64 (36% ) of 177 lesions
curetted and grafted with freeze-dried
cancellous bone allograft recurred
to the extent that reoperation was in
dicated. They also reported greater
difficulty with upper humeral lesions.
Follow-up ranged from 7 months to
13 years (mean 27 months). In their
later paper, reporting 144 lesions
curetted and grafted with freezedried crushed cortical bone allograft,
their overall recurrence rate was
25%; follow-up ranged from 1 to 4
years.
A different surgical approach was
reported by Fahey and O’Brien8 in
a small series of 20 patients, that of
subtotal resection and autologous or
homologous bone grafting. Using
strict criteria they had a recurrence
rate of 5% at an average follow-up
of 3.9 years. McKay and Nason9 ob
tained a comparable recurrence rate
(9%) in 21 patients treated by sub
total resection without grafting and
followed up for a similar period. In
both series some patients had had
previous surgical treatment.
In the 76 cases reported here, using
the criterion of reoperation as the
standard for recurrence, our rate was
8%. Clearly this rate would be much
higher if the criteria used by Spence
and associates,6,7 and by Fahey and
O’Brien8 were applied, but our series
is comparable to that of Neer and
associates.5
We believe the important feature in
judging results of treatment of uni
cameral bone cyst is the morbidity or
disability the individual patient ex
periences in relation to restriction of
his activities, not the roentgenographic
appearance following operative treat
ment and therefore not the “recur
rence rate”. If, in upper extremity or
lower extremity cysts, there is suffi
cient bone strength to permit unre
stricted childhood activities, then the
treatment has been successful whether
or not there is radiologic recurrence
or residual disease. If, on the other
hand, there is insufficient confidence

THE CANADIAN JOURNAL OF SURGERY

331

R e fe re n c e s

in the strength of the bone to allow
the patient reasonable activity, then
this may be the most valid crite
rion of failure and the best indication
for a second operation.
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As Cohen4 pointed out, no con
clusions are possible in a retrospective
review such as this. Our observations,
however, support the need for a
greater understanding of the natural
history of unicameral bone cyst,
whether it be untreated, affected by
fracture, treated surgically or, as
more recently reported, treated by
steroid injection.10

6. Spence KF jr . Bright RW, F itzgerald
SP, Sell K W : Solitary unicam eral bone

cyst: treatm ent with freeze-dried crushed
cortical-bone allograft. A review of one
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Oncocytoma of the Lung
M arco

A.

This report describes the clinical,
anatomical, histologic and
ultrastructural features of a bronchial
oncocytoma. Histologically the
oncocytes have granular eosinophilic
cytoplasm. Ultrastructurally this
corresponds to mitochondrial
hyperplasia. Because cytoplasmic
eosinophilia may be due to an
abundance of cytoplasmic organelles
other than mitochondria, it is
emphasized that electron-microscopic
study is an essential component in
the diagnosis of oncocytomas.
Cette communication decrit les
caracteristiques cliniques, anatomiques,
histologiques et d’ultrastructure
de I'oncocytome bronchique. Sur le
plan histologique, les oncocytes
possedent un cytoplasme granulaire
eosinophile. L’ultrastructure
correspond a celle d’une hyperplasie
mitochondriale. Comme I'eosinophilie

F e r n a n d e z , m d * and

J.

N y ssen , ba, ph D f

cytoplasmique peut etre due a une
abondance d'organelles cytoplasmiques
autres que les mitochondries, on
souligne I’importance de considerer
I’examen en microscopie electronique
comme une composante essentielle
du diagnostic des oncocytomes.

Oncocytoma is a rare variant of bron
chial adenoma and is characterized by
large cells in contrast to the small
cells of the more common carcinoid.
Seen under the electron microscope,
the eosinophilic cells of the oncocy
toma have cytoplasm filled with mito
chondria. This tum our may occur in
salivary, parathyroid and thyroid
glands. Only a few cases diagnosed
as bronchial oncocytoma fulfil the
criterion of mitochondrial hyperplasia.
We present a case of oncocytoma of
the lung confirmed by ultrastructural
studies.

ical examination was an enlarged
thyroid. It felt nodular but was smoothedged and enlarged, especially on the
right. There was no lymphadenopathy.
A chest roentgenogram demonstrated
a coin lesion, 3.5 cm in diameter, in
the basal segment of the lower lobe of
the right lung. Results of skin tests for
fungus were negative. A thyroid scan
showed many areas of reduced uptake,
suggesting a nodular goitre. Iodine-131
uptake indicated a euthyroid state.
Computerized axial tomography of
the thorax confirmed the presence of
a well-circumscribed mass in the pos
terior basal segment of the right lower
lobe (Fig. 1). Mediastinal nodes were
not enlarged.
On bronchoscopic examination a
cherry red tumour was found blocking
the medial division of the right lower
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Two weeks before admission to hos
pital this previously healthy 30-year-old
man had sudden onset of cough and
hemoptysis. He had recently been on a
diet and a program of strenuous exer
cise in order to lose weight. During the
previous 4 months he had lost 8 kg.
He had had two episodes of pneumonia
in the previous 2 years and had smoked
25 cigarettes daily for 10 years.
The only abnormality found on phys
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F IG . 1— C om puterized tom ogram of
thorax shows well-circumscribed mass
(arrow) which is in posterior basal seg
ment of right low er lobe.

THE CANADIAN JOURNAL OF SURGERY

bronchus. The lesion was quite friable
and bled easily. No biopsy specimen
was obtained. Because of the presence
of cold nodularity and the possibility
of an occult carcinoma of the thyroid,
surgical exploration of the thyroid was
carried out and multiple biopsy speci
mens were obtained that showed chronic
thyroiditis. One week after the thyroid
exploration, a right lower pulmonary
lobectomy was performed.
The gross specimen showed an oval,
pink tumour, 1.5 cm in maximum
dimension, projecting into the lumen
of the bronchus but also having an
extrabronchial component. Distal to the
tumour the bronchus was markedly

FIG. 2—Oval sessile tumour (small
arrow) partially occluding bronchus, and
diffuse dilatation (large arrow) distal to
lesion.

dilated forming a cylindrical cavity,
6 x 5 cm, that was filled with old
blood (Fig. 2).
Microscopically, the tumour was
composed of polyhedral cells with abun
dant granular eosinophilic cytoplasm.
Their nuclei were generally small and
vesicular but a few large pleomorphic
forms with finely distributed chromatin
were present. Mitoses were rare. The
cells tended to form solid nests sur
rounded and outlined by numerous
thin-walled blood vessels (Fig. 3). The
edge of the tumour was not obviously
infiltrative.
None of the lymph nodes contained
tumour. Some atelectasis of the paren
chyma around the dilated, chronically
inflamed bronchus was noted. Hemo
siderin-filled macrophages were promi
nent in that area. Silver stain by the
Fontana—Masson method revealed a
few argentaffin granules in some of the
tumour cells. For electron microscopy
the formalin-fixed tissue was sequentially
postfixed in 3 % cacodylate-buffered
glutaraldehyde and 2% osmium tetroxide and was stained with uranyl acetate
and lead citrate. Electron-microscopic
examination showed that the tumour
cells contained numerous mitochondria
and a few membrane-bound dense
bodies. The appearance was that of an
oncocytoma (Fig. 4).

very few of these cells are true
oncocytes. F or example, the eosino
philic granularity of ovarian hilar,
corpus luteal and testicular Leydig
cells is due to abundant endoplasmic
reticulum that fills the cytoplasm.3
The cells of the granular cell m yo
blastoma contain lysosomal-like bod
ies.4 The granularity of chemodectomas is due in large part to neuro
secretory granules.5
Mitochondrial hyperplasia is the
essential characteristic of oncocytes
of the salivary6 and parathyroid
glands,7 the H u rth le' cells of the
thyroid gland8 and the epithelial com 
ponent of W arthin’s tum our9 and this
explains the deep eosinophilia of the
cytoplasm seen with hematoxylin and
eosin staining.
The main criterion for the diag
nosis of the oncocytoma is m ito
chondrial hyperplasia. Fechner and
Bentinck10 first demonstrated this in
a bronchial oncocytoma. Our case
of bronchial oncocytoma confirms
this observation and re-emphasizes
the importance of the ultrastructural
appearance.

Discussion
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FIG. 3—Polyhedral cells with granu
lar eosinophilic cytoplasm. Nuclei are
small with finely-distributed chromatin
(hematoxylin and eosin, reduced by 45%
from X400).

FIG. 4—Electron-microscopic appear
ance showing marked mitochondrial hy
perplasia. Some membrane-bound dense
bodies (arrow) are also present (original
magnification X8000).
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Cholestatic Jaundice Caused by Sulindac
Y von G iroux , m d , c s p q , f r c p [c ],* M arcel M oreau , m d , c spq , FRCs[c]f
AND T.G . KASS, M D , M SC, CSPQ, FRCS[C]t

The authors describe a case of
cholestatic jaundice in a 66-year-old
woman that was caused by sulindac
(Clinoril). The diagnosis was confirmed
by challenging the patient with the
drug. Abdominal pain, nausea,
constipation, dizziness, somnolence,
vertigo, inhibited platelet activity
and hepatotoxicity have all been
described in association with
sulindac therapy, but this is the first
time, to the authors' knowledge,
that cholestatic jaundice has been
reported as a side-effect.
Les auteurs decrivent un ictere
cholestatique apparu chez une femme
de 66 ans et cause par le sulindac
(Clinoril). Le diagnostic fut confirme
par provocation de la patiente avec
le medicament. Douleurs abdominales,
nausee, constipation, etourdissements,
somnolence, vertige, inhibition de
I'activite plaquettaire et hepatotoxicite
ont tous deja ete decrits en rapport
avec le traitement au sulindac.
Toutefois, a la connaissance des
auteurs, c'est la premiere fois qu’un
ictere cholestatique est signale
comme effet secondaire de ce
medicament.

Sulindac, (z)-5-fTuoro-2-methyl-l-{ [p(methylsulfinyl)phenyl] methylene}-lHindene-3-acetic acid (Clinoril), is
an anti-inflammatory and analgesic
agent. Its exact mode of action is
unknown, but it appears to inhibit the
synthesis of prostaglandins. The max
imal clinical effect is observed 3
hours after intake.1 It is not a steroid,
and is derived from indene. Its bio
logical activity appears to be localized
in the sulfur containing moiety.
On absorption, sulindac is metab
olized in the liver, the reduction of
sulfoxide to sulfur raising the plasma
level of the active principle. Sulindac

A 66-year-old white woman under
went acromioclavicular arthroplasty on
May 14, 1979. When she was discharged
from the hospital, sulindac (Clinoril)
(200 mg bid) was prescribed for persist
ent pain. A few days after starting
treatment she became anorexic, nause
ated and feverish but did not seek med
ical advice. She was also taking isosorbide dinitrate (Isordil), nitroglycerin and
flurazepam hydrochloride (Dalmane) as
she had been for many years. She did
not drink alcohol.
On Sept. 1, 1979 she was admitted
for investigation of progressive jaundice

and pruritus. Sulindac was discontinued
at that time. The total serum bilirubin
was 6.9 mg/dl (118 p.mol/1) (mainly di
rect) (normal 0.2 to 1.4 mg/dl [3.42
to 23.9 u.mol/1]). There were no physical
signs of chronic liver disease. The
serum values of amylase, lipase and
creatine phosphokinase, and the hemo
gram and urinalysis findings were all
normal as were the blood urea, sugar
and electrolyte levels, the prothrombin
time, blood platelets, serum iron, iron
binding capacity and serum protein, and
the results of electrophoresis. Several
serum levels were elevated: glutamic
oxaloacetic transaminase was 211 U/ml
(normal 8 to 40 U/ml), glutamic pyruvic
transaminase was 328 U /m l (normal 9
to 35 U/ml), lactic dehydrogenase
was 198 U /m l (normal 109 to 193
U/ml) and alkaline phosphatase was
92 IU/1 (normal 9 to 35 IU/1). Ultra
sonography was thought to show gall
stones, so the patient was operated on.
The gallbladder appeared to be normal
and there were no gallstones. An intra
operative cholangiogram was normal
and the intrahepatic and extrahepatic bile
duct system was well visualized, so a
liver biopsy was done.
The biopsy specimen showed normal
architecture with well-oriented columns,
though some of the cells were irregu
larly shaped. The portal spaces were
normal. There were scattered areas of
infiltration by lymphocytes (no plasmacytes or polymorphs). No necrosis was
found and sinusoids were normal. There
were signs of bile stasis; biliary canals
were widely dilated and filled with bile,
mainly in the centrilobular area. Bile

FIG. 1— Biopsy specimen of liver
clearly shows well-oriented columns of
cells (hematoxylin and eosin, reduced by
52% from X200).

FIG. 2— Biopsy specimen shows bile
stasis with bile plugs (hematoxylin and
eosin, reduced by 54% from X 1200).

and its sulfur metabolite are bound to
serum albumin and excreted princi
pally by the kidneys, but also in the
bile and feces.
Sulindac is used by some in the
treatment of osteoarthritis, rheumatoid
polyarthritis, ankylosing spondylitis,
bursitis, tendinitis and gout (acute
phase).
Side-effects include abdominal pain,
nausea, constipation, dizziness, som
nolence, vertigo and inhibition of pla
telet activity.2 Hepatotoxicity3,4 has
been observed.
We present in this article what is,
to our knowledge, the first case of
cholestatic jaundice associated with
the use of this drug. The diagnosis
was confirmed by challenging the pa
tient with sulindac.
Case Report
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was also noted in Kupffer cells and
some hepatocytes (Figs. 1 and 2). There
was no cholangitis but, in some areas,
mild fibrosis was noted in the spaces
of Disse.
The patient was seen by a gastro
enterologist and the diagnosis of cho
lestatic jaundice, probably secondary to
sulindac, was made.
Fifteen days after the operation, the
total serum bilirubin value was 20.0
mg/dl (342 y.mol/1) (direct 15.4 mg/dl
[263 ij.mol/1]); the serum transaminase
levels were normal, as were the pro
thrombin and partial thromboplastin
times. The serum was negative for Aus
tralia antigen and the serum creatinine
value was normal. The alkaline phos
phatase value was elevated to 73 IU/1.
On Sept. 28, the patient was still
jaundiced (total bilirubin 16.4 mg/dl
[280 u.mol/1]; direct 12.6 mg/dl [215
u.mol/1]). Because of the persistent
cholestasis, she was given prednisone (20
mg/d). The alkaline phosphatase level
was 188 IU/1 and transaminase levels
were normal. There had been a slow
drop in bilirubin concentration before
the cortisone was given. Steroids were
discontinued on Dec. 5, 1979.
On Jan. 23, 1980, the results of liver
function tests were normal. The total
serum bilirubin level was 1.4 mg/dl (23.9
u.mol/1) (half direct). Serum alkaline
phosphatase and transaminase levels were
also normal.
With the patient’s consent, she was
challenged with sulindac to determine
if that had been the cause of the chole
static jaundice. On Mar. 5. 1980 she
started taking sulindac (2 tabs/d) for 1
week. On the third day she became
anorexic, nauseated, jaundiced and suf
fered pruritus. The total serum bilirubin
level rose to 3.2 mg/dl (54.7 ixmol/1)
(direct 2.2 mg/dl [37.6 u.mol/1]) and
alkaline phosphatase to 76 IU/1. The
serum transaminase levels were slightly
elevated.
The medication was discontinued for
humanitarian reasons and because it was
clear that sulindac was the cause of
the jaundice. The liver function test re
sults returned to normal after challenge.
Retrograde
cholangiopancreatography
showed that the pancreas, intrahepatic
and extrahepatic bile ducts, cystic duct
and gallbladder were all normal.

no gallstones were found. The patient
was not drinking alcohol. Postoperatively, the transaminase levels rapid
ly returned to normal and microscopic
examination of a liver biopsy speci
men showed no evidence of necrosis.
The challenge with sulindac in
duced a new elevation of serum bili
rubin, alkaline phosphatase and trans
aminase levels — supporting a chole
static more than a hepatotoxic action.
The mode of action of sulindac is
not well understood and the mecha
nism by which it produces cholestasis
remains to be elucidated. We cannot
conclude that the steroids helped in
the recovery because that could have
been the normal response to discon
tinuing the sulindac.
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NOTICES
Vascular Surgery
Vascular surgery will be the m ajor
topic of the 46th annual surgery
course sponsored by the department
of surgery of the University of M inne
sota Medical School. The course will
be held on June 14-16, 1982 at the
University of Minnesota. For further
information contact: Office of C on
tinuing Medical Education, University
of Minnesota Hospital Box 293, 420
Delaware St. SE, Minneapolis, MN
55455: (612) 373-8012.
Clinical Application
of Hyperbaric Oxygen
The 7th Annual Conference on the
Clinical Application of Hyperbaric
Oxygen is scheduled for June 9 to 11,
1982 at the Disneyland Hotel in A na
heim, California. Included in the con
ference will be plenary sessions on the
use of hyperbaric oxygen in neuro
logic disorders and anaerobic infec
tions. Original papers will be pre
sented and there will be workshops
and exhibits. F o r more information,
write: Baromedical department, M e
morial Hospital Medical Center, 2801
Atlantic Ave., Long Beach, CA 908011428, or call (213) 595-3613.
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Discussion
We have demonstrated that sulindac
can produce cholestasis similar to
that produced by phenylbutazone. To
our knowledge, this is the first case
reported
The patient (considering the ele
vated serum transaminase levels) may
have presented a degree of hepatotoxicity following ingestion of sulindac
but cholestasis was the primary mani
festation. This picture of cholestasis
persisted for 3 months. At operation
VOLUME 25, NO. 3, M A Y 1982

/

Dulcolax— A family laxative
Available in Tablets 5 mg
Suppositories 10 mg
Suppositories 5 mg for children
Micro-Enema 10 mg/5 ml
FULL PRESCRIBING INFORMATION AVAILABLE ON REQUEST

Boehringer Ingelheim (C anada) Ltd.
977 Century Drive. Burlington, Ontario L7L 5J8

THE CANADIAN JOURNAL OF SURGERY

335

Wemadethis
oneproduct
O n g u & n t t io m v r r o id a l A I 'h y d r o c o r t i a o n e

Hem orrhoidal Ointment with
W v rtro c o rt\ »o n «

thismuch
better
DIN 505773

Anusor-HC
◄

Anusol-HC
HEMORRHOIDAL PREPARATIONS
Ointments and Suppositories

im

Contains 0.5% Hydrocortisone
D IR E C T IO N S — Apply ointment
»n tis

NOW
non-staining,Ina
newpetrolatum
base.

u

Hen'*''""

Haity or s*s d\rected toy

Follow-up therapy without
hydrocortisone also available
in ANUSOL ointment or
suppositories.

1

«l

300

1

PARKE-DAVIS
Parke-Davis Canada Inc., Scarborough,Ontario
*Reg. T.M. Warner-Lambert Canada Inc.
Parke-Davis Canada Inc. auth. user.

PAAB
CCPP

Alkaline Reflux Gastritis:
Roux-en-Y Diversion is Effective
D aniel T asse, md , frcs[c],* Pierre Ghosn, md ,* M ichel G agnon, md , F R C P [ c ] , f F rancois M artin , md ,
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Evert though controversy persists
over the physiopathology of alkaline
reflux gastritis, Roux-en-Y diversion
is a well-accepted surgical treatment
and was used in 23 patients over
a 6-year period at the Hdpital St-Luc
in Montreal. Of the 23 patients, 21 had
complete relief of symptoms.
Objective criteria for the selection
of patients who would benefit from
operation are still to be defined. The
authors discuss the physiopathology
through an extensive review of the
literature.

normal in 15 o f 16 patients. E ndo
scopy demonstrated varying degrees
o f gastritis in all patients. Bile reflux
o f varying severity was also observed
in all patients; in 16 it was severe
with intense staining o f the gastric
mucosa.
The histologic findings in the antral
mucosa in primary reflux gastritis
were characterized by edema, conges
tion and a superficial inflammatory
infiltrate
(lymphoplasmacytic).
In
some there was a marked degree o f
diffuse interstitial fibrosis without evi
dence o f intestinal metaplasia or
glandular atrophy.
In secondary reflux gastritis there
was edema, congestion, nonspecific in
flammatory infiltration o f the lamina
propria with or without glandular
atrophy and intestinal metaplasia but
no interstitial fibrosis.
Eight o f the patients had an intact
pylorus, but only three had not had
previous gastrointestinal surgery. F if
teen patients had secondary bile gas
tritis, following various surgical p ro
cedures on the stomach (Table II).
The delay between the first operation
and the occurrence o f symptoms
ranged from 1 month to 14 years.
These patients had dumping syndrome
and one had chronic pancreatitis. All
patients had a trial o f medical ther
apy with various drugs, before opera
tion. A little relief o f short duration
was experienced in seven patients. In
most the symptoms were unchanged
and sometimes worsened by the med
ical regimen. The results obtained
with different medications are shown
in Table III.

to a chronic afferent loop obstruction
syndrome. T w o decades ago, a new
entity, “ alkaline reflux gastritis” , was
first noted.1,2 It has been further de
fined recently.3,4 Although its physio
pathology is not yet clearly under
stood, treatment by operative methods
has gained wide acceptance in the
literature.
The purpose o f this report is to
describe our experience with the sur
gical management o f this syndrome in
23 patients over the past 6 years.

Patients and Methods
Bien que la physiopathologie de la
gastrite alcaline soit encore
incompletement connue, la derivation
sur anse de Roux-en-Y donne
d'excellents resultats cliniques. L'objet
de cette publication est de rapporter
notre experience dans le traitement
chirurgical de cette condition chez
23 patients operes au cours des
6 dernieres annees. Une disparition
complete des symptomes est observee
dans 21 des cas. Des criteres
objectifs de selection des patients
candidats a une intervention
chirurgicale n'ont pas encore ete
definis. Les mecanismes physiopathologiques de cette entite sont etudies
a travers une revue extensive de
la litterature.

Epigastric pain and bilious vomiting
are distressing symptoms frequently
encountered after gastric surgery.
Until recently, these symptoms were
included in the postgastrectomy syn
dromes and were frequently attributed

From the departments of *surgery
and t medicine, Universite de Montreal,
Montreal, PQ; *section of digestive
surgery and t section of gastroenterology,
Hdpital St-Luc, Montreal
Presented at the annual meeting o f the
Association of General Surgeons of
Quebec, Quebec, PQ, May 7 and 8,
1981
Accepted for publication D ec. 22, 1981

From 1974 to 1980, 23 patients (14
men, 9 women) with the diagnosis o f
alkaline reflux gastritis were admitted
for operation. The mean age was 45.1
years (range from 23 to 89 years).
The diagnosis was based on symptoms
and radiologic, endoscopic and histo
logic findings.
The most frequent symptom was
burning epigastric pain, unrelated to
meals, that was found in 95.6% o f
the patients (Table I). The mean
weight loss was 10 kg. Roentgeno
grams after barium ingestion appeared

Table I—Symptoms in 23 Patients
with Alkaline Reflux Gastritis
Symptom
Pain
Bile vomiting
Diarrhea
Weight loss
Headache

%
95.6
91.2
39.1
30.0
26.0

Table II —Previous Operations
Primary gastritis
(n = 8)

1982

3

Cholecystectomy
Cholecystectomy and transduodenal
sphincteroplasty of Oddi

2

No previous operation

3

Parietal cell vagotomy
Vagotomy and antrectomy
Billroth 1
Billroth II
Vagotomy and pyloroplasty
Subtotal gastrectomy
Gastrojejunostomy
Esophagogastrectomy

Reprint requests to: Dr. Daniel Tasse,
Departement de chirurgie, Hopital
St-Luc, 1058, rue St-Denis, Montreal,
PQ H2X 314
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Secondary gastritis
(n = 15)

No.
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1
7
5
2
3
2
1
1
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At surgery, 22 of the 23 patients
had a Roux-en-Y diversion and one
patient had a previous gastrojejunos
tomy taken down and then a vagot
omy and pyloroplasty done. Additional
procedures are listed in Table IV.
There were no operative deaths. Two
patients were lost to follow-up, while
21 were examined regularly for a
mean period of 25.4 months (range
from 4 to 62 months).
Eighteen were completely asympto
matic. One patient was relieved of
pain and bilious vomiting, but still
had the preoperative manifestations
of a dumping syndrome and early
satiety. This was attributed to a “small
reservoir” following a previous sub
total gastrectomy. Two patients were
considered as failures, not because of
persistence of the same symptoms, but
because of emergence of new and dif
ferent complaints (diarrhea, parietal
pain) after the operation. Two pa
tients died in the follow-up period.
In the months following the opera
tion, three patients had stenosis at the
anastomosis; this had to be corrected
surgically. Five patients showed signs
of mild gastric stasis and did not re
quire another operation.
Discussion
Alkaline reflux gastritis is a recently
described syndrome that was previous
ly confused with the chronic afferent
loop syndrome. It is attributed to the
effect of the duodenal contents, pri
marily the biliary acids, on the gastric
mucosa.
The damaging effect of whole bile
on gastric mucosa was first noted by
Smith in 1914.5 Interest in this effect
was initiated in 1965 by Toye and
Williams® who demonstrated that bile
alone did not produce gastric mucosal
injury while diversion of duodenal
contents to the stomach produced pro
gressive atrophic gastritis. Byers and
Jordan7 did not find any inflamma
tory change in isolated gastric mucosa
explanted into the gallbladder. Menguy and Max8 and Delaney and co
workers5 noted the presence of gas

tritis when the gastric mucosa was
bathed in bile and kept in continuity
with the digestive tract. These changes
were even greater when the mucosa
was exposed to the whole intestinal
content.9
Delaney and colleagues10 reported
that jejunal contents produced inflam
matory changes in the gastric mucosa,
but the changes were mild when pure
bile or pure pancreatic juice was used.
Subsequently, the effect of biliary
acids on gastric mucosa was studied
extensively by Silen and Ritchie and
others.1118 The theory that a mucosal
barrier may be damaged by the biliary
acids or other components was pro
posed. The mucosal damage causes a
back-diffusion of H + ions into the
mucosa and this induces the gastritic
changes noted. The effect is more
severe in the presence of H + ions
and is maximum in the ischemic mu
cosa. Acute hemorrhagic gastritis can
develop in these circumstances.5'19’22
In spite of these extensive studies,
the pathophysiology of reflux gas
tritis is not clearly understood. Or
ganic compounds other than bile, such
as lysolecithin, have been incrimi
nated,23 but the responsible offending
agent has not been positively ident
ified.
Clinically the syndrome has been
described by Du Plessis,1,2 van Heerden and colleagues,3 Bushkin and col
leagues24 and Miranda and asso
ciates;25 it was clearly distinguished
from the chronic afferent loop syn
drome. Its characteristics are con
tinuous burning pain not relieved by
antacids and aggravated by meals.
Vomiting has little or no effect on
the pain. Vomiting occurs unpredictably and is not as projectile as in
the chronic afferent loop syndrome;
often the vomitus contains residuals
of previous meals.26 Some degree of
malnutrition is present, but is not as
severe as in the chronic afferent loop
syndrome. No diagnostic test is pa
thognomonic and the diagnosis re
mains one of exclusion. However, in
most cases, some degree of gastric
flaccidity exists and analysis of gastric

Table III— Results of Medical Treatment
Treatment
Antacids
Cholestyramine
Metoclopramide
Cimetidine
Diet only
Sucralfate
Propantheline

338

Improved

Worsened

Unchanged

7
2
4
4
3
0
0

2
0
2
2
0
2
0

10
5
9
7
4
0
1
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secretion demonstrates basal hypOchlorhydria and minimal response to
stimulation. A microcytic hypochro
mic anemia is usually present.
Endoscopic examination shows dif
fuse erythematous and friable mu
cosa that bleeds easily on contact.
Areas of superficial erosions and
atrophy are often present. Biliary re
flux is always noted in the stomach
and may be severe in some cases.
Biopsy specimens reveal a decrease
in number of the chief and parietal
cells, superficial erosions and atrophy
of the mucosa and an inflammatory
cell infiltration, predominantly of
lymphocytes, in the gastric glands.
Although this syndrome may be seen
in those who do not undergo opera
tion, it is usually encountered after a
surgical procedure on the stomach,
especially for duodenal ulcer. Its in
cidence is unknown, although it may
be as high as 20%.27,28 This does not
coincide with the incidence of gas
tritis alone, which is encountered in
64% to 95% of cases29 after opera
tion for duodenal ulcer. In a recent
study of 205 patients, 10 to 22 years
after gastric surgery, Malchow and
associates30 found severe chronic gas
tritis in 40 (32%) of 125 patients
after a Billroth I gastrectomy and in
28 (35%) of 80 patients after a Bill
roth II gastrectomy. Moderate changes
were seen in 23.2% and 26%, re
spectively, in these two groups of
patients. Loup and associates31 ob
served two cases (0.9%) of reflux gas
tritis in 248 patients following va
gotomy and pyloroplasty.
Conservative management of this
condition has been deceiving. Anta
cids and antisecretory drugs have no
effect on the symptoms. Cholestyra
mine was tried extensively, but little
benefit was obtained32 and it soon fell
into disuse. The effect of total paren
teral nutrition is incomplete and the
symptoms recur with the resumption
of oral alimentation.33

Table IV— Surgical Procedures Associated
with Roux-en-Y Diversion
Procedure

No.

Vagotomy and antrectomy
Revision of incomplete
vagotomy
Revision of incomplete
vagotomy and antrectomy
Revision of previous
gastrojejunostomy
Antrectomy
Antiperistaltic interposition
ofalO-cm segment*

11
2
3
3
1
2

•For associated severe dumping.
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The reported results of surgical
treatment have been conflicting. Some
authors found that relief was incom
plete.34,35 However, most reports claim
dramatic and nearly complete success
after diversion of duodenal contents.
Many techniques have been proposed:
Henley loop interposition,26 The Soupault operation,26 the Tanner 19 pro
cedure26 and simple dismantling of gas
troenterostomy. However, Roux-enY loop interposition of a 40- to 50-cm
segment of intestine is the most fre
quently used procedure and the one
that uniformly gives the best results.
The long-term success rate with this
operation varies between 65% and
100%.36-11 Our own results are simi
lar; 90.5% of our patients became
asymptomatic.
Finally, we were particularly sur
prised to find severe stenosis of the
gastrojejunal anastomosis in three pa
tients after a Roux-en-Y procedure
for alkaline reflux gastritis. These are
the only instances of stenotic anas
tomosis in almost 400 gastric opera
tions. This is due to the severe inflam
matory changes encountered in the
mucosa and submucosa of the stom
ach.
In conclusion, we have found that
diversion of duodenal contents using
a Roux-en-Y loop is a very satisfac
tory method of treating alkaline reflux
gastritis.
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BOOK R E V IE W S
continued from page 327
A substantial portion of the book is
devoted to peptic ulcer disease. There
is an excellent discussion on the natural
history of bleeding peptic ulcers. The
value of gastric lavage, antacids and
cimetidine in the management of bleed
ing ulcers may be over emphasized.
Surgical therapy is well discussed. The
chapter on the pathophysiology of erosive
gastritis and stress ulceration is infor
mative. There is mention of therapeu
tic endoscopy, and the principles in
volved in laser therapy and photocoa
gulation are well summarized. The
chapter on therapeutic angiography is
excellently illustrated. Portal hyperten
sion and bleeding varices are discussed
in detail, but the chapter on the use of
sclerotherapy is, on account of the
timing of this publication, not an up-todate “state of the art” review. “Miscel
laneous” causes of gastrointestinal bleed
ing are covered in the concluding por
tion.
This book would be an extremely
valuable addition to any medical library.
A.S.C.

S e k a r , m d , f r c p [c ]

Ste. 205
474 Holland Ave.,
Ottawa, Ont.
SURGERY OF THE AORTA AND ITS
BODY BRANCHES. Edited by John
N. Bergan and James S.T. Yao. 632
pp. IUust. Grune & Stratton, Inc.,
New York; Academic Press Canada
Limited, Don Mills, 1979. $56.25.
ISBN 0-8089-1240-2.

This volume represents the papers pre
sented at a symposium on surgery of
the aorta. The editors, well-known vas
cular surgeons from Northwestern Uni
versity Medical School in Chicago, have
organized the book well. Although there
are some areas of overlap because of
multiple authorship, the text is readable
and presents the information in an or
derly and informative fashion.
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STEMETIL®

Bon Mot
J.L. Shugar ,
The pressures of common usage
shape and change the quality of words.
Sometimes the changes are permanent.
New words are born, and eventually
their origins are forgotten or are not
apparent. Who knows whether “gold
bladder” or “very close veins” will
eventually stick. Does what seems to
be merely mispronunciation contain
a kernel of truth, as in “minipause” —
let it last just a short time, please —
or does the dropping of a syllable
really hide a forlorn hope of finding
an “anti-inflation pill”? A group of
patients can be “separated by sex” for
purposes of analysis but what if the
author of that study has them “sep
arated fo r sex”? Can investigators
carry out “an evaluation of several
regiments of breast cancer”? Saved
just in time, the March issue of this
journal almost had an article on “open
hearth surgery” — a cosy topic. How
can you contradict your patient when
she says that when she bends over,
everything “goes out of kilt”? Perhaps
it does. An elderly gentleman, who is

MD,

(prochlorperazine)

FRCSfc]

worried about atheromatous arteries,
asks to have his “serum castor oil”
level checked. Can you deny him?
Watch for changes in “Gray’s. Ana
tomy”, which will describe a new ana
tomical entity — “the elbone” and the
“appendic” for when only one is
meant. In the future, broken bones
will be fixed with “scrools”. The hurt
will be described by a colourful word
— “paint”. But watch out for pathol
ogy reports that say, according to an
O.R. nurse, “Dr. Armour, your pants
are pressed.” That’s enough to give
you a “migrant” headache.
Can you help me, especially you
over-60 types, clear up a mystery?
What is a wartime clamp?
My thanks to my mother, my pa
tients, David Woods, Peter Morgan,
Gillian Pancirov and Ph. d’Entremont
for their contributions.
“Bon Mot’’ will appear in the Journal
from time to time as material becomes
available. We earnestly solicit your con
tributions.

SESAP III Critique
ITEM 626
The possibility that this patient has a testicular tumor must be ruled
out. Baseline studies of chest roentgenograms, an intravenous pyelogram,
and levels of human chorionic gonadotropin (HCG) and a-fetoprotein
should be obtained. If the presence of a tumour is suspected, an inguinal
incision with orchiectomy should be done. Treatment with antibiotics is
not indicated unless pain and pyuria point to epididymitis. Needle biopsy
and scrotal incision are contraindicated because of the risk of local
dissemination of the tumour, which changes the route of metastases to
include the inguinal lymph nodes. The spermatic cord should be occluded
with a noncrushing clamp while the testis is being examined. If a tumor
is suspected on visualization and palpation, the orchiectomy should be
performed, but not a biopsy.

0
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monograph.
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Maquet Osteotomy for Chondromalacia Patellae:
Avoiding the Pitfalls
A . H a d jipa v lo u , m d , m sc , f r c s [ c ], FACS, H. H e l m y , m d , fr c s [c ], P. D ubravcik , m d , fr c s [c ],
L. H e l l e r , m d , fr c s [c ], facs and M. K e r n e r , m d , f r c s [c ]

The authors' modification of the
classic Maquet procedure of anterior
displacement of the tibial tubercle
allows effective decompression of
the patellofemoral joint. Strict
adherence to the modified technique
has prevented all major complications.
Forty-four patients underwent this
procedure. They were divided into a
retrospective group of 20 and a
prospective group of 24. Nine patients
in the prospective group had the
modified Maquet procedure following
a failed Hauser operation. All had an
excellent result due to decrease
in the patellofemoral compression
force. The modified Maquet procedure
was also valuable in those who had
an extensor lag following patellectomy
(two patients), failed proximal
realignment (three patients) and
failed patellar shaving procedures
(three patients).
Les modifications apportees par les
auteurs a I’operation classique de
Maquet par deplacement anterieur du
tubercule du tibia, permettent une
decompression efficace de I'articulation
femoro-patellaire. En s'en tenant de
fapon stricte a cette technique
modifiee, on a pu prevenir toutes les
complications majeures. Quarantequatre patients ont subi cette
intervention. Ils ont ete divises en
groupe retrospectif de 20 sujets et
en groupe prospectif de 24. Neuf
patients du groupe prospectif ont eu
I'operation modifiee de Maquet suite
a un echec de I’operation de Hauser.
Tous ont beneficie d'excellents
resultats grace a la diminution de la
force de compression de I’articulation
femoro-patellaire. L'operation modifiee
de Maquet s'est aussi revelee utile
chez les sujets presentant un
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retard d'extension a la suite d’une
patellectomie (deux patients), dans
les cas d'echec d’un realignement
proximal (trois patients), et lors de
I’echec d’une operation de planage
de la rotule (trois patients).

The treatment of patellar chondroma
lacia is one of the most controversial
issues in orthopedic surgery. The term
patellar chondromalacia implies dam
age to the articular cartilage resulting
in softening, Assuring or fragmenta
tion. The knee may be asymptomatic
or transiently symptomatic with crepi
tus and pain over its anterior aspect.1-4
When the symptoms become clinically
important or debilitating, conservative
management should be used before
surgical intervention.
Many surgical procedures have been
considered for correcting each of the
underlying causes of degeneration of
the patellofemoral joint. These include
the realignment procedures (prox
imal5,6 and distal7'9). Soft tissue lining
for patellar arthroplasty10 and excision
of the damaged articular cartilage
(shaving, chondrectomy,7,11-14 hemipatellectomy [Sullivan J: personal
communication] or patellectomy11,15'17)
have also been tried. More advanced
cases of joint degeneration have also
been treated by total replacement of
the patella by a prosthesis.18,19
Patellectomy may reduce pain at
the patellofemoral joint, but retention
of the patella is functionally superior
as it enhances the power and function
of the quadriceps mechanism.20 Never
theless, there are occasions when pa
tellectomy is necessary because of per
sistant pain. Maquet21 and Bandi22
have described displacement of the
tibial tubercle anteriorly to allow de
compression of the patellofemoral
joint, an attractive concept in view of
the poor results of other procedures.
Patients

We used the Maquet21 procedure in
44 patients between January 1976 and
February 1981. The patients ranged
in age from 18 to 60 years (mean 27.1
years). There were 20 men and 24
women divided into two groups. In
group 1 we carried out a retrospec
tive study of 20 consecutive pa
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tients (11 men, 9 women). Follow-up
ranged from 27 to 54 months (mean
35.3 months). Group 2 comprised
24 patients (9 men and 15 wom
en) studied prospectively. Follow-up
ranged from 6 to 26 months (mean
18.8 months).
The diagnosis of chondromalacia
was made by means of arthrotomy or
arthroscopic examination. The chondromalacic lesion in our series was
grade 3 or 4 according to the Outerbridge classification.23
Indications for Operation

The Maquet procedure was indi
cated for the following problems: (a)
chondromalacia due to chronic mal
alignment (25 patients), (b) severe
chondromalacia of the patella second
ary to trauma (12 patients), (c) osteo
arthritis of the patellofemoral joint
(5 patients) and (d) extensor lag fol
lowing patellectomy (2 patients).
Of the 25 patients with malalign
ment, 13 knees had failed to respond
to conservative therapy and 12 knees
to previous surgical realignment pro
cedures (three proximal and nine dis
tal Hauser realignments). Of the 12
patients with patellar chondromalacia
due to patellar trauma, conservative
therapy in 8 had failed, and in the
other 4, previous surgical procedures
(shaving in 3 patients, hemipatellectomy in 1) had failed.
Results

Criteria used to determine the re
sults of the procedure included: (a)
the degree of pain at the patello
femoral joint, (b) the range of motion
of the knee and (c) the functional
capacity of the knee with respect to
the activities of daily living (walking
stairs, running, sitting and kneeling).
Four groups emerged: no improve
ment, improvement, marked improve
ment and asymptomatic knee.
Patients with improved knees could
walk longer distances without pain
than before operation. The range of
motion was normal with mild pain on
walking up and down stairs or when
kneeling. There was increased pain
only when running.
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In patients rated as markedly im
proved, there was only occasional
pain and no disability when walking
and only infrequent mild pain after
long periods of fast walking, climbing
or descending stairs or running.
Asymptomatic patients had no pain
and could walk up and down stairs,
kneel and run and had a normal range
of motion of the knee.
Table I sets forth the results in the
two groups of patients. Patients with
extensor lag were markedly improved.
There were no cases of infection or
peroneal nerve palsy in the prospective
group.
Complications (Table II)

V-

*
t

►
►

4

The complications were attributed
to certain predictable difficulties and
compromised the overall results in
our retrospective group of patients.
Most of these complications arose
within the first 2 months after opera
tion. Of the three patients with nerve
palsy, two had completely recovered
at 6 months after operation and one
had partially recovered but had resid
ual causalgia. In one case of fracture
of the distal end of the osteotomized
bone, there was penetration of the
skin and osteomyelitis, which was
finally cured by sequestrectomy. Of
two other cases of osteomyelitis with
skin necrosis, one was cured, but in
the other the site was still draining at
the time of follow-up 32 months after
operation.

Although our technique closely re
sembles that of Maquet and Bandi,
strict adherence to certain minute de
tails previously ignored reduced con
siderably the number of complications
and improved the results in the sub
sequent 24 patients of the prospective
group.
Operative Technique in Prospective
Group
Tibial Osteotomy

The plane of the tibial osteotomy
is critical. At the proximal end the
osteotomy is in the coronal plane. At
about 6 cm distal to the tibial tubercle
the osteotomy changes its plane and
becomes parallel to the anteromedial
surface of the tibia (Fig. 1); it is flat
and pliable. The original osteotomy
resulted in a triangular cross-section
of bone at its distal segment and
therefore allowed a fracture to occur
more readily (Fig. 2). The shape of
the tongue of bone is flat and rec
tangular measuring approximately
10 X 1.5 X 0.5 cm (Fig. 3).

al side, has the appearance of a trunc
ated right triangle. The proximal end
or short side is 1.5 cm to 2 cm thick
and tapers distally to 0.8 cm to 1 cm.
The longer side measures 5 cm to
6 cm lying flat against the osteotom
ized surface of the tibial diaphysis.
The hypotenuse lies flat under the
raised tongue of bone; the distal gap
is packed with cancellous bone. We
have maintained the anterior eleva
tion of 1.5 cm to 2 cm since we be
lieve, as shown by Burke (personal
communication, 1979) that decom
pression of the patellofemoral joint
occurs effectively with this amount
of displacement.
Incision

Two incisions are used (Fig. 6).
One is a long incision over the ante
romedial surface of the tibia, extend
ing from the level of the tibial tu
bercle to the middle third of the leg.
This allows the tibial tubercle to be

Bone Graft

The bone graft that supports the
anteriorly displaced tibial tubercle
(Fig. 3) is obtained from the bone
bank or the patient’s iliac crest (Figs.
4 and 5). It is important that the two
longer surfaces of the bone graft be
parallel to the two surfaces of the
tibial osteotomy within which the
graft is to be wedged. The shape of
the graft, when viewed from the later-
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FIG. 2—Plane of osteotomy of tibia.
(A) Incorrect triangular configuration.
(B) Triangular tongue of bone has no
elastic properties.
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FIG. 1—Plane of osteotomy of tibia.
(A) Correct plane of osteotomy with
large flat surface to prevent fracture of
elevated tongue of bone. (B) Flat cut is
more pliable than triangular cut.
/

F'lG. 3— Lateral view of osteotomized
and anteriorly displaced tibial tubercle
(a) before, (b) after.
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elevated. A large medial skin flap is
created by dissecting the deep sub
areolar space and the tibial crest is
not denuded from the overlying soft
tissues. A second lateral parapatellar
incision, 5 cm long, is made for ex
ploration of the knee joint; this allows
good visualization of the joint and
bypasses the infrapatellar branch of
the saphenous nerve, thus avoiding
damage that could result in formation
of a neuroma. The lateral retinaculum
is released under direct vision and the
genicular artery is ligated. Through
a lateral incision, the fascia of the
anterior compartment can be released
with a straight Smillie meniscectomy
knife. Care must be taken not to
denude the tibial crest.
Discussion
By strict attention to details, the re
sults in our series of patients were
markedly improved in those studied
prospectively, by preventing trouble
some technical complications.
• Skin necrosis can be eliminated
by using a long anteromedial inci
sion of the subcutaneous tibial sur
face. This contributed to better skin

closure without tension after the tibial
tubercle was elevated, even to the
extent of 2.5 cm.
• Two patients in our retrospec
tive series had a troublesome neuro
ma of the infrapatellar branch of the
saphenous nerve. The infrapatellar
nerve crosses the medial aspect of the
knee joint only slightly distal to the
medial joint line. Damage to this nerve
may be avoided by using a lateral
parapatellar incision for the knee ex
ploration and by beginning the long
anteromedial skin incision at the level
of the tibial tubercle.
• Through the lateral parapatellar
incision, the lateral retinaculum of the
knee joint can be released, thereby
preventing the tethering effect of the
knee joint capsule on the patella
(Fig. 7).
• Postoperative hematoma and
hemiarthrosis may be averted by tour
niquet release before closing the
wound and by ligating the lateral in
ferior genicular artery if severed. Hemovac drainage is used.
• The three instances of peroneal
nerve palsy in the retrospective group
were attributed to excessive traction
on, and displacement of, the anterior
fascia of the leg caused by the ante
rior displacement of the tibial tubercle
(Fig. 8). In one case, the common

peroneal nerve was found to be dis
placed anteriorly and angulated when
explored. One can prevent this com
plication by releasing the lateral
fascia; this may also prevent anterior
compartment syndrome.14 Fig. 9 shows
the path of the common peroneal
nerve. The proximal cut shows the
nerve at the posterolateral surface of
the head of the fibula between fascia
and bone. The middle cut shows the
nerve anterior to the neck of the fib
ula and the distal cut shows the nerve
remaining anterior to the proximal
shaft of the fibula. In the middle and
distal cuts the nerve is not lying be
tween fascia and bone.
The suggested shape of the bone
graft and osteotomy of the tibia allow
a good total contact, a snug fit and
no pivoting of the graft when it is
wedged between the anteriorly dis
placed tongue and the remaining tibia.
No transfixion screw is necessary. The
graft should extend to the bony at
tachment of the patellar tendon in
order to support the tongue fully and

FIG. 7—Release of lateral retinacu
lum prevents patellar tilt.

FIG. 4— Bone graft. (A) Graft for
proximal osteotomy area. (B) Cancellous
bone for distal portion of osteotomy site.

FIG. 5— Bone graft wedged into os
teotomy site.
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FIG. 6—Incisions. Dotted line shows
site of lateral retinaculum release
through lateral parapatellar incision.
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FIG. 8—Anterior displacement of ti
bial tubercle exerts excessive tension on
fascia (A) resulting in traction or com
pression of peroneal nerve against fibula
(B), or both.
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SO prevent it breaking when it receives
a direct blow from a fall. In the pros
pective study, lateral tilt of the patel
la occurred in one case because the
lateral release was not done at the
time of the original Maquet proce
dure. This was carried out later and
corrected. Although follow-up in some
cases in our retrospective group was
only 6 months, even this short fol
low-up demonstrated that there are
difficulties that can be prevented. The
complications in this group arose
within 1 to 2 months after operation
and the outcome of the procedure
was directly related to these compli
cations.
In the retrospective group, the use
of banked bone eliminated the need
for an iliac incision; there was ex
cellent incorporation of the graft.
All cases of distal and proximal re
alignment fell within the markedly
improved or asymptomatic group and
the shaving or hemipatellectomy cases
within the improved group.
The Maquet osteotomy is indicated
for patients with patellofemoral ar
thritis, chondromalacia of the patella
secondary to direct patellar trauma
and failed surgical intervention. We
also use it for severe patellar chon
dromalacia with only a mild malalign
ment that does not require tibial tu
bercle transplantation to correct the Q
angle.

We thank Mr. David Saxe, depart
ment of photography, Jewish General
Hospital and Miss Christine Lalonde,
Lady Davis Institute, for their work on
the illustrations and Carmela Iuculano
and Barbara Dubravcik for preparing the
manuscript.
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BOOK REVIEWS

continued from page 339
This book is divided into six sections.
The first section deals with evaluation
and investigation of patients being con
sidered for aortic surgery. It includes
a discussion on physiologic changes that
occur during aortic cross-clamping.
The second section deals with prin
ciples of surgery of the thoracic and
abdominal aorta, including some special
chapters on the types of bypass sys
tems used during thoracic aortic cross
clamping, “the small aorta syndrome”
and the problem of colonic ischemia
following surgery on the abdominal
aorta. There is excellent discussion on
the abdominal aortic aneurysm, from
the standpoint of elective and emergency
surgery of ruptured aneurysms.
Aortoiliac occlusive disease forms
the basis for the third section, which in
cludes a discussion on importance, extraanatomic bypasses and management of
aortocaval problems.
There follow sections on renal vas
cular hypertension and mesenteric
ischemia, and discussions of the roles
of percutaneous and iliac occlusive
disease.
The last section deals with special
problems in aortic surgery and con
siders such topics as splanchnic artery
aneurysms, surgery for infected aortic
grafts, spinal cord ischemia after aortic
surgery and aortoenteric fistulas.
This book provides an exhaustive out
line of the aorta and its surgical prob
lems. One would have hoped that some
of these areas would have been dealt
with in greater detail, but overall, this
book serves as a good guide to current
thoughts in the management of aortic
diseases and will be of value to students
of aortic disease, be they housestaff or
vascular surgeons.
E l l io t T. G elfa n d , m d , facs , f r c s [c ]
Assistant clinical professor,
Department of surgery,
University of Alberta,
Edmonton, Alta.
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Solu-Medrol

Surgery for Morbid Obesity

(methylprednisolone sodium succinate)
Action:

Solu-Medrol, like other corticosteroids, exerts its action
by its anti-inflammatory effect.
Indications and Clinical Uses:

Intravenous administration of Solu-Medrol is indicated
in situations in which a rapid and intense hormonal
effect is required.
Shock:

In severe shock adjunctive use of intravenous methyl
prednisolone sodium succinate (Solu-Medrol) may aid
in achieving hemodynamic restoration. Corticoid
therapy should not replace standard methods of
combating shock, but present evidence indicates that
concurrent use of large doses of corticoids with other
measures may improve survival rates. In particular,
large pharmacological doses of Solu-Medrol have been
proven useful in bacteremic or endotoxin shock,
hemorrhagic shock, traumatic shock, and cardiogenic
shock.
Contraindications:

Except when used for short-term or emergency therapy
as in acute sensitivity reactions, Solu-Medrol is
contraindicated in patients with arrested tuberculosis,
herpes simplex keratitis, acute psychoses, Cushing’s
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:

Existence of diabetes, osteoporosis, chronic psychoses,
active tuberculosis, renal insufficiency or predisposition
to thrombophlebitis requires that Solu-Medrol be
administered with extreme caution. In the presence of
infection, the causative organism must be brought
under control with appropriate anti-bacterials, or
therapy with Solu-Medrol should be discontinued.
While therapy with corticoids does not appear to be
contraindicated in pregnancy, caution is recommended,
particularly during the first trimester. Also, newborn
infants of mothers who received such therapy during
pregnancy should be observed for signs of hypoadrenalism and appropriate measures instituted if such
signs are present. Since Medrol, like prednisolone, sup
presses endogenous adrenocortical activity, it is highly
important that the patient receiving Solu-Medrol be
under careful observation, not only during the course
of treatment but for some time after treatment is
terminated. Adequate adrenocortical supportive
therapy including ACTH, must be employed promptly
if the patient is subjected to any unusual stress such as
surgery, trauma, or severe infection. Patients should be
advised to inform subsequent physicians of the prior
use of Solu-Medrol.
There have been a few reports of cardiovascular
collapse associated with the rapid intravenous admini
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause
and relation to other medications (i.e., diuretics) is not
known at this time, but physicians should be alert to
this possibility.

Adverse reactions are not likely to result from short
term intravenous administration of Solu-Medrol, but
may be anticipated if continued therapy with oral or
intra-muscular corticosteroid preparations is to follow.
Medrol has less tendency than prednisolone to induce
retention of sodium and water, and in some cases has
been observed to produce diuresis and an increased
excretion of sodium. Likewise, therapy with Medrol
appears to produce less nervousness and psychic
stimulation than that produced by prednisolone. While
epigastric distress has not been totally lacking in
patients receiving Medrol, the incidence and severity of
this side reaction to date suggest that although Medrol
has an enhanced anti-inflammatory potency when com
pared with prednisolone on a weight basis, the socalled ulcerogenic potential of this corticosteroid is no
greater, and may even be less, than that of
prednisolone.
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Symptoms and Treatment of Overdosage:

Single large doses of Solu-Medrol do not have any
apparent toxic effect and require no specific therapy.
Continuous overdosage would require careful gradual
reduction of dosage in order to prevent the occurrence
of acute adrenal insufficiency.
Dosage and Administration:

In treating severe shock there is a tendency in current
medical practice to use massive (pharmacological)
doses of corticosteroids. The following are Solu-Medrol
doses suggested by various authors:
Author

Dose

Repeat

Oaks
Weil
Melby
Cavanagh
Dietzman

100 mg
200 mg
250 mg
15 mg/kg
30 mg/kg

Every 2-6 hours
100 mg. every 4-6 hours
Every 4-6 hours
Every 24 hours
In 4 hours if needed

Therapy is initiated by administering Solu-Medrol
intravenously over a period of at least 10 minutes. In
general high dose corticosteroid therapy should be
continued only until the patient’s condition has
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose
short term corticoid therapy are uncommon, peptic
ulceration may occur.
In other indications initial dosage will vary from 10 to
500 mg depending on the clinical problem being
treated. The larger doses may be required for short
term management of severe, acute conditions. The
initial dose usually should be given intravenously over
a period of at least 10 minutes. Subsequent doses may
be given intravenously or intramuscularly at intervals
dictated by the patient’s response and clinical
condition.
Availability:

As Solu-Medrol (methylprednisolone sodium succinate)
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials
with water for injection.
Product monograph is available on request.

Adverse Reactions:

With the exception of the differences noted in the
preceding paragraph, Medrol is similar to hydro

cortisone and prednisolone in regard to the kinds of
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To the editors.— The “editorial” of Free
man and Burchett on page 247 of this
issue requires comment. It does not ac
tually tell “where we are going” in the
surgery for morbid obesity. Indeed our
follow-up is comprehensive, with charts
of patients who undergo jejunoileal by
pass and gastric partitioning each having
separate drawers in our filing-cabinets,
and summarized in loose-leaf books. Preoperatively we explain to the patient that
lifelong medical surveillance is manda
tory. If patients do not keep appoint
ments, a letter is sent, followed by a
telephone call; some o f the patients who
had to be thus retrieved had the best
results.
One patient who had a jejunoileal by
pass has moved and is now under the
care of another surgeon well known in
this field. One underwent reversal else
where as stated in our paper and the
remaining 62 (not 61) jejunoileal bypass
patients are well and being followed up
by us. One patient who had gastric parti
tioning will not return for follow-up,
and we are only aware of her state
through her friends who have undergone
the procedure.
Our graphs are intended as a simple
means o f displaying the data: weight loss
is shown on the left, mean percent loss
in body weight on the right, with the im
portant standard deviation from the mean
and number of patients at each point of
follow-up being included. The follow-up
(in months), to the time the manuscript
was submitted, is shown on the bottom
o f the graphs, and is obviously not long
term in the gastric partitioning group. In
the jejunoileal bypass groups, with the
measurements and technique outlined in
the paper, more than 80% o f patients
maintain a weight loss greater than 25%
o f body weight, but 100% have weight
loss of more than 15% of body weight.
Surgeons who have never performed
jejunoileal bypass tend to decry this
procedure, and we have emphasized its
hazards, but Payne o f Los Angeles with
more than 20 years’ experience,1 Gourlay
of Vancouver with 535 intestinal bypass
patients over 9 years,1 and Buchwald2
after operating on 800 patients have all
found this to be an acceptable procedure.
Because the post-bypass course demands
the surgeon’s availability, many have
switched to gastric procedures. Serious
liver problems have been rare in non
alcoholics. One o f us (M.A.), together
with the two pathologists acknowledged
at the end of our paper, has continued
to follow-up the condition o f the livers
in these patients and this is the topic of
another paper. We have found the de
crease in stool frequency to agree with
that noted by MacLean in his review;3
diarrhea is rare in our patients after 18
continued on page 351
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Fate of Omental Graft after Revascularization
of the Heart
T o m a s A. S a l e r n o , m d , f r c s [c ],* R.O. W e s t , MD,f
R. B e v e r l y L y n n , m d , f c c p , f r c s ,
FRCS[C], FACS* AND EDWARD J.P. CHARRETTE, MD, FCCP, FACS, FACA, FRCS[C]*

Three patients who had had
epicardiectomy, and internal mammary
artery and omental grafts implanted
as part of myocardial revascularization,
recently underwent a second
operation for coronary artery bypass
grafting. All internal mammary
artery implants were patent and
appeared to revascularize the myo
cardium distal to the occluded
segment of the coronary artery, as
determined by angiography. Although
adhesions were present at operation,
there was no evidence of the free
omental graft in two patients. The
pedicled omental graft was present
and viable in the remaining patient,
but did not appear to have vascular
communication with the epicardiectomized myocardium.
Trois patients qui avaient eu une
epicardiectomie, avec une greffe
d'artere thoracique interne et greffe
epiploi'que comme moyen de revascu
larisation du myocarde, ont du subir
recemment une seconde operation,
soit un pontage aorto-coronarien. Les
greffes d'arteres thoraciques
internes etaient toutes permeables
et paraissaient, a i'angiographie, avoir
revascularise la partie du myocarde
distale au segment oblitere de I’artere
coronaire. Bien que des adherences
aient ete visibles a I’operation, chez
deux patients il n'y avait aucun indice
de permeabilite des greffes epiploiques.
Chez le troisieme patient le pedicule
de la greffe epiploi'que etait present
et viable, mais ne semblait pas avoir
de communication vasculaire avec le
myocarde epicardiectomise.

placed in patients who had had in
ternal mammary artery implantation,
epicardiectomy and omental grafting
and who underwent coronary artery
bypass grafting because of recurrent
angina.
Case Reports

Case 1
A 60-year-old man had undergone
left internal mammary artery implanta
tion, epicardiectomy and free omental
grafting 8 years before admission. He
presented with incapacitating angina.
Coronary angiography revealed severe
triple-vessel coronary artery disease and
a patent internal mammary artery im
plant without the formation of colla
teral vessels via the free omental graft
(Fig. 1). At operation, adhesions were
found between the pericardium and the
epicardium without visual and micro
scopic evidence of the presence of the
omental graft. Triple-vessel coronary
artery bypass grafting was performed;
recovery was smooth.

f r c s ( e d in ),

operative findings were similar to those
in case 1.
Case 3
Ten years before admission, a 63year-old farmer had undergone left in
ternal mammary artery implantation,
epicardiectomy and pedicled omental
grafting. He presented with angina re
fractory to medical therapy. Coronary
angiographic examination revealed triplevessel coronary artery disease and a
patent internal mammary artery implant.
There was no evidence of collateral
circulation by way of the omental graft
(Fig. 3). At operation, the pedicled
omental graft was found to be viable.
It occupied a large space in the postero
lateral and inferior pericardial sac. The
graft was easily peeled away from the
epicardium. Through-and-through left
ventricular myocardial biopsy was per
formed in an area where the omental

Case 2
A 64-year-old man had had right and
left internal mammary artery implants,
epicardiectomy and free omental graft
ing 9 Vi years previously. On admis
sion he was suffering from unstable
angina. Cardiac catheterization re
vealed triple-vessel coronary artery dis
ease. Both internal mammary artery im
plants were patent but there was no
evidence of collateral circulation through
the free omental graft (Fig. 2). The

FIG. 2— Case 2. Coronary angiogram
shows no evidence of collateral circula
tion between heart and omental grafts.

The objective of this paper is to re
port the findings at reoperation of
the fate of the omental graft
From the departments of *surgery and
t medicine (cardiology), Queen’s
University, Kingston, Ont.
Supported by Ontario Heart
Foundation grant 2-4
Accepted for publication Dec. 21, 1981
FIG. 1—Case 1. Coronary angio
gram gives no evidence of collateral
circulation between heart and omental
grafts.
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Department of surgery, Royal Victoria
Hospital, 687 Pine Ave. W, Montreal,
PQ H3A 1A1
VOLUME 25, NO. 3, M A Y 1982

/

FIG. 3— Case 3. Coronary angiogram
gives no evidence of collateral circula
tion between heart and omental grafts.
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graft was intact and appeared to com
municate with the epicardium. Micro
scopic examination revealed no evidence
of increased collateral circulation or
communication with the omental graft.
After triple-vessel coronary artery by
pass grafting the patient made an uncom
plicated recovery.
Discussion
O’Shaugnessy1 in 1936 first used
the greater omentum attached to its
abdominal blood supply to revascu
larize the ischemic myocardium. This
was followed by extensive work by
Vineberg and associates2-4 on the free
omental graft as an adjunct to myo
cardial revascularization with the in
ternal mammary artery implant. Using
the dog as the model, Vineberg and
his coworkers5’6 demonstrated that in
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the ameroid constricted coronary ar
tery, collaterals developed between
the ischemic epicardiectomized heart,
the free omental graft and the sur
rounding tissues. Free omental strips
were successfully implanted into the
walls of both ventricles in animals.'
Vineberg and associates,5 in an adden
dum to their manuscript, reported
that the implanted omentum would
fill with dye when either coronary
artery was injected in a patient who
died 18 months after operation.
For whatever reasons, coronary ar
tery bypass grafting has recently
gained popularity in the treatment of
ischemic heart disease, whereas the
free and pedicled omental grafting,
epicardiectomy and the internal mam
mary artery implantation are infre
quently used. Yet several clinical
reports8'10 attest to the efficacy of in
ternal mammary artery implantation
in revascularizing the human heart.
Similarly, epicardiectomy and free
omental grafting have been shown to
increase collateral flow in the ischemic
hearts of dogs; collateral channels and
viable omental grafts have been dem
onstrated at 6 months after opera
tion."
Little is known about the fate of
the omental graft in the human heart,
the degree of vascularity created by
epicardiectomy and omental grafting,
and the technical difficulties that
might be encountered if coronary ar
tery bypass grafting is contemplated
in such patients. The omentum was
not apparent in both patients who had
received a free omental graft, as de
termined by lack of collateral flow
at angiography, lack of bleeding dur
ing operation and by light microscopy
of the myocardial biopsy specimen.
The pedicled omental graft, on the
other hand, was found to be present
and viable at time of operation, oc
cupying a large space in the opened
pericardium. It was peeled away from
the epicardium without difficulty and
the myocardial biopsy specimen did
not show invasion of the epicardium
by omental vessels, nor was there
evidence of increased vascularity. By
light microscopic examination the
epicardial layer of these three hearts
could not be distinguished from an
other heart that did not have epicar
diectomy or omental grafting. In all
three patients the internal mammary
artery implants were carefully pre
served.12 The bypass surgery was per
formed without technical difficulties.
One should be cautious in drawing
conclusions based on three patients,
when animal work would appear to
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support the concept of omental graft
ing in addition to internal mammary
artery implantation and epicardiec
tomy. The difference between our
patients and the animal model could
be due to species differences or tech
niques of surgery, or both. That these
patients had internal mammary ar
tery implantation, epicardiectomy and
omental grafting did not preclude
subsequent coronary artery bypass
grafting. The technical aspects of the
procedure did not differ from routine
bypass grafting reoperations, except
that the internal mammary artery had
to be snared during cardioplegic
arrest12 in order to prevent noncoro
nary collateral flow from washing off
the cardioplegic solution. Also, the in
ternal mammary artery is a valuable
source of blood in these ischemic
hearts and care must be taken to
preserve it.
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continued from page 348
months; then it occurs only after exces
sively greasy meals. Freeman and Bur
chett do not give the reference for diar
rhea persisting after 1 year in 20% and
being the main cause for reversal. They
give no references for any of their state
ments.
For gastric partitioning we did not use
the technique of Pace, but chose our
outlet on the greater curvature side,
where future procedures would be more
accessible. The first 56 patients who did
not have reinforcement of the outlet are
not all failures; the data and standard
deviations indicate that adequate weight
loss occurred in a proportion. The “nonreinforced” group of 56 patients continue
to show weight loss that is greater than
25% in 18 patients, with a maximum loss
in body weight at 36 months of 36%;
weight loss is greater than 20% in 25
of the 56 patients and greater than 15%
in 28, which we regard as unacceptable.
As noted in the paper, four patients
returned to their preoperative weight.
However, we are suspicious that many
of the “non-reinforced” patients who
have lost significant amounts of weight
have been able to maintain this through
their own effort after an initial substan
tial weight loss. The reoperation to re
inforce the outlet is usually not a major
undertaking.
We agree that the circumferential im
bricating suture “does not guarantee per
fect results”. However, in the recent
report by Gomez,4 published 2 months
after we submitted our manuscript, using
the identical technique, there was a mean
weight loss of 32% at 12 and 18 months,
and 33 % at 24 months. He had only one
postoperative death in approximately 200
patients (0.5%), from cardiac cause.4 The
patients with outlet reinforcement con
tinue to vomit if they attempt to overeat.
Patient compliance is directly related to
the time in explanation that anyone who
undertakes this surgery must spend with
the patient.
Freeman and Burchett do not give a
reference for the 4% mortality with re
operation, and do not indicate if this is
a personal experience.
A properly reinforced stoma should
not enlarge, unless the suture is broken.
We do not concur that a patient spitting
up saliva and feeding via a jejunostomy
for 6 months or longer is acceptable;
moreover, a stricture may become tight
er. We suggest that dilatation by a Gruntzig balloon catheter inserted through a
pediatric gastroscope be attempted. Re
operation in our experience may be
simple or arduous. We disagree that fail
ures are those who have lost more than
15% of their initial weight. We believe
that loss of less than 25% of body
weight should be regarded as a failure.
If Freeman and Burchett’s 15% is used,
50% of our patients with “unreinforced”
partitions and 100% of those with “re
inforced” partitions have lost adequate
weight.
VOLUME 25, NO. 3, M A Y 1982
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In markedly obese patients who pre
sent at weight-loss clinics, sustained
weight loss has been reported in 2% at
2 years,5 and there is a high rate of
recidivism on long-term follow-up, with
an ultimate weight loss of less than 1%.6

2.
3.
4.

M . D e i t e i ., m d , f r c s [ c ]
M .A . B o j m , m d , f r c s [c ]
M .D . A t i n , b s c
G.S. Z a k h a r y , m d

5.

St. Joseph’s Health Centre,
Toronto, Ont.

6.
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particularly to drugs. If an allergic reaction to CLAFORAN occurs, the drug should be
discontinued and the patient treated with the usual agents (e.g. epinephrine,
antihistamine, pressor amines or corticosteroids).

PRECAUTIONS
Pregnancy: The safety of CLAFORAN (cefotaxime sodium) in pregnancy has not been
established. Consequently, use of the drug in pregnant women requires that the likely
benefit from the drug be weighed against the possible risk to the mother and fetus.
Nursing Mothers: CLAFORAN is excreted in human milk in low concentrations. Caution
should be exercised when the drug is administered to nursing mothers.
Pediatric Use: The safety and effectiveness of CLAFORAN in infants and children have
not yet been established. It has, however, been used in children at a dosage range o f
100-150 m g /kg /d a y in 2-4 divided doses.
Kidney : Although CLAFORAN rarely produces alterations in kidney function, evaluation
of renal status is recommended, especially in severely ill patients receiving high doses.
Patients w ith markedly impaired renal function should be placed on the special dosage
schedule recommended under DOSAGE AND ADMINISTRATION, because normal
doses in these individuals are likely to produce excessive serum concentration of the
metabolites.
Prolonged use o f CLAFORAN may result in the overgrowth of nonsusceptible
organisms. Constant observation of the patient's condition is essential. If superinfection
occurs, therapy should be discontinued and appropriate measures taken.
Positive direct Coomb's test is known to develop in individuals during treatment with
the cephalosporin group o f antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur w ith reducing
substances but not with the use of specific glucose oxydase methods.

ADVERSE REACTIONS

The most frequent adverse reactions encountered are:
Local (5%) - injection site inflammation with intravenous administration. Pain,
induration and tenderness after intramuscular injection.
Hypersensitivity (1.8%) - Rash, pruritus, fever.
Gastrointestinal (1.7%) - Colitis (not pseudomembranous), diarrhea, nausea, and
vomiting. A few cases of pseudomembranous colitis have been reported.
Hemic and Lymphatic System - Mild reversible leukopenia, granulocytopenia and
thrombocytopenia have been reported. Some patients developed positive direct
Coomb's test during treatment w ith CLAFORAN (cefotaxime sodium).
Genitourinary System - Moniliasis, vaginitis.
Central Nervous System (0.2%) - Headache.
Liver - Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline
phosphatase levels have been reported.
Kidney - Increased serum creatinine and BUN have occasionally been observed.

SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case o f overdosage has been reported to date with CLAFORAN, no specific
information on symptoms or treatment is available. Treatment o f overdosage should be
symptomatic.
DOSAGE AND ADMINISTRATION
CLAFORAN (cefotaxime sodium) may be administered intravenously or
intramuscularly after reconstitution (see table with recommended mode of
reconstitution according to route of administration). Dosage and route of administration
should be determined by susceptibility of the causative organisms, severity of the
infection and condition o f the patient.

USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
Daily Dost
(grams)

Type of Infection

Frequency end Route

Uncomplicated Gonorrhea

1

1 gram IM (single dose)

Uncomplicated infections
such as pneumococcal
pneumonia or acute urinary
tract infection

2

1 gram every 12 hours
IM or IV

Moderately severe
infections

3-4

1 gram every 6-8 hours
IM or IV

Severe infections

4-6

1 gram every 4-6 hours
IM or IV

Infections commonly
needing antibiotics in
higher dosage
(e.g., septicemia)

6-8

2 grams every 6-8 hours IV

Life-threatening infections

up to 12

a

2 grams every 4 hours IV

THE MAXIMUM DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 hours
after the patient defervesces or after evidence of bacterial eradication has been
obtained; a minimum of 10 days of treatment is recommended for infections caused by
Group A beta-hemolytic Streptococci in order to guard against the risk of rheumatic
fever or glomerulonephritis; frequent bacteriologic and clinical appraisal is necessary
during therapy of chronic urinary tract infections and may be required for several
months after therapy has been completed; persistent infections may require prolonged
treatment. Doses less than those recommended should not be employed.
DOSAGE FOR PATIENTS WITH IMPAIRED RENAL FUNCTION
In patients with estimated creatinine clearance o f less than 20 m l/m in/1.73m 2the dose
of CLAFORAN must be halved (see PRECAUTIONS). If serum creatinine values alone are
available, the following formula (based on sex, weight and age of the patient) may be
used to convert these values into creatinine clearance.
Males:

Weight (kg) x (140 - age)
72 x serum creatinine

Females:

0.85 x above value

RECONSTITUTION
The following table is provided as a guide for reconstituting CLAFORAN (cefotaxime
sodium) for both intramuscular and intravenous administration.
AMOUNT OF
APPROXIMATE
APPROXIMATE
DILUENT TO
AVERAGE
WTTHDRAWABLE
BE ADDED
CONCENTRATION
VOLUME
STRENGTH
(ml)
(mg/ml)
(ml)*
Intramuscular
500 mg vial
1 g vial
2 g vial

2
3
5

2.2
3.4
6.0

230
300
330

10
10
10

10.2
10.4
11.0

50
95
180

◄

i

Intravenous
500 mg vial
1 g vial
2 g vial

'Shake to dissolve.
Parenteral drug products should be inspected visually for particulate matter and
discoloration prior to administration. Solutions of CLAFORAN range from light yellow
to amber, depending on concentration and diluent used. The dry powder as well as
solutions tend to darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted only w ith Sterile Water for
Injection in accordance with the volumes recommended in the preceding table.
For intravenous bolus use: 500 mg, 1 gram and 2 gram vials should be reconstituted
with at least 10 ml of any of the solutions recommended under COMPATIBILITY/
STABILITY.
For intravenous infusion use: 1 or 2 grams of CLAFORAN may be reconstituted
w ith 50 or 100 ml of any of the solutions recommended under COMPATIBILITY/STABILITY.

V
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ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxime sodium) should be injected well within the body
of a relatively large muscle such as the upper outer quadrant of the buttock (i.e., gluteus
maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel.
Intravenous: The intravenous route is preferable for patients with bacteremia, bacterial
septicemia, or other severe or life-threatening infections, or for patients who may be
poor risks because of lowered resistance resulting from such debilitating conditions as
malnutrition, trauma, surgery, diabetes, heart failure, or malignancy, particularly if
shock is present or impending.
For bolus administration a solution containing 1 gram or 2 grams of CLAFORAN can be
injected over a period of three to five minutes. Using an infusion system, it may also be
given over a longer period of time through the tubing system by which the patient may
be receiving other intravenous solutions. Butterfly® or scalp vein type needles are
preferred for this type of infusion. However, during infusion of the solution containing
CLAFORAN, it is advisable to discontinue tem porarily the administration of other
solutions at the same site.

COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxime sodium) may be reconstituted with any of the following and
should be used freshly prepared:
Sterile Water for Injection
Sodium Chloride Injection B.P.
5% Dextrose Injection B.P.
Dextrose and Sodium Chloride Injection
Compound Sodium Lactate Injection B.P.
If a solution must be stored, only the solution prepared with Sterile Water for Injection
may be kept under refrigeration (below 5°C) fo r not longer than 24 hours. Any unused
solutions should be discarded.
CLAFORAN is compatible with 1% lignocaine. Only freshly prepared solutions should
be used. CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
A solution of 1 gram of CLAFORAN in 14 ml o f Sterile Water for Injection is isotonic.
Solutions of CLAFORAN must not be admixed w ith aminoglycoside solutions. If
CLAFORAN and aminoglycosides are to be administered to the same patient, they must
be administered separately and not as a mixed injection.

DOSAGE FORMS
CLAFORAN (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder, in
vials containing 500 mg, 1.0 gram and 2.0 grams of cefotaxime sodium (expressed as
acid on a dry basis).
CLAFORAN in the dry state should be stored at room temperature (below 30°C),
protected from light and heat. Solutions of CLAFORAN range from light yellow to
amber, depending on concentration and the diluent used. The solutions tend to darken
depending on storage conditions and should be protected from elevated temperatures
and excessive light.
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